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Abstract 
 
Recent years have witnessed a burst of studies in the rapidly developing field of “epitranscriptomics”, 
which encompasses post-transcriptional changes of transcripts that have a functional relevance. Several new 
experimental approaches coupled with high-throughput-sequencing enabled the transcriptome-wide mapping of 
various RNA modifications, including those that are guided by the well-characterized small nucleolar RNAs 
(snoRNAs). In the projects presented in this thesis, we have taken advantage of these new tools to comprehen-
sively examine snoRNA functions in various cellular systems as well as in a health/disease context.  
The first question that we set to answer is how complete is the catalog of human snoRNAs and snoRNA pro-
cessing products, since it is known that a variety of small RNAs derive from other RNAs with well-known func-
tions such as tRNAs and snoRNAs. To answer this question we sequenced long and short RNAs, RNA fragments 
obtained in photoreactive nucleotide-enhanced cross-linking and immunoprecipitation (PAR-CLIP) of core snoR-
NA-associated proteins and small RNAs that co-precipitate with the Argonaute 2 (Ago2) protein. A striking out-
come of this study was that virtually all C/D box snoRNAs are specifically processed inside the regions of terminal 
complementarity, retaining in the mature form only 4-5 nucleotides upstream of the C box and 2-5 nucleotides 
downstream of the D box. Further we found several new non-coding RNA targets that were repeatedly identified 
as bound by the core snoRNPs and that were validated as carrying 2’-O-methyl sites and/or pseudouridines. 
Analysis of the total and Ago2-associated populations of small RNAs in human cells revealed that despite their 
cellular abundance, snoRNA-derived small RNAs are not efficiently incorporated into the Ago2 protein. We 
therefore concluded that a miRNA-like function for these products in human is unlikely. 
Identification of the targets for the many newly discovered regulatory RNAs remains a challenge. To address this 
problem, in a second project, we combined two powerful experimental high-throughput methods (CLIP-seq and 
RiboMeth-seq) with computational modelling to map 2’-O-methylation sites in human rRNA and to comprehen-
sively associate C/D box guide snoRNAs with targets. We thereby determined that many “orphan” snoRNAs ap-
pear to guide 2’-O-ribose methylation at sites that are targeted by other snoRNAs. Moreover, we found that 
snoRNAs can be reliably captured in interaction with many mRNAs, yet a subsequent 2’-O-methylation of these 
mRNAs cannot be detected. Our study provides a reliable approach to the comprehensive characterization of 
snoRNA-target interactions in species beyond those in which these interactions have been traditionally studied 
and contributes to the rapidly developing field of “epitranscriptomics”. 
Finally, we applied the same approach to study a particular group of orphan snoRNAs that have been implicated 
in a rare neurodevelopmental disorder called Prader-Willi syndrome (PWS). PWS is characterized by excessive 
appetite, morbid obesity, mental and growth retardation, which are due to the loss of paternal expression of the 
maternally imprinted SNORD116 C/D box snoRNAs. snoRNP-CLIPs in mouse and human cell lines as well as 
mouse primary neurons revealed that SNORD116 snoRNAs associate with snoRNP proteins, yet the RiboMeth-
seq indicates that they do not have a primary snoRNP guide function. Nevertheless, the 2’-O-methylation land-
scape of wild-type mouse differs from that of a mouse model that does not express Snord116, and the identified 
candidate target sites are now subject to validation by mass spectrometry.  
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Chapter 1 Introduction 
 
With the start of the human genome project (HGP) in 1990 research in biology entered a new and 
very exciting era. The project was the world’s largest collaborative biological project [1, 2] having the goal 
of determining the sequence of base pairs that make up the Homo sapiens genome. The long-term purpose 
of this undertaking was to identify all the genes and their location in the genome, and to characterize their 
function in health and disease at an unprecedented level of detail. The HGP was successfully completed in 
early 2003 [1], providing the public with a high-quality version of the human genome sequence. This land-
mark event led to a paradigm shift in biomedical research and propelled it into the genomic and further 
into the post-genomic era, where we are today. Combining whole genome sequencing of multiple individu-
als with other information such as their medical history, the task of identifying genes responsible for dis-
eases, once requiring large research teams, many years of work, and immense financial spending can be 
accomplished today within a few weeks by a single graduate student with access to deoxyribonucleic acid 
samples and associated phenotypes, an internet connection to the public genome databases, a thermal 
cycler, and a sequencing machine.  
The implications of deciphering human and non-human genomes for biological and medical science are 
vast. Since all living organisms are related through evolution and store and process genetic information 
using the same molecules - deoxy ribonucleic acid (DNA) and ribonucleic acid (RNA) – powerful compara-
tive genomics approaches [3] enabled rapid functional elucidation of many newly identified genome-
encoded elements and a better understanding of how genetic networks and protein pathways contribute 
to cellular and organismal phenotypes. Analyzing the genetic makeup of increasing numbers of volunteers 
and patients progressively makes it possible to develop a detailed understanding of the heritable variation 
in the human genome [4-6]. Furthermore, genome studies particularly of model organisms such as yeast, 
worm, and mouse revealed many fundamental processes that are common to all living organisms, and at 
the same time opened the way for research directions that could translate into health benefits. Genes and 
pathways with a role in health and disease and their interactions with environmental factors can be identi-
fied more efficiently and studied in detail. The advent and progress of sequencing technologies facilitated 
the development of diagnostic methods for the prediction of susceptibility to disease, the prediction of 
drug response, the early detection of illness, and the accurate molecular classification of disease.  
Paradoxically, the more data has been generated, the more seems to be necessary to be able to interpret 
the results of large-scale experiments. It is easy to underestimate the challenge of understanding the be-
havior of molecular networks with thousands of components considering that the number of conditions in 
which the operation of these networks was observed was orders of magnitude smaller. Furthermore, alt-
hough sequencing technologies have become more efficient and affordable every year, the development of 
tools to analyze all of these data has lagged behind. It became more evident, if that were necessary, how 
important bioinformatics and computational biology are if one wants to take full advantage of these pio-
neering technologies and the richness of the generated data. On the other hand, the anticipation that all 
diseases would be fundamentally understood and would become more readily treatable once the genome 
was deciphered was curbed. Numerous human diseases are not monogenic but rather caused by the joint 
contribution of a number of independently acting or interacting genes and/or other non-genetic factors [7]. 
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In addition, the contribution of individual genes to a particular phenotype may be small or context-
dependent, making it very challenging to assign multifactorial diseases to a genetic locus in the DNA. None-
theless, more than a decade after the announcement of the successful completion of the HGP, the hard 
work of biologists, computational scientists, and clinicians has laid a solid foundation that is embodied in 
many knowledge bases that enable researchers to explore many systems of their interest, putting new re-
sults in the perspective of the vast amount of data that has been collected so far by researchers world-
wide.  
With the current tools at hand, this is a truly exciting time for researchers to immerse themselves into the 
world of genomics to further pursue open questions in various fields ranging from fundamental biological 
processes to mechanisms that contribute to health or disease in humans.  
Working together with interdisciplinary scientists at the interface between experimental biology and com-
putation provided me with an excellent environment to carry out research along these lines. With the work 
presented here I hope to contribute my grain of knowledge to the scientific community. 
 1.1 Regulation of gene expression 
All living organisms store and process their hereditary information using the same molecules, DNA and RNA 
[8]. The chemical building blocks of DNA and RNA are the nucleotides, each consisting of a sugar (deoxyri-
bose in DNA and ribose in RNA), a phosphate group, and a nitrogenous base. There are four different DNA 
nucleotides, each with a specific base: adenine (A), thymine (T), guanine (G), and cytosine (C). The chemical 
structure of the nucleotides is such that they pair with each other through hydrogen bonds, A pairing with 
T, and G with C. A and T, and G and C are called complementary nucleotides. When the nucleotides are 
strung together in a chain through phosphodiester bonds, they form a structure known as polynucleotide 
[8], which has a directionality, one end of the strand being called the 5’end, the other the 3’end. Comple-
mentary DNA polynucleotides coil around each other to form a double helix. A specific sequence of nucleo-
tides can make up a gene, the physical and functional unit of heredity that carries the information required 
for constructing RNA polymers in a process called transcription [9]. These RNA polymers can either serve as 
a template for the translation of proteins (in this case they are referred to as messenger RNA (mRNA)), or 
the RNA itself can be a functional entity itself, as is the case for ribosomal RNA (rRNA), spliceosomal RNA 
(snRNA), transfer RNA (tRNA), microRNAs (miRNAs), or small nucleolar RNAs (snoRNAs). The process of 
generating a functional effector molecule from a gene is referred to as gene expression. It is intriguing that 
all the cells of a eukaryotic multicellular organism such as the human carry the same genetic information, 
yet their phenotypes and functions can be highly distinct (e.g. neuron vs. muscle cell). This functional diver-
sity is achieved through different patterns of gene expression in different cell types. The different expres-
sion patterns in turn are brought about by a complex regulation of gene expression, which occurs at various 
steps of the process (DNA/chromatin level, transcription level, and post-transcriptional level) through vari-
ous mechanisms [8]. 
In the subsequent sections I will very briefly introduce the different layers of gene expression regulation 
and then particularly elaborate on post-transcriptional regulation with focus on the “epitranscriptome” and 
“snoRNA-mediated 2’-O-methylation”, since the work presented in this thesis relates to these mechanisms. 
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1.1.1 Chromatin accessibility controls gene expression 
In eukaryotic cells, the DNA is tightly folded and wrapped around histone proteins. One consequence of this 
packaging is that under normal circumstances, most of the DNA is not readily accessible to the RNA poly-
merase and Transcription Factors (TFs) [8]. Tightly folded and inaccessible DNA is referred to as hetero-
chromatin, whereas accessible DNA is referred to as euchromatin. Thus, by selectively changing the acces-
sibility of certain segments of the DNA to the transcription apparatus at specific times, eukaryotic cells can 
control gene expression simply by making DNA sequences sterically available to RNA polymerase binding 
[8]. The transition from “active” euchromatin to “silent” heterochromatin is regulated by histone modifica-
tion. Among numerous histone modifications, the methylation and acetylation of specific lysine residues on 
the N-terminal histone tails are the best studied and are fundamental for the formation of euchromatin and 
heterochromatin [10]. For example, the acquisition of active chromatin marks, such as the acetylation of 
H3K9 and the addition of two or three methyl groups to H3K4 (H3K4Me2/3), is associated with chromatin 
decondensation which distinguishes actively transcribed genes from other genes [11]. Repressed genes are 
characterized by marks such as H3K27Me3 [12], H3K9Me2/3 [13, 14], H4K20Me3 [15]. The DNA itself can 
be subject to modification that impacts the chromatin state, for instance CpG islands are often found to be 
methylated on the fifth residue of the cytosine base [16]. DNA methylation is essential for mammalian de-
velopment and DNA methylations are particularly frequent in the genome. The methylation state of CpG 
islands in promoters can impact the transcriptional activity of a gene [16]. A low level of CpG island methyl-
ation in promoters is associated with active transcription, whereas high methylation is associated with si-
lenced genes. Histone and DNA modifications are brought about by various chromatin-interacting proteins 
that can reversibly shape the transcriptional status of a gene locus, depending on the need of the cell [10, 
16]. 
 1.1.2 Transcriptional regulation of gene expression 
Another means by which cell fates and complex body plans are established is through TF-dependent, cell-
type-specific transcription regulation. Again in eukaryotes, the transcriptional control of gene expression is 
very complex and involves numerous TFs. Initiation of transcription includes the binding of RNA Polymerase 
II and general TFs to the core promoter,  a region of approximately 40 base pairs upstream and down-
stream of the transcription start site [17]. Transcription initiation is modulated by various cis-regulatory 
modules such as enhancers, which can be located up to 1’000’000 base pairs away from the transcription 
start site [17], and are bound by proteins to activate transcription. Repressor elements, also located up-
stream of transcription start sites, that bind repressor proteins to silence gene expression are also known 
[18]. It is estimated that the genome contains hundreds of thousands of such regulatory elements [19] that 
govern the gene expression. The activity of these regulatory elements can be restricted to a particular tis-
sue or cell type, a time point in life, or to specific physiological, pathological or environmental conditions. 
This is accomplished through a variety of mechanisms [17, 20]. 
 1.1.3 Post-transcriptional regulation of gene expression 
Once the gene product is produced through transcription, its stability, subcellular traffic and localization, as 
well as its interactions with other cellular components are influenced through numerous processes that are 
referred to as “post-transcriptional regulation”. They are briefly summarized in the following sections. 
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1.1.3.1 Splicing and alternative splicing 
Splicing of mRNA precursors (pre-mRNAs), the removal of introns and joining of the exons, is a crucial step 
in the expression of most genes in higher eukaryotes. Although often referred to as a post-transcriptional 
mechanism, splicing also occurs co-transcriptionally [21], being carried out by the spliceosome, a large 
structure consisting of five small nuclear ribonucleoprotein particles (snRNPs) and a large number of pro-
teins that cooperate to accurately recognize a splice site and to catalyze the splicing reaction[22]. The se-
quence of exons that that is spliced together may differ between cell types or conditions, leading to alter-
native splicing. Alternative splicing is an important mechanism for transcript and protein diversification in 
higher eukaryotes. The resulting proteins differ in their peptide sequence and hence in their chemical and 
biological activities [23]. Through alternative splicing many more proteins can be synthesized from the ge-
nome than would be expected from 20’000 protein-coding genes [24]. Interestingly, splicing requires the 
presence of five uridyl-rich snRNAs, namely U1, U2, U4, U5, and U6. snRNAs are closely associated with 6-
10 proteins each, and they base pair with the pre-mRNA in the spliceosome complex that contains approx-
imately 170 proteins [25]. 
 1.1.3.2 5’ Capping and polyadenylation 
All eukaryotic pre-mRNAs are modified at their two ends in the process of generating a mature mRNA. 
When an RNA is transcribed, the 5’ end of the nascent RNA chain that emerges from the surface of RNA 
polymerase is immediately targeted by several enzymes that together synthesize the 5’cap, a 7-
methylguanylate that is connected to the terminal nucleotide of the RNA [25]. The cap protects the mRNA 
from enzymatic degradation through 5’-exoribonucleases and is important for its export to the cytoplasm. 
In eukaryotes, all mRNAs except the histone mRNAs, have a 3’ poly(A) tail, which is added through a com-
plex mechanism that starts with the 3’-end cleavage. Essential for the reaction is a sequence called poly(A) 
signal, which is usually AAUAAA and is located 10-35 nucleotides upstream of the cleavage site (also called 
poly(A) site), where cleavage takes place. A multitude of proteins associating in the 3’-end processing com-
plex are involved in this process, of which the most generally involved are [25, 26]: the cleavage and poly-
adenylation specificity factor (CPSF), which first binds to and forms an unstable complex with the upstream 
poly(A) signal, the cleavage stimulatory factor (CStF), which interacts with a G/U-rich sequence typically 
located downstream of the cleavage site, and the cleavage factors I and II (CFI, CFII). Finally, poly(A) poly-
merase (PAP) binds to the complex before the cleavage can occur, in order that the free 3’ end generated 
after cleavage is rapidly polyadenylated and no essential information is lost to exonuclease degradation of 
an unprotected 3’ end. As soon as the synthesis of the poly(A) tail starts, poly(A)-binding protein (PABP) 
binds to the short A tail initially added by PAP, stimulating the further addition of A nucleotides. Once 200-
250 nucleotides are added, the poly(A) tail allows the mature mRNA to be exported from the nucleus. 
 
As discussed above, mature mRNAs must have their ends protected to avoid being degraded by nuclear 
exonucleases. Interestingly, these mechanisms can also be fine-tuned and impact the gene expression. 
Most genes typically have several poly(A) sites, leading to different isoforms of the gene product in a pro-
cess called alternative polyadenylation. The different isoforms can e.g. have 3’ untranslated regions (3’-
UTR) that differ in their length, where the shorter 3’-UTRs can be devoid of miRNA- or other RNP-binding 
sites and thus are associated with an altered protein output [26]. 
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1.1.3.3 MicroRNA regulation 
Once an mRNA is transported to the cytoplasm it is subject to several mechanisms that can control its sta-
bility and the efficiency of its translation to proteins. MiRNA-dependent regulation of translation is one of 
these mechanisms. It is a widespread post-transcriptional mechanism that can be found in all multicellular 
plants and animals. I deliberately provide only a short description of miRNAs, since miRNA-regulation is not 
the major focus of the work presented here. However, there are some parallels between miRNAs and other 
guide RNAs that I would like to emphasize. 
MiRNAs are short, non-coding RNAs, approximately 22 nucleotides long that regulate the expression of 
target mRNAs. Since their discovery, it has become clear that miRNAs are involved in numerous biological 
processes and they are essential for organism development [27]; e.g. several miRNAs have been demon-
strated to be crucial for development in Caenorhabditis elegans [28, 29] and in Danio rerio [30]. Because 
miRNAs are involved in the normal functioning of eukaryotic cells, it is not surprising that deregulation of 
miRNAs can result in disease. MiRNAs have been implicated in various diseases such as cancer and heart 
disease [31]. MiRNAs are transcribed from the genome, their primary transcripts folding into stem-loops 
that contain individual miRNAs. After passing through the miRNA biogenesis cascade (reviewed in [32]), 
one of the two strands of the resulting RNA duplex is loaded into a mature RNA-induced silencing complex 
(RISC). The single-stranded miRNA is bound by the multidomain Argonaute (Ago) protein which in many 
organisms has multiple homologues [25]. The miRNA-RISC complex then associates with target mRNAs by 
base pairing between the Ago-bound mature miRNA and complementary regions that are located predom-
inantly in the 3’-UTR of the mRNA. This leads to the repression of target expression. There has been much 
debate regarding the repression of the mRNA and its precise mechanism. It is now generally accepted that 
binding of the miRNA-RISC complex to its targets, at least in animals, leads to an initial translational inhibi-
tion, later followed by mRNA destabilization (reviewed in [33]). 
 1.1.3.3.1 MicroRNA target identification/prediction 
According to most recent estimations there are more than 6’000 miRNAs in the human genome, many of 
them only expressed in specific cell types [34]. Determining the function/targets of all these miRNAs has 
been a highly active area of research. The straightforward identification of miRNA targets has been ham-
pered by the fact, that in human and animals the degree of complementarity between mRNA and miRNAs 
is only partial, involving about 7-8 nucleotides at the 5’ end of the miRNA [35].Based on a developed bio-
physical model that takes into account additional interactions (other than the 2-7 seed) between miRNA 
and mRNA, our group has developed a tool to predict targets to improve and aid the identification of miR-
NA targets from cross-linking and immunoprecipitation (CLIP) data sets [36, 37], complementing other 
miRNA-target prediction tools [38-40]. 
CLIP experiments have been the state-of the art assay to capture both a guide RNA and its target from a 
ribonucleprotein complex [41, 42]. Because in humans and mice the main RISC effector is Arognaute 2 
(Ago2), numerous Ago2-CLIPs have been performed with the intent to identify miRNA and corresponding 
targets [43-46]. However, until very recently [47], these approaches did not simultaneously capture the 
miRNA and the target. The task of identifying the guide miRNA for a specific Ago2-CLIP site was solved 
computationally [36-40] until it has been noticed that Ago2-CLIP data sets lead to the capture of miRNA-
target interactions in the form of chimeric reads [47]. These are thought to form due to cellular enzymes 
ligating the guide RNA to its target RNA during CLIP [47-49]. The chimeras that form between miRNA and 
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target in Ago2-CLIP experiments were first used for the systematic discovery of unambiguous miRNA-target 
interactions in vivo [47].  
 1.1.4 The epitranscriptome 
In addition to the well-characterized post-transcriptional modifications that I outlined above, there are over 
100 distinct chemical modifications that can be catalyzed on RNA nucleotides post-synthesis [50], potential-
ly serving as yet another regulatory layer of gene expression. 
Long before the first genome was sequenced, various nucleotide modifications of DNA had already been 
described, such as 5-methylcytosine [51] and 5-hydroxyl-methylcytosine [52]. Presently, numerous DNA 
modifications have been reported [53] and together with histone modifications they constitute important 
regulatory mechanisms for controlling gene expression and function. The sum of all DNA and histone modi-
fications is often referred to as the “epigenome”. Characterizing DNA modifications has become relatively 
easy, since approaches like bisulfite sequencing have significantly contributed to decipher the epigenetic 
landscape, and large-scale projects such as the NIH Roadmap Epigenomics Mapping Consortium [54] or the 
BLUEPRINT Consortium [55] are well underway to produce a rich resource of human epigenomic data from 
various human tissues and organs.  
Likewise post-translational modifications of proteins, sometimes referred to as “epiproteome”[56], are 
well-recognized mechanisms necessary for the regulation of protein activity. Post-translational modification 
can occur on the amino acid side chains or at the protein’s termini. Phosphorylation for instance, is the 
most common post-translational modification and is essential for regulating the activity of enzymes [57]. It 
is estimated that there are over 200 post-translational modifications in human adding to the complexity of 
the proteome [58]. 
The regulatory layer that lies between DNA and proteins, called the “epitranscriptome”, is far less under-
stood. Only in recent years, the development of high throughput methods enabled the transcriptome-wide 
study of various nucleotide modifications. One of the most studied nucleotide modification is the methyl-6-
adenosine (m6A) which is found in thousands of mammalian genes [59, 60]. m6A was shown to be enriched 
in specific regions of mRNA, namely near the beginning of the 3’-UTR. Despite these advances in the map-
ping of m6A, the purpose and molecular function of m6A is still unknown. Several hypotheses were made 
(reviewed in [61]). The proposed functional implications of m6A are in protein recruitment, conformational 
change of RNA, effects on mRNA splicing, regulation of mRNA translation, and effects on mRNA expression 
and degradation. Initial mapping approaches localized m6A residues to transcript regions 100-200 nucleo-
tides-long and could not identify the precise m6A positions, which made it challenging to answer questions 
regarding the precise molecular mechanism of m6A. However very recent work demonstrated transcrip-
tome-wide single-nucleotide-resolution mapping of m6A [62]. This advancement is a bold example for the 
dynamics and the rapid technology development found in this highly active research area. Several other 
RNA modifications have been mapped in high throughput fashion and they include 5 methylcytosine [63], 
pseudouridine [64], and 2’-O-ribose methylation [65]. We took advantage of these emergent technologies, 
taking a recently developed high throughput assay called RiboMeth-seq [65], used to map snoRNA guided 
2’-O-ribose methylation (2’O-Me), to improve it (CHAPTER 3), and apply it to study 2’-O-Me’s and snoRNAs 
in a health and disease context (CHAPTER 5). 
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1.1.4.1 Small nucleolar RNAs guide RNA nucleotide modifications: Pseudouridylation and 2’-O-ribose methylation 
SnoRNAs belong to a large and abundant family of small non-coding RNAs crucial for ribosome biogenesis 
and snRNA function. SnoRNAs can be found in all eukaryotes as well as archaea and they form well-
characterized ribonucleoprotein complexes referred to as snoRNPs [66]. There are two main classes of 
snoRNAs, the box C/D and the box H/ACA snoRNAs, which differ in terms of their characteristic motifs, 
structure and in their protein binding preferences. C/D box snoRNPs (each snoRNA is complexed with four 
proteins; Fibrillarin, NOP56, NOP58, and 15.5K) guide and catalyze site-specific 2’-O-methylation of the RNA 
ribose (FIGURE 1.1 from [67]). H/ACA box snoRNPs (each snoRNA is complexed with Dyskerin, NHP2, GAR1, 
and NOP10) direct site-specific isomerization of the nucleoside uridine in a process called pseudouridyla-
tion (FIGURE 1.1) [68].  
 
Typical C/D box snoRNAs are between 60 
and 90 nucleotides in length and have 
characteristic conserved boxes C (consen-
sus sequence RUGAUGA) and D (consensus 
sequence CUGA) near their 5’ and 3’ ends, 
respectively (FIGURE 1.2) [69-71]. The C and 
D boxes align and fold into the so-called 
kink-turn motif, and the ends of the snoR-
NA form a double-stranded stem structure 
[72]. This structure at the end of the snoR-
NAs is essential for biogenesis and proper 
localization, serving as a binding site for 
core for box C/D snoRNP proteins [69, 72]. 
C/D box snoRNAs carry additional motifs, 
the boxes C’ and D’ which have the same 
consensus sequences as the boxes C and D, 
respectively, and are found in the central 
region of the molecule, but typically these 
motifs are less well conserved and often 
degenerate. The snoRNA guide regions with 
complementarity to the targets are located 
directly upstream from the boxes D’ and/or 
D. The target nucleotide that pairs with the fifth nucleotide of the snoRNA anti-sense sequence acquires 
the 2’-O-Me mark [69, 72]. As previously mentioned, 2’-O-methylation requires the C/D box snoRNA to 
associate with a set of four evolutionary proteins, Fibrillarin, NOP56, NOP58, and 15.5K. The enzymatic 
activity is mediated by the highly conserved RNA methyltransferase fibrillarin [73]. 
 
 
Figure 1.1 Schematic depiction of the two most abundant nucleotide modifications 
in rRNA and snRNA. Top: Pseudouridine is a rotational isomer of uridine, with one 
additional hydrogen bond donor (d), while the number of hydrogen bond acceptors 
(a) is unchanged. Bottom: Schematic representation of a 2’-O-methylated ribose.  
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Figure 1.2 Schematic representation of C/D box snoRNPs (left) and H/ACA box snoRNPS (right). Target RNA is depicted in red, modified nucleo-
tides are indicated by CH3 and Ψ for 2’-O-methylation and pseudouridylation, respectively. 
 
The longer H/ACA box snoRNAs, which range from 120 to 140 nucleotides in length, display a characteristic 
secondary structure consisting of two hairpins (FIGURE 1.2). The two hairpins are connected by a hinge re-
gion which is formed of the H box (ANANNA where N can be any nucleotide). Upstream of the 3’-end of the 
molecule and immediately downstream of the second hairpin there is a highly conserved ACA box [74]. The 
guide regions of the H/ACA box snoRNAs can be found in the middle of the hairpins, specifying by comple-
mentarity the exact position to be pseudouridylated in the target. The pseudouridine site in the target RNA 
is typically located 14-15 nucleotides upstream from the H or ACA box [72, 74]. The enzymatic activity of 
H/ACA snoRNPs is conferred by the pseudouridine synthase Dyskerin [68]. Both C/D box snoRNAs and 
H/ACA box snoRNAs can recognize up to two different substrates [74]. 
 1.1.4.2 Function of 2’-O-methylation and pseudouridylation 
rRNA and spliceosomal snRNAs are the canonical targets of snoRNAs and carry numerous 2’-O-methylations 
and pseudouridines [75, 76]. Over the last few decades, much effort has been directed at studying the 
mechanisms by which these modifications are introduced as well as their molecular functions. To date, 
progress has been most significant in the area regarding the introduction of these modifications, and recent 
advances including the efforts of our group (CHAPTER 3) have now enabled the transcriptome wide study of 
pseudouridines [64] and 2’-O-Me’s [65] and their H/ACA box and C/D box snoRNA guides, respectively. 
However, knowledge regarding the function of posttranscriptional modifications including 2’-O-Me’s and 
pseudouridines has lagged behind.  
Although snRNAs had been known to be extensively post-transcriptionally modified since their discovery, 
only in the 1990s their function became clear. Particularly studies performed on U2 and U6 snRNA shed 
light on the importance these nucleotide modifications. To this end, reconstitution systems were devel-
oped that involved the specific depletion of one of the endogenous spliceosomal snRNAs followed by sup-
plementation of that respective snRNA synthesized in vitro [77]. As in in vitro synthesized snRNAs lack mod-
ifications, the ability or the lack thereof of the RNA to reconstitute pre-mRNA splicing would indicate 
whether the modifications were required for pre-mRNA splicing. Summarizing, several studies using recon-
stitution systems, performed in yeast [77-79], Xenopus [80, 81], and HeLa cells [82], led to the conclusion 
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that post-transcriptional modifications of snRNAs are essential for proper pre-mRNA splicing. Particularly 
snRNP assembly is impaired when snRNAs are void of modifications [80]. 
rRNA is an integral component of the ribosome, and similar to snRNAs, it is subjected to extensive post-
transcriptional modifications, with 2’-O-methylation and pseudouridylation being the most common modi-
fications. Several lines of evidence suggest rRNA modifications are important for ribosome function. For 
instance, the analysis of a three-dimensional map obtained from Escherichia coli and S. cerevisiae ribo-
somes indicates the clustering of modifications in functionally important regions of the ribosome [83]. Even 
though it is difficult to elucidate the functions of individual modifications, since most deletions of any 
snoRNA alone result only in a minor phenotype [84], global deletions of 2’-O-methylation and pseudo-
uridylation through mutations in Nop1 [85] and  
Cbf5p (yeast homolog of Dyskerin) [86], respectively, resulted in significant growth defects and defects in 
ribosome assembly in S. cerevisiae.  
The data are clear that post-transcriptional modifications within the rRNA and snRNA are important for pre-
mRNA splicing and protein synthesis. The mechanisms behind how these modifications exert the effect are 
still not well understood. However, it is well-known that 2’-O-methylation and pseudouridylation differ in 
their chemical properties from their unmodified counterparts. These modifications can potentially impact 
various aspects of the RNA, including structure, thermal stability, and biochemical interactions. 
For 2’-O-Me’s several biophysical contributions to RNA were suggested: they may increase the stability of 
RNA conformations, alter the ability of the ribose to engage in hydrogen bonding, and may play a role in 
protecting the RNA from hydrolysis [87, 88]. Similarly, pseudouridylation seems to make the RNA more 
stable, alter/stabilize RNA conformation, and the base presents an extra hydrogen bond donor at the non-
Watson-Crick edge that may potentially alter the pairing of pseudouridine with other bases [89]. 
 1.1.4.3 Biogenesis of snoRNAs 
SnoRNAs are typically generated from the introns of other, host genes. Once the intron is spliced out from 
the pre-mRNA and disbranched, the snoRNAs are processed by exonucleolytic trimming. Since vertebrate 
introns are rapidly degraded immediately upon co-transcriptional removal, there are mechanisms in place 
to protect the snoRNA. This is achieved by binding of the box C/D and H/ACA snoRNP proteins to the in-
tron-embedded snoRNA sequences. This requires the snoRNP proteins to be actively recruited to the nas-
cent intronic snoRNAs during the synthesis or before splicing of the host pre-mRNA [90]. Occasionally, the 
spliced exons of the pre-mRNA are devoid of open reading frames, indicating that the sole function of the 
transcript may be the expression of the snoRNA [91]. As previously mentioned, the 5’ and 3’ ends of the 
snoRNA form a specific structure called the kink-turn motif, which confers stability to the snoRNA and is 
important for proper snoRNA biogenesis.  
To study snoRNA processing in more detail, we performed CLIP experiments on snoRNP components and 
extensively analyzed the 5’ end 3’ ends of the snoRNAs. Our findings are summarized in CHAPTER 2.  
 1.1.4.4 Alternative roles of snoRNAs 
Other than exerting their canonical functions that are 2’-O-methylation and pseudouridylation, snoRNAs 
are suspected to have alternative roles. For instance the snoRNAs of the SNORD115 cluster have been im-
plicated in the modulation of alternative splicing [92] and RNA editing [93]. Another interesting observation 
is the frequent generation of small, processed snoRNA fragments that, in isolated cases, have been demon-
strated to exhibit miRNA-like features by being actively loaded into RISC and down-regulating their specific 
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targets (reviewed in [94]). In CHAPTER 2 we also explore the possibility of a miRNA-like behavior of snoRNAs 
in human cells. To this end we have sequenced and analyzed Ago2-associated populations of small RNAs in 
HeLa cells.  
1.1.4.5 SnoRNA target identification 
Assigning snoRNAs to their target site has always presented a challenge. This is reflected in the snoRNA 
database [95], where several known rRNA modifications remain without any guide snoRNA. Conversely, 
many so-called orphan snoRNAs remain without a known target. As previously mentioned, guide/target 
identification has recently been facilitated through the observation that chimeras form between a guide 
RNA and its target in CLIP experiments. At the same time, it has become possible to map 2’-O-
methylations[65] and pseudouridines[64] in high throughput. In CHAPTER 3 we demonstrate an integrated 
approach that combines two powerful experimental methods (snoRNP CLIP-seq and RiboMeth-seq) with 
computational modelling to map 2’-O-methylation sites in human rRNA and to assign them the C/D box 
guide snoRNAs.  
In CHAPTER 4 we present a new high-throughput variant of the classical reverse-transcriptase-based method 
for identifying individual 2’-O-methyl modifications in RNAs that we termed RiM-seq. RiM-seq presents an 
additional high-throughput method to validate 2’-O-Me’s. 
1.1.4.6 SnoRNA and disease 
SnoRNAs have been implicated in several diseases. It has been known that defects in ribosome maturation 
and function can cause the disruption of vital processes and lead to diseases and transformation of healthy 
cells into cancer cells [96]. Therefore, it is plausible that snoRNA expression levels can affect the physiologi-
cal conditions of cells and tissues, since they are involved in the regulation of post-transcriptional modifica-
tion of rRNAs. Thus, snoRNA expression levels may be changed in disease or the change of snoRNA expres-
sion levels itself may influence emergence and progression of disease. Several snoRNAs have been shown 
to be increased or decreased in various cancers, suggesting that snoRNAs may exhibit oncogenic or tumor 
suppressor properties (reviewed in [97]). Further, the expression of snoRNAs seems to be perturbed in 
several other conditions such as in human cells during the antiviral response or in mammalian cells subject-
ed to stress or drugs, although their role in these responses has not been clearly established yet [97]. 
A very well-described disorder where snoRNAs are thought to play an important role is the neurodevelop-
mental disease Prader Willi Syndrome (PWS). The lack of paternal expression of maternally imprinted C/D 
box snoRNAs is believed to be the main cause of this disorder [98, 99]. In CHAPTER 5 we attempted to study 
these snoRNAs in more detail using a knockout mouse model void of these snoRNAs, mimicking the situa-
tion found in human PWS patients. 
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 2.1 Abstract 
Background 
In recent years, a variety of small RNAs derived from other RNAs with well-known functions such as tRNAs 
and snoRNAs, have been identified. The functional relevance of these RNAs is largely unknown. To gain 
insight into the complexity of snoRNA processing and the functional relevance of snoRNA-derived small 
RNAs, we sequence long and short RNAs, small RNAs that co-precipitate with the Argonaute 2 protein and 
RNA fragments obtained in photoreactive nucleotide-enhanced crosslinking and immunoprecipitation 
(PAR-CLIP) of core snoRNA-associated proteins. 
 
Results 
Analysis of these data sets reveals that many loci in the human genome reproducibly give rise to C/D box-
like snoRNAs, whose expression and evolutionary conservation are typically less pronounced relative to the 
snoRNAs that are currently cataloged. We further find that virtually all C/D box snoRNAs are specifically 
processed inside the regions of terminal complementarity, retaining in the mature form only 4-5 nucleo-
tides upstream of the C box and 2-5 nucleotides downstream of the D box. Sequencing of the total and 
Argonaute 2-associated populations of small RNAs reveals that despite their cellular abundance, C/D box-
derived small RNAs are not efficiently incorporated into the Ago2 protein. 
 
Conclusions 
We conclude that the human genome encodes a large number of snoRNAs that are processed along the 
canonical pathway and expressed at relatively low levels. Generation of snoRNA-derived processing prod-
ucts with alternative, particularly miRNA-like, functions appears to be uncommon. 
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2.2 Background 
Small nucleolar RNAs (snoRNAs) are a specific class of small non-protein coding RNAs that are best known 
for their function as guides of modifications (2'-O-methylation and pseudouridylation) of other non-protein 
coding RNAs such as ribosomal, small nuclear and transfer RNAs (rRNAs, snRNAs and tRNAs, respectively) 
[83, 100, 101]. Based on sequence and structural features, snoRNAs are divided into two classes. C/D box 
snoRNAs share the consensus C (RUGAUGA, R = A or G) and D (CUGA) box motifs, which are brought into 
close proximity by short regions of complementarity between the snoRNA 5' and 3' ends [102, 103] and are 
bound by the four core proteins of the small ribonucleoprotein complex (snoRNP), namely 15.5K, NOP56, 
NOP58 and Fibrillarin (FBL) [74, 104, 105] during snoRNA maturation. Fibrillarin is the methyltransferase 
that catalyzes the 2'-O-methylation of the ribose in target RNAs [85]. Most C/D box snoRNAs also contain 
additional conserved C' and D' motifs located in the central region of the snoRNA. The other class of snoR-
NAs is defined by a double-hairpin structure with two single-stranded H (ANANNA, N = A, C, G or U) and 
ACA box domains [106], and are therefore called H/ACA box snoRNAs. They associate with four conserved 
proteins, Dyskerin (DKC1), Nhp2, Nop10 and Gar1, to form snoRNPs that are functionally active in pseu-
douridylation. Although all four H/ACA proteins are necessary for efficient pseudouridylation [106], it is 
Dyskerin that provides the pseudouridine synthase activity [107]. While H/ACA and C/D box snoRNAs ac-
cumulate in the nucleolus, some snoRNAs reside in the nucleoplasmic Cajal bodies (CBs) where they guide 
modifications of snRNAs [100] and are called small Cajal body-specific RNAs (scaRNAs). In addition to the 
typical H/ACA snoRNA features, vertebrate H/ACA box scaRNAs carry a CB localization signal called CAB box 
(UGAG) in the loop of their 5' and/or 3' hairpins [108]. 
Immediately upstream of the D box and/or the D' box, C/D box snoRNAs contain 10 to 21 nucleotide-long 
antisense elements that are complementary to sites in their target RNAs [109-111]. The nucleotide in the 
target RNA that is complementary to the fifth nucleotide upstream from the D/D' box of the snoRNA is tar-
geted for 2'-O-methylation by the snoRNP [110, 111]. H/ACA box snoRNAs contain two antisense elements 
termed pseudouridylation pockets, located in the 5' and 3' hairpin domains of the snoRNA [112, 113]. Sub-
strate uridines are selected through base-pairing interactions between the pseudouridylation pocket and 
target RNA sequences that flank the targeted uridine. 
Deep-sequencing studies revealed a surprising diversity of small RNAs derived from non-coding RNAs 
(ncRNAs) known as small derived RNAs (sdRNAs) with well-established functions such as tRNAs [114, 115], 
Y RNAs [116], vault RNAs [117], ribosomal RNAs [118], spliceosomal RNAs [119] and snoRNAs [120-122]. In 
fact, the profile of sequenced reads observed for some of these small RNA species are very characteristic 
and have even been used for ncRNA gene finding based on sequencing data [123, 124]. The majority of C/D 
box and H/ACA snoRNAs seems to be extensively processed, producing stable small RNAs from the termini 
of the mature snoRNA [125] and the processing pattern is conserved across cell types [126]. Thus, it ap-
pears that snoRNAs are versatile molecules that give rise to snoRNA-derived miRNAs [120, 127], other small 
RNAs [121, 125] or longer processing fragments [128]. 
To gain insight into the complexity of snoRNA processing and the functional relevance of the derived 
sdRNAs, we undertook a comprehensive characterization of products generated from snoRNA loci, combin-
ing high-throughput sequencing of long and short RNA fragments with photoactivatable-ribonucleoside-
enhanced cross-linking and immunoprecipitation (PAR-CLIP) of core snoRNA-associated proteins and with 
data from Argonaute 2 (Ago2) immunoprecipitation sequencing (IP-seq) experiments. We found that many 
loci in the human genome can give rise to C/D box-like snoRNAs. Among the novel snoRNAs that we identi-
fied are very short sequences, extending little beyond the C and D boxes, which are essential for the bind-
ing of core snoRNA proteins. Compared to the snoRNAs that are already known, the novel snoRNA candi-
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dates exhibit a lower level of evolutionary conservation and a lower expression level. These findings indi-
cate that the C/D box snoRNA structure evolves relatively easily and that C/D box snoRNA-like molecules 
are produced from many more genomic loci than are currently annotated. We further found that C/D box 
snoRNAs are very specifically processed inside the regions of terminal complementarity, retaining in the 
mature form only four to five nucleotides upstream of the C box and two to five nucleotides downstream of 
the D box. Sequencing of the small RNA population as well as of the small RNAs isolated after Ago2 im-
munoprecipitation revealed that despite their cellular abundance, C/D box-derived small RNAs are not effi-
ciently incorporated into the Ago2 protein. Our extensive data thus indicate that, contrary to previous sug-
gestions [121, 129], snoRNA-derived small RNAs that carry out non-canonical, particularly miRNA-like, func-
tions are rare. 
 2.3 Results 2.3.1 PAR-CLIP of C/D box and H/ACA box snoRNP core proteins identifies their RNA bind-ing partners 
To investigate the RNA population comprehensively that associates with both C/D box and H/ACA box small 
nucleolar ribonucleoproteins we performed PAR-CLIP as previously described [41] with antibodies against 
the endogenous Fibrillarin (FBL), NOP58 and Dyskerin (DKC1) proteins, in HEK293 cells (for details see Ma-
terials and methods). For NOP56 we used a stable cell line expressing FLAG-tagged NOP56 and anti-FLAG 
antibodies. Because we recently found that the choice of the ribonuclease and reaction conditions influ-
ences the set of binding sites obtained through cross-linking and immunoprecipitation (CLIP) [130, 131], we 
also generated a Fibrillarin PAR-CLIP library employing partial digestion with micrococcal nuclease (MNase) 
instead of RNase T1. PAR-CLIP libraries were sequenced on Illumina sequencers, mapped and annotated 
through the CLIPZ web server [131]. The obtained libraries were comparable to those from previous PAR-
CLIP studies in terms of size, rates of mapping to genome and proportion of cross-link-indicative T→C mu-
tations (TABLE 2.1). The DKC1 PAR-CLIP library shows a lower frequency of T→C mutations compared to all 
other libraries, but T→C mutations were still the most frequent in this library as well (data not shown). 
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Table 2.1 Summary of CLIPZ mapping statistics and annotation categories for PAR-CLIP samples. 
 
Ago2: Argonaute 2; DKC1: Dyskerin; FBL: Fibrillarin; miRNA: micro RNA; MNase: micrococcal nuclease; PAR-CLIP: photoactivatable-ribonucleoside-
enhanced cross-linking and immunoprecipitation; rRNA: ribosomal RNA; snoRNA: small nucleolar RNA; snRNA: small nuclear RNA; tRNA: transfer 
RNA. 
 
Compared to the libraries that we previously generated for HuR and Ago2 [130], two proteins whose prima-
ry targets are mRNAs, we found that snoRNAs, rRNAs and snRNAs were strongly enriched in PAR-CLIP li-
braries generated for the snoRNP core proteins (TABLE 2.1). The fact that not only snoRNAs but also the 
primary targets of snoRNAs, namely ribosomal RNAs and small nuclear RNAs, are enriched in these samples 
suggests that like Ago2 cross-linking, which captures both miRNAs and their targets [41, 130], cross-linking 
of core snoRNPs efficiently captures both snoRNAs and targets. To quantify the specificity of our PAR-CLIP 
libraries, we intersected the 200 clusters with the highest read density per nucleotide from each library 
with curated snoRNA gene annotations based on snoRNA-LBME-db [95] (TABLE 2.2). Currently, snoRNA-
LBME-db lists about 153 human C/D box snoRNA loci and 108 human H/ACA box snoRNA loci that are 
known to be ubiquitously expressed. For each of the C/D box specific PAR-CLIP libraries, more than 100 of 
the top 200 clusters could be assigned to C/D box snoRNAs indicating the specificity of our CLIP experi-
ments and the broad coverage of the snoRNA genes by the sequencing reads obtained from HEK293 cells. 
The Dyskerin PAR-CLIP data set showed a weaker enrichment in snoRNAs compared to the data sets for the 
core C/D box-specific proteins, with 57% of all known H/ACA box snoRNAs being represented among the 
200 top-ranking clusters. scaRNAs were detected in both H/ACA box and C/D box specific libraries, as ex-
pected because many scaRNAs have both C/D box and H/ACA box elements. Finally, minor fractions of 
H/ACA box snoRNAs were also found in PAR-CLIP libraries of the C/D box-specific proteins, and vice versa. 
This could be caused by the close spatial arrangement of snoRNPs on the target molecule, or could indicate 
that H/ACA box snoRNAs and C/D box snoRNAs guide modifications on each other.  
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Table 2.2 Annotation summary of the top 200 clusters inferred from PAR-CLIP experiments with snoRNA core proteins. 
 
 
Ago2: Argonaute 2; DKC1: Dyskerin; FBL: Fibrillarin; MNase: micrococcal nuclease; PAR-CLIP: photoactivatable-ribonucleoside-enhanced cross-
linking and immunoprecipitation; scaRNA: small Cajal body-specific RNA; snoRNA: small nucleolar RNA. 2.3.2 Binding patterns of core proteins on snoRNAs 
As mentioned in the introduction, both C/D box and H/ACA box snoRNAs carry very specific functional se-
quence and structure elements, which are recognized by the snoRNP core proteins. We thus asked whether 
different C/D box core proteins have distinct preferences in binding different regions of the C/D box snoR-
NAs. FIGURE 2.1Adepicts PAR-CLIP read profiles along selected snoRNA genes (profiles for all scaRNA and 
snoRNA genes are in Additional file 1). Both C/D box core proteins as well as the H/ACA box specific Dysker-
in bind to SCARNA6, which has a hybrid structure composed of both C/D box and H/ACA box elements. 
However, while the CLIP reads from the Fibrillarin, NOP56 and NOP58 samples cover the C and D box mo-
tifs, Dyskerin was preferentially cross-linked to the H-box motif and to the 5' end of the first H/ACA box 
stem. For the C/D box snoRNAs, different snoRNA core proteins gave very similar cross-linking patterns 
(FIGURE 2.1B), which we quantified through the correlation coefficient between read densities obtained 
along individual snoRNAs in pairs of samples. Comparing NOP58 to Fibrillarin and NOP56 we found that 109 
(78%) and 111 (80%) snoRNA genes had a correlation coefficient of at least 0.9. To put this in perspective, 
between biological replicates of NOP58, 130 out of 139 snoRNAs investigated have a correlation coefficient 
of at least 0.9. This indicates that Fibrillarin, NOP56 and NOP58 form a tight complex that contacts the 
snoRNA. As noticed before, however [130], the nuclease treatment has a strong influence on the relative 
number of tags obtained from different positions along a snoRNA (FIGURE 2.1C). Only 19 snoRNA genes 
(14%) show a correlation ≥ 0.90 in their tag profiles obtained with RNase T1- and MNase-treated Fibrillarin 
PAR-CLIP samples, reflecting the fact that T1 nuclease is more efficient and generates a more biased posi-
tion-dependent distribution of reads than MNase (FIGURE 2.1A). FIGURE 2.1D and FIGURE 2.1E summarize 
these results, showing that nucleotides in D' boxes are most frequently cross-linked, followed by nucleo-
tides in the C' and C boxes, and then by nucleotides in the D box and in the rest of the snoRNA. MNase 
treatment in particular results in very poor coverage of the D box. On the other hand, we observed gene-
specific differences in the binding of the core proteins. For example, SNORD20 only shows a peak of CLIP 
reads at the D box, SNORD30 only at the C box, while SNORD76 has peaks at both C and D boxes (FIGURE 
2.1A).  
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Figure 2.1 Summary of PAR-CLIP data of snoRNP core proteins.  (A) Profiles of sequencing reads obtained from PAR-CLIP experiments for selected 
snoRNAs. Black bars in the profiles indicate the number of T→C mutations observed in PAR-CLIP reads at a particular nucleotide. (B) Similarity of 
binding profiles of core proteins that associate with C/D box snoRNAs. (C) Comparison of protein binding profiles as inferred from RNase T1-treated 
and MNase-treated PAR-CLIP samples. (D, E) Preferential binding of Fibrillarin to box elements as inferred from PAR-CLIP samples prepared with T1 
(D) and MNase ribonucleases (E). (F) Comparison of binding preferences at D'/D box elements and guide regions for snoRNAs with and without a 
known target. (G) Analysis of binding preferences of Dyskerin for H/ACA box snoRNA-specific elements. D, E, F and G show the cumulative distribu-
tions of CLIP read coverage z-scores for nucleotides located in various regions of the snoRNA relative to the overall coverage of the snoRNA. CLIP: 
cross-linking and immunoprecipitation; MNase: micrococcal nuclease; PAR-CLIP: photoactivatable-ribonucleoside-enhanced cross-linking and im-
munoprecipitation; snoRNA: small nucleolar RNA; snoRNP: small nucleolar ribonucleoprotein. 
 
We further asked whether the binding pattern of Fibrillarin reflected in the abundance of CLIP reads differs 
between guide regions of the snoRNAs that have a target annotated in snoRNA-LBME-db and orphan guide 
regions. For guide regions, we took the nine nucleotides upstream of the D and D' boxes and as a reference 
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we compared the coverage of the D and D' boxes themselves (FIGURE 2.1F). We found that guide regions 
with a known target and their associated D/D' boxes generally have a higher coverage compared to those 
that are orphan (70% compared to 40% positive z-scores of the average coverage per position in the guide 
region relative to the entire snoRNA, FIGURE 2.1G). This could indicate that the binding to the target ren-
ders the snoRNA-core protein complex more accessible to cross-linking. 
For H/ACA box snoRNAs we found that Dyskerin strongly prefers the H box nucleotides (FIGURE 2.1G), 
which in 70% of the snoRNAs have a positive z-score for coverage compared to the entire snoRNA. This is 
expected because these snoRNAs are highly structured, with most nucleotides being engaged in base pairs 
in the two hairpin stems and a few nucleotides are free to interact with the proteins. 
 2.3.3 Identification of novel snoRNA genes from PAR-CLIP and small RNA sequencing 
We screened the top 500 clusters from each PAR-CLIP library that did not overlap with known ncRNAs, 
mRNAs or repeat elements for potentially novel snoRNA genes. To identify H/ACA box genes we employed 
the SnoReport program [132], while for C/D box snoRNA detection we applied a custom approach search-
ing for a C box motif (RUGAUGA, R = A or G; allowing one mismatch) at the 5' end and a D box motif (MU-
GA, M = A or C) at the 3' end, requiring that a terminal stem of at least four canonical base pairs can be 
formed by the nucleotides flanking the C and D boxes. We combined these computational screens with 
isolation and sequencing of the 20 to 200 nucleotide RNA fraction from HEK293 cells, which provides evi-
dence for expression of the predicted snoRNAs. Requiring a minimal average coverage per nucleotide of at 
least 1 tag per million (TPM) in least one type-specific CLIP library as well as in the small RNA-seq library, we 
identified 77 and 20 putative C/D and H/ACA box snoRNAs, respectively (Additional files 2 and 3). We addi-
tionally screened 14 distinct small RNA sequence libraries from the recently released ENCODE data [133] 
and found that more than 75% of our putative C/D box snoRNAs were detected in at least one cell type 
other than HEK293 (see Additional file 4). We further tested the expression of the 20 most abundantly se-
quenced candidate snoRNAs by Northern blotting (see Additional file 5). Nine of the twenty candidates 
were also detectable in this assay, while an additional nine C/D box snoRNAs are supported by the ENCODE 
data (see Additional file 4). 
To determine whether the candidates we identified as described are entirely novel snoRNA genes or so far 
undescribed homologs of known snoRNAs, we performed a BLAST search against the snoRNA genes from 
snoRNA-LBME-db (requiring an E-value ≤ 10-3). We further compared the loci of the putative snoRNAs with 
the snoRNA annotation available in ENSEMBL release 65 [134], which is based on automatic annotation 
with sequence/structure models available in the Rfam database [135]. Out of the 20 H/ACA box snoRNA 
candidates, 18 show sequence or structural homology to known snoRNAs, while candidates ZL4 (annotated 
as nc053 in [136], but not classified as a snoRNA by the authors) and ZL36 appear to be novel H/ACA box 
snoRNAs without a known homolog. The homology search additionally revealed that ZL4 is conserved until 
Xenopus tropicalis. 
Of the 77 C/D box snoRNAs, only seven showed sequence homology to known C/D box snoRNA genes, but 
in one case (ZL1) the homology consisted solely of a long GU-rich region. The evolutionary conservation of 
the guide regions of five of these snoRNAs (ZL11, ZL109, ZL126, ZL127 and ZL132) suggests that they target 
the same nucleotides on ribosomal RNA as their homologs. A sixth snoRNA, ZL142, appears to be a human 
homolog of the GGN68 snoRNA of chickens [137, 138]. An additional comparison with the results of anoth-
er large snoRNA analysis [139], revealed that ZL2 and ZL107 have been previously described as SNORD41B 
and Z39, respectively. In order to further characterize the 69 potentially novel C/D box snoRNAs (including 
ZL1, which only had homology with a known snoRNA in a GU-rich region), we first asked whether their C 
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and D boxes are evolutionarily conserved (Additional file 1). To this end, we computed their average posi-
tion-wise phastCons scores [140], which we obtained from the UCSC genome browser. Five candidates in-
cluding ZL1 showed an average phastCons score per nucleotide higher than 0.25 for C and D box nucleo-
tides. A comprehensive homology search of vertebrate genomes allowed us to trace the evolutionary origin 
of these snoRNAs and to annotate C' and D' boxes as well as putative guide regions based on sequence 
conservation. ZL1 is highly conserved in vertebrates including Petromyzon marinus, while for ZL5, ZL6, ZL8 
and ZL24 we were not able to retrieve any homologs outside of mammals. 
The remaining C/D box snoRNAs show overall weak conservation in mammals and in primates (Additional 
file 1). The C' and D' box elements of these snoRNAs, which are typically more variable in sequence, were 
particularly difficult to annotate without supporting evidence from evolutionary conservation. Because it is 
not clear that these snoRNAs have a C-D'-C'-D box architecture, we refer to them as C/D box-like. The small 
RNA sequence data indicates that these C/D box-like snoRNAs are only weakly expressed (Additional file 6). 
Interestingly, while the shortest C/D box snoRNA that has been characterized so far is SNORD49B, which 
has 48 nucleotides, 23 of our C/D box-like snoRNAs are even shorter. FIGURE 2.2 depicts PAR-CLIP tags and 
small RNA-seq reads for four of these snoRNAs which we called mini-snoRNAs. ZL77 is among the shortest, 
with 27 nucleotides in length, and only 7 nucleotides available as a potential guide region between the C 
and D boxes, while ZL49 and ZL103 are slightly longer (14 and 15 nucleotides between the C and D boxes). 
Another mini-snoRNA, ZL63, generated a considerable number of reads in all the CLIP libraries as well as in 
the RNA sequence data. 
 
 
Figure 2.2 Small RNA-seq and PAR-CLIP reads mapping to mini-snoRNAs.  Mini-snoRNAs ZL77, ZL49, ZL103 and ZL63 are shown. Black bars in the 
panels corresponding to PAR-CLIP libraries indicate the number of T→C mutations observed at individual nucleotides. CLIP: cross-linking and im-
munoprecipitation; PAR-CLIP: photoactivatable-ribonucleoside-enhanced cross-linking and immunoprecipitation; snoRNA: small nucleolar RNA. 
 
Our screen could further identify a snoRNA with mixed C/D box and H/ACA box structure. SCARNA21, a 
computationally predicted H/ACA box snoRNA [141], is surrounded by conserved C and D box elements 
enclosed by a terminal stem structure (Additional file 7). Northern blot analysis revealed that the prevalent 
form in the cells is the one that contains the C/D box elements and not the short form, which would be the 
single H/ACA box snoRNA. 
 2.3.4 Target prediction for newly identified snoRNA genes 
To gain insight into the function of the novel snoRNAs that we identified, we sought to determine whether 
they have canonical targets. We employed the programs RNAsnoop and PLEXY to predict targets of H/ACA 
box and C/D box snoRNAs, respectively [142, 143]. As potential target sequences we considered ribosomal 
Chapter 2: Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 
20 
and spliceosomal RNAs obtained from snoRNA-LBME-db. Indeed, for the highly conserved C/D box snoRNAs 
ZL1, ZL5 and ZL6 (which share the guide region), as well as for the H/ACA box snoRNA ZL4, we could identify 
canonical targets (FIGURE 2.3). ZL1 and ZL4 are both predicted to guide modifications on the U2 snRNA, 2'-
O-methylation of U47 and pseudouridylation of U15, respectively. The pseudouridylation of U2 snRNA at 
U15 has already been described, but the guiding snoRNA was not known [67]. With primer extension assays 
we could further validate the U47 modification (see Additional File 8). SnRNA modifications are known to 
occur in Cajal bodies. Consistent with ZL4 H/ACA box snoRNA being a scaRNA that is recruited to Cajal bod-
ies, is the presence of the CAB box motif (UGAG), known to mediate this transport [108], in the hairpin 
loops. For the C/D box snoRNA ZL1 targeting U2 snRNA we could not identify an H/ACA box-like structural 
domain with a CAB box. Interestingly, however, this snoRNA candidate contains a long GU repeat, a feature 
shared by SCARNA9, the only Cajal body-associated snoRNA that lacks H/ACA and CAB boxes. This suggests 
that the GU element serves as an import signal into Cajal bodies. For ZL5/6, the predicted modification site 
on the 28S rRNA is in fact a known modification site for which the guide was so far unknown. We could not 
predict a target for the newly identified C/D box domain of SCARNA21. 
 
 
 
Figure 2.3 Predicted structure of hybrids between novel snoRNAs and target RNAs. The snoRNAs are given at the top of each panel together with 
the symbol of the host gene in which the snoRNA resides (in parentheses). The targets are indicated at the bottom of the panels. rRNA: ribosomal 
RNA; snoRNA: small nucleolar RNA; snRNA: small nuclear RNA 
 
We were especially interested to find out whether the non-conserved C/D box-like snoRNAs and in particu-
lar the mini-snoRNAs, could guide 2'-O-methylations. To this end, we took a simple approach searching for 
8-mer Watson-Crick complementarity between the putative guide regions upstream of the D boxes to ribo-
somal and spliceosomal RNAs. We did indeed identify seven putative interaction sites, but none of these 
are known modification sites (Additional file 2). Thus, the targets of these C/D box-like snoRNAs remain to 
be identified. 
 2.3.5 Non-canonical RNA partners of core snoRNA proteins 
Although snoRNAs are best known for guiding modifications of rRNAs, snRNAs and tRNAs [83, 100, 101], 
some evidence has emerged for the involvement of full-length mature snoRNAs also in other biological 
processes such as alternative splicing [92]. To investigate this possibility, we searched our PAR-CLIP data 
sets for RNAs that were abundantly cross-linked, yet not known to associate with the core snoRNA pro-
teins. In contrast to the HuR PAR-CLIP that we performed before [130], the PAR-CLIP experiments conduct-
ed with C/D box snoRNP core proteins repeatedly identified several non-coding RNAs including vault RNA 1-
2, 7SK RNA and 7SL RNA as well as H/ACA box snoRNAs. Similarly, in the Dyskerin PAR-CLIP we observed 
cross-linking of several C/D box snoRNAs. 
We performed primer extension experiments to determine potential sites for 2'-O-methyl and pseudouri-
dine modification in prominent ncRNAs such as 7SK RNA, 7SL RNA and vault RNA 1-2 (see Additional file 9 
for primer extension assays and Additional file 10 for a catalog of identified modifications sites and target 
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predictions). Indeed, we found that all three of these RNA species carry modifications. Vault RNA 1-2 con-
tains four 2'-O-methyl sites, 7SK RNA carries at least six 2'-O-methyl sites and one pseudouridylation site, 
and 7SL RNA contains several sites of pseudouridylation. Additionally, we sought to determine whether C/D 
box and H/ACA box snoRNAs guide modifications on each other. We thus performed 2'-O-methylation pri-
mer extension assays on SNORA61 and pseudouridylation assays on SNORD16 and SNORD35A. We found 
that SNORA61 potentially carries one 2'-O-methylation, while SNORD16 and SNORD35A carry two and six 
pseudouridylated residues, respectively. To identify C/D box snoRNAs that could guide the observed 2'-O-
methylations, we searched for 8-mer complementarity upstream of D and D' boxes of C/D box and C/D box-
like snoRNAs, but we did not find sequences complementary to the modification sites. To predict guiding 
H/ACA box snoRNAs we employed the program RNAsnoop using stringent filtering criteria. We identified 
potential guiding H/ACA box snoRNAs for 7SK RNA residue Ψ250 and 7SL RNA residue Ψ226. 
Previous studies reported that snoRNAs may function in alternative splicing [92, 128] and we also repeated-
ly observed cross-linking of C/D box core proteins to regions that are annotated as exons of protein coding 
genes. To determine whether these mRNA regions are targeted by snoRNAs, we selected, from the top 
1,000 clusters located in mRNA exons in NOP58 libraries, the 157 that were present in both NOP58 repli-
cates and a third CLIP library with at least 10 TPM per nucleotide (Additional file 11). We identified com-
plementarities to the 8-mer guide regions of snoRNAs in 79 of these clusters. In contrast, in shuffled CLIPed 
regions we only found 60 complementarities to snoRNA guide regions (average of 100 simulations on shuf-
fled sequences). Thus, the mRNA sequences that we isolated in the CLIP experiments are consistent with 
the possibility that snoRNAs act as guides in some steps of mRNA processing. 
 2.3.6 snoRNA processing patterns 
It has become apparent that many ncRNAs such as tRNAs, snRNAs, rRNAs and snoRNAs are extensively 
processed into small, stable RNA fragments originating mainly from the termini of the mature ncRNA [125], 
which in some cases are incorporated in the Argonaute proteins to function as microRNAs [120]. To identify 
snoRNA-derived small RNAs that could potentially act as miRNAs comprehensively, we isolated and se-
quenced the RNA fraction of 18 to 30 nucleotides from HEK293 cells. Small RNAs derived from C/D box 
snoRNAs constitute about 1.7% of the small RNA pool in this size range in HEK293 cells (TABLE 2.3). Con-
sistent with the results of Li and colleagues [125], we found that most of the 513,339 reads overlapping 
with C/D box snoRNA genes originate from the 5' or 3' ends (38.7% and 46.0%, respectively). Visual inspec-
tion of the alignment of these reads to the snoRNAs revealed, however, that start and end positions of the 
reads do not generally coincide with the annotated snoRNA termini, which were inferred based on the 
characteristic C/D box snoRNA terminal stem (FIGURE 2.4A). Instead, the reads that we obtained indicate 
specific trimming that generates sharp 5' ends for 5'-end-derived reads and sharp 3' ends for 3'-end-derived 
reads. To determine whether this trimming may occur in the process of generating small RNAs from mature 
C/D box snoRNAs, we isolated small RNAs of length 20 to 200 nucleotides that presumably included the 
full-length, mature snoRNAs (average C/D box snoRNA length is 70 to 90 nucleotides) and performed a 150-
cycle sequencing run. FIGURE 2.4A depicts the alignment of reads obtained in the small RNA fraction and 
the reads obtained in the 150-cycle sequencing run for three selected C/D box snoRNAs. Strikingly, the 
sharp ends of C/D box snoRNA-derived small RNAs coincide with the 5' and 3' ends of the mature form. 
More generally, we found that for 84% and 70% of the top 50 expressed C/D box snoRNAs, the most prom-
inent start and end positions, respectively, obtained from long sequencing reads coincided with the most 
prominent start and end positions obtained from small RNA sequencing. This suggests that the observed 
trimming of the terminal closing stem occurs during the excision of the snoRNA from the intron and is not 
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specific to the processing of the mature snoRNA form into smaller fragments. Furthermore, we found that 
it is the distance to the C or D boxes that seems to determine the observed ends of the snoRNAs rather 
than the length of the terminal closing stem (FIGURE 2.4B). The 5' end is sharply defined four to five nucleo-
tides upstream of the C box, while the 3' end is more variably located two to five nucleotides downstream 
of the D box. In most cases this will leave mature C/D box snoRNAs with a terminal 5' overhang compared 
to the 3' end. This suggests that, similar to other small RNAs [127, 144, 145], snoRNAs are trimmed pre-
sumably by exonucleases, to boundaries that are determined by the proteins with which these small RNAs 
are complexed. 
 
Table 2.3 Functional annotation of sequencing reads obtained in sRNA sequencing and HeLa Ago2 IP sequencing. 
 
Ago2: Argonaute 2; IP: immunoprecipitation; snRNA: small nuclear RNA; snoRNA: small nucleolar RNA; sRNA: small RNA; tRNA: transfer RNA. 
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Figure 2.4 Terminal processing of C/D box snoRNAs. (A) Profiles of sequencing reads obtained from two small RNA seq libraries for three selected 
C/D box snoRNAs (SNORD8, SNORD21 and SNORD29). Upper: sdRNA sequencing, 18 to 30 nucleotides. Lower: sRNA sequencing, 20 to 200 nucleo-
tides. Secondary structure annotation of the terminal closing stem is given on the top of the figure, while the locations of C and D motifs are shown 
on the bottom. (B) Detailed analysis of terminal stem processing for C/D box snoRNA expressed in HEK293 cells. The y-axis indicates individual 
nucleotides, with their specific identity for the nucleotides in C/D boxes and position relative to the boxes for the flanking nucleotides. Each column 
corresponds to a snoRNA, whose identity is shown at the top of the panel. Grey boxes indicate nucleotides that are predicted to be paired in the 
terminal stem. The size of black boxes is proportional to the number of sRNA sequencing reads that start (5' end) or end (3' end) at a particular 
nucleotide. See Additional File 16 for analysis of all C/D box snoRNAs expressed in HEK293 cells. sdRNA: small derived RNA; snoRNA: small nucleolar 
RNA; sRNA: small RNA. 
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Small RNAs derived from C/D box snoRNA termini appear to be abundant in the cells, and can be incorpo-
rated into Argonaute proteins to act as miRNAs [127]. To determine the relative participation of various 
small RNA classes in the Argonaute-dependent gene silencing, we immunopurified Ago2 from HeLa cells 
and sequenced the associated small RNA fraction. We found that, as expected, miRNAs constitute the most 
abundant RNA class that associates with Ago2 (approximately 90%), while C/D box snoRNAs account only 
for 0.005% of the IP-seq reads (TABLE 2.3). Assuming that overall proportions of small RNAs derived from 
tRNAs and snoRNAs are fairly constant across cell types, we can estimate the efficiency with which small 
RNAs (from the total small RNA pool) are incorporated in the Argonaute proteins. We found, for example, 
that although small RNAs derived from tRNAs are 5.6 times more abundant than C/D box derived snoRNAs, 
tRNA fragments are 40 times more abundant in the Ago2-associated fraction. Thus, tRNA-derived small 
RNAs appear to be more efficiently incorporated in Ago2 than C/D box snoRNA fragments. This is consistent 
with observations that tRNAs are cleaved by nucleases such as Angiogenin and even Dicer to generate pro-
cessing fragments that are active in translation regulation [146, 147]. Similarly, small RNAs derived from 
H/ACA box snoRNAs are 5.5 times less abundant than small RNAs derived from C/D box snoRNAs in the 
total RNA fraction, but are 5.2 times more efficiently picked up by Ago2. The H/ACA box snoRNA SCAR-
NA15, which has been shown to be processed into smaller fragments that act as microRNAs [120], is repre-
sented in this library with 3,636 reads, 29% of all reads mapped to H/ACA box snoRNA loci (see Additional 
file 12 for a full listing of all snoRNAs). The C/D box snoRNA with the highest number of reads in the Ago2 IP 
library is SNORD1A with 1,140 reads, but the majority of C/D box snoRNAs are represented by less than 50 
reads. 
Of all categories of small RNAs, C/D box snoRNA fragments are those that show the strongest nuclear re-
tention, and are found in the cytoplasm with only low frequency [148]. Thus, this physical separation could 
account for the low frequency of association between C/D box snoRNA-derived RNAs and Ago2. We there-
fore wondered whether the association of this abundant class of RNA fragments with Ago2 increases in the 
mitotic phase of the cell cycle, when the nuclear membrane is dissolved. We collected HeLa cells that were 
in the mitotic phase through mitotic shake off, immunopurified Ago2 and again sequenced the Ago2-
associated small RNA fraction. We found that, indeed, the relative abundance of C/D box-derived frag-
ments in Argonaute increased in this condition (TABLE 2.3), to 0.054% relative to 0.005%. Nonetheless, 
these results indicate that C/D box snoRNAs do not generally carry out miRNA-like functions, and that the 
number of H/ACA box snoRNAs with a dual function is very limited. 
 2.4 Discussion 
To gain insight into the processing of snoRNAs and the functions of snoRNA-derived small RNAs, we per-
formed PAR-CLIP experiments with snoRNP core proteins. Analysis of PAR-CLIP reads showed that C/D box 
core proteins Fibrillarin, NOP56 and NOP58 have a very similar binding pattern, overlapping with the box 
elements. Excluding snoRNA families SNORD113 to SNORD116, which are multi-copy families and do not 
have guide complementarity to rRNAs or snRNAs, snoRNA-LBME-db currently lists 153 C/D box snoRNAs, of 
which 40 and 78 have a guide region targeting a known modification at the D box and D' box, respectively. 
Evolutionary conservation profiles of the remaining putative guide regions suggest that most of them are 
not functional. In support of this concept, our analysis revealed that C/D box core proteins cross-linked 
more effectively to guide regions that are known to have a target compared to orphan guide regions. 
Combining computational prediction with data from small RNA sequencing and PAR-CLIP we identified 
novel C/D and H/ACA box snoRNAs, and assigned guiding snoRNAs to several modifications on rRNAs and 
snRNAs that were previously described as orphans. In addition to these bona fide snoRNAs, we uncovered a 
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group of C/D box-like snoRNAs that only have a C and a D box as opposed to the common C-D'-C'-D archi-
tecture. These C/D box-like snoRNAs are only weakly conserved and most of them are expressed at low 
levels. The unusual architecture and the weak evolutionary conservation are likely reasons why these RNA 
species have not been uncovered by computational ncRNA gene finders [149]. Some of the identified C/D 
box-like snoRNAs are extremely short, one being only 27 nucleotides in length, leaving hardly enough space 
for a guide region. The requirements for C/D box snoRNA biogenesis appear to be simply the presence of C 
and D boxes and a short region of complementarity flanking these boxes, leading probably to the produc-
tion of many snoRNA-like molecules as the C/D box core proteins scan intronic regions of pre-mRNAs. An 
interesting lead to follow in further investigating the potential function of the C/D box-like snoRNAs origi-
nating in the introns of many genes comes from a recent study conducted in Drosophila, in which Schubert 
and colleagues showed that snoRNAs are required for maintenance of higher-order structures of chromatin 
accessibility [150]. 
In our PAR-CLIP experiments we also repeatedly cross-linked ncRNAs that are not usual snoRNA targets. We 
observed H/ACA box snoRNAs in PAR-CLIP experiments targeting the C/D box core proteins. Vice versa, we 
found C/D box snoRNAs in the PAR-CLIP targeting Dyskerin, which is an essential component of H/ACA box 
snoRNPs. Primer extension assays indicated that these snoRNAs carry modifications that would be ex-
pected from the protein complexes to which they were cross-linked, but we were, in general, not able to 
identify snoRNAs that could guide these modifications. One drawback may be that in the case of the 2'-O-
methyl primer extension assays we cannot be sure that it was indeed a 2'-O-methyl modification as op-
posed to any other nucleoside modification that caused the stoppage of the reverse transcriptase. Howev-
er, we can be fairly certain that we identified bona fide pseudouridylation sites. Particularly, in the case of 
SNORD35A we were able to identify five putative pseudouridylated residues but no convincing guiding se-
quence in a known H/ACA box snoRNA. This suggests either that even more snoRNAs remain to be identi-
fied or that these pseudouridylations are caused by a protein-only mechanism not requiring guidance by 
H/ACA box snoRNAs. 
The processing patterns of snoRNAs have raised substantial interest and some controversy in recent years 
[94, 126, 128]. We strikingly found that snoRNA excision out of the intron follows a well-defined pattern 
leaving mature snoRNAs with four to five nucleotides upstream of the C box, and two to five nucleotides 
downstream of the D box, irrespective of the length of the terminal closing stem. Our data support the 
observations of Darzacq and Kiss [103] that the terminal stem serves to bring the C and D box elements into 
close proximity so as to be more easily recognized by snoRNP proteins, which then protect the snoRNA 
from further trimming by the exosome, but may not be needed for the functional, mature snoRNA. This 
implies that the core proteins actively protect and stabilize the maturing snoRNA. 
We further quantified the abundance of snoRNA-derived small RNAs in HEK293 cells, and consistent with 
other studies [125], we found that small RNAs derived from the ends of C/D box snoRNAs are indeed abun-
dant. However, we did not find evidence that these sdRNAs efficiently associate with Ago2 to act as mi-
croRNAs, even in conditions when the accessibility of these sdRNAs to Ago2 should be higher, such as in 
mitotic cells. We thus conclude that a microRNA-like function of snoRNA-derived small RNAs is an excep-
tion rather than a rule. Most of the sdRNAs from C/D box snoRNAs originate from the termini of mature 
snoRNAs, and hence carry C and D box motifs. It might be that snoRNA core proteins are still attached to 
these fragments, protect them from total degradation, sequester them in the nucleus and prevent these 
sdRNAs from being loaded into Ago2. 
Deep-sequencing-based studies revealed a very complex landscape of transcription and processing of RNAs. 
The non-canonical products identified initially in such studies raises the question of additional, yet un-
known, functions of molecules that have been studied for many years. What has become apparent more 
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recently, however, is that deep sequencing allows us to construct a very detailed picture of the kinetics of 
processing various classes of RNAs and of their interactions with proteins that protect them from degrada-
tion. Intersection of many data sets such as those generated in our study will eventually reveal kinetic and 
regulatory aspects of cellular processes at a fine level of detail. 
 2.5 Materials and methods 2.5.1 PAR-CLIP experiments 
PAR-CLIP was performed with HEK293 Flp-In cells (Invitrogen). Cells were grown in thirty 15-cm cell culture 
plates per experiment to approximately 80% confluency. At 12 h before harvest, 4-thiouridine (Sigma) was 
added to the cells to a final concentration of 100 µM. PAR-CLIP was carried out as described previously 
[41]. For immunoprecipitation, antibodies were coupled to protein-A or protein-G Dynabeads (Invitrogen). 
Antibodies used against endogenous proteins were α-NOP58 (sc-23705 from Santa Cruz Biotechnology), α-
Dyskerin H-300 (sc-48794, Santa Cruz Biotechnology), α-Dyskerin C-15 (sc-26982, Santa Cruz Biotechnology) 
and α-Fibrillarin AFB01 monoclonal antibody line 72B9, lot 011 (from Cytoskeleton, Inc, AFB01). The α-Ago2 
(11A9) monoclonal antibody was a gift from Gunter Meister. For PAR-CLIP with NOP56 we used a HEK293 
cell line with a stably integrated FLAG-NOP56 fusion gene and IP was done with monoclonal α-FLAG anti-
body M2 from Sigma. For one Fibrillarin targeted PAR-CLIP the immunoprecipitated complexes were treat-
ed with micrococcal nuclease (MNase, from New England Biolabs) for 5 min at 37°C [130]. After SDS-PAGE, 
gels were blotted onto nitrocellulose membranes to reduce the background from free RNAs [151]. The PAR-
CLIP libraries were prepared as described in Additional file 13 and submitted to deep sequencing on an 
Illumina HiSeq 2000. 
The reads obtained from PAR-CLIP experiments were mapped to the human genome (hg19 assembly from 
UCSC, February 2009) and annotated with the CLIPZ server [131]. Reads marked with the CLIPZ annotation 
categories 'fungal', 'bacterial,' or 'vector' were discarded and only reads that mapped uniquely to the ge-
nome were used in the analyses. The library size was scaled to 1,000,000 for all samples to obtain a normal-
ized expression value (tags per million). 
 2.5.2 Small RNA sequencing 
Small RNA sequencing libraries were prepared from size-selected RNAs of 18 to 30 nucleotides (sdRNA se-
quencing) and 20 to 200 nucleotides (sRNA sequencing). HEK293 total RNA was extracted and treated with 
DNase. Next, 20 units of T4 polynucleotide kinase and 2 µl of [γ-32P] ATP (10 µCi/µl) were used to radio-
label 10 µg of RNA at the 5'-ends. The RNA was separated together with a radiolabeled 20-nucleotide lad-
der on a 12% polyacrylamide gel, the bands corresponding to 18 to 30 nucleotides (for sdRNA sequencing 
libraries) or 20 to 200 nucleotides (for sRNA sequencing libraries) were excised, the RNA was extracted 
overnight in a 0.4-M NaCl solution and finally precipitated with ethanol. Small RNA libraries were prepared 
according to a published protocol [152] and sequenced on an Illumina HiSeq 2000 instrument, for 36 
(sdRNA sequencing) and 150 cycles (sRNA sequenicng library). Adaptor removal was done with the CLIPZ 
server, and the mapping to the human genome was then done with the Segemehl software (v. 0.1.3) with 
parameters '-D 1 -A 90' [153]. The Gene Expression Omnibus (GEO) accession number for the PAR-CLIP and 
sRNA-seq data is GSE43666. 
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2.5.3 Identification of novel C/D snoRNAs and H/ACA snoRNAs from PAR-CLIP and small RNA sequencing data 
For each PAR-CLIP library we inferred binding regions of the proteins of interest by clustering reads whose 
corresponding loci were at most 25 nucleotides apart. To annotate known snoRNA and scaRNA genes we 
first retrieved sequences from the snoRNA-LBME-db [95], mapped them to the human genome (a list of 
motif and secondary structure annotated snoRNAs is available in Additional file 13). The 500 binding re-
gions that accumulated the highest number of reads in each individual CLIP library, but did not overlap with 
known snoRNA or scaRNA genes, ncRNA genes or repeat elements, were screened for novel snoRNA candi-
dates. We used SnoReport [132] to detect H/ACA box snoRNAs, while for detection of C/D box snoRNAs we 
searched for protein-binding regions that contained motifs corresponding to the C box (RTGATGA; allowing 
one mismatch) and to the two most common D box motifs (CTGA and ATGA). Sequences that contained 
both a C box and a D box motif were extended by ten nucleotides in order to search for a terminal closing 
stem. If a compact closing stem composed of at least four canonical base pairs with at least two G-C/C-G 
base pairs was found, the sequence was considered a snoRNA candidate. To evaluate the specificity of our 
C/D box snoRNA gene finding approach, we applied the same procedure to two types of clusters of PAR-
CLIP reads from the NOP58 rep A sample both extended by 25 nucleotides on each side. First were the top 
100 clusters (defined in terms of the number of reads associated with the cluster) that overlapped with C/D 
box snoRNA annotation, which served as a positive control. In this set, our program reported 80 sequences 
as putative snoRNAs. The second type of cluster contained the top 100 clusters that overlap with mRNA 
exon annotation. These should not contain snoRNAs, and indeed, we only obtained five putative C/D box 
snoRNAs candidates. Similarly low numbers of snoRNA candidates were obtained from randomized se-
quences (not shown). Altogether, these tests indicated that our method has very good specificity. In con-
trast, the number of predictions we obtained from CLIPed clusters without a known annotation was 11 for 
the top 100 such clusters. 
Candidates that showed expression of at least 1 TPM per nucleotide in the 20 to 200 nucleotides small RNA 
sequencing run (only uniquely mapped reads that covered at least 50% of the candidate snoRNA sequence 
were considered), and had at least 1 TPM per nucleotide in at least one of the type-specific CLIP libraries 
were considered putative snoRNAs. They were consecutively numbered, and named as 'ZL#'. To further 
validate the newly found snoRNAs, we searched for evidence of expression in recently published small 
RNA-seq libraries from the ENCODE project [133, 154]. Files with the genome coordinates of mapped reads 
(BAM files) were obtained from the ENCODE data coordination center at UCSC [154] and uniquely mapping 
reads were used for the analysis. In addition, we selected the 20 candidate C/D box snoRNAs with the high-
est read count in our data for validation by Northern blotting (see Additional file 13 for details on the ex-
periment). To evaluate the evolutionary conservation of the putative snoRNAs, we carried out a homology 
search against the vertebrate genomes available in the UCSC genome browser. Once an initial set of homo-
logs was identified, we built sequence/structure models and continued to search for more distant homo-
logs with the Infernal software [155]. 
 2.5.4 Detection of 2'-O-ribose-methylated and pseudouridylated residues 
To identify 2'-O-methylated residues we used a reverse transcriptase-based method coupled with poly-
acrylamide gel analysis as described in [156]. The method is based on the observation that cDNA synthesis 
is noticeably impaired in the presence of a 2'-O-methyl when deoxynucleotide triphosphate fragments 
(dNTPs) are limiting [156, 157], giving rise to a characteristic pattern of gel banding immediately preceding 
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the 2'-O-methyls, with strong bands at low dNTP concentrations (0.004 mM) [157], becoming weaker with 
increasing concentrations of dNTPs. 
To map pseudouridines in candidate RNAs we used a method that relies on chemical modification of RNA 
bases with N-cyclohexyl-N'-β (4-methyl morpholinium) -ethylcarbodiimide (CMC) [158]. The method in-
volves carbodiimide adduct formation with U, G and pseudouridine followed by mild alkali treatment, 
which removes the adduct from U and G but not from the N-3 of pseudouridine. This modification results in 
the blockage of reverse transcription one residue 3' of the pseudouridine on the sequencing gel. For a de-
tailed description of assays used to map 2'-O-methyls and pseudouridines see Additional file 13. As a proof 
of principle, we first applied these assays to the spliceosomal RNA U6, which is known to carry 2'-O-
methylated and pseudouridylidated residues. In addition to the well-documented sites, we also observed 
novel 2'-O-methyl sites that have not been previously reported so far (Additional file 14). 
To predict C/D box snoRNAs that could guide 2'-O-methylation, we searched for 8-mer complementarity 
(only canonical base pairs allowed) to regions immediately or one nucleotide upstream of the D and D' 
boxes of C/D box and C/D box-like snoRNAs. To predict H/ACA box snoRNAs that could guide pseudouri-
dylations, we used the program RNAsnoop [142]. We first determined for each H/ACA snoRNA stem an 
energy cutoff value by running simulations on 1,000 random sequences of length 100. Only if an RNAsnoop 
prediction had an energy value lower than 90% of the random sequences, and at least three canonical base 
pairs on each side of the binding pocket, did we consider it as a hit. 
 2.5.5 Ago2 immunoprecipitation sequencing of asynchronous and mitotic cells 
Mitotic cells were collected using mitotic shake-off [159, 160], a technique based on the observation that 
cells become rounded and more easily detachable from the culture vessel as they progress into metaphase 
during mitosis [161]. Details of the experimental setup are given in Additional file 13. To be able to confirm 
microscopically that we collected mitotic cells we used HeLa cells with the human histone H2B gene fused 
to green fluorescent protein (see Additional file 15). 
Ago2 was immunoprecipitated from mitotic and asynchronous cells; the Ago2-associated RNAs were ex-
tracted and used to prepare cDNA libraries as described above [152], which were then submitted to deep 
sequencing. Adaptor removal was with the CLIPZ server, and reads were then mapped with Segemehl as 
described above. In the analysis of small RNA libraries (Ago2-IP and HEK293 sdRNA sequencing (18 to 30 
nucleotides)), we considered both uniquely and multi-mapping reads that were annotated based on their 
mapping to genes in one of the following categories: tRNAs (from the UCSC Table Browser), microRNAs 
(from mirBase) and snRNAs (from ENSEMBL release 59), C/D box snoRNAs and H/ACA box snoRNAs (curat-
ed data set from this work). 
 2.6 Abbreviations 
Ago2: Argonaute 2, CB: Cajal body, CLIP: cross-linking and immunoprecipitation, DKC1: Dyskerin, dNTP: 
deoxynucleotide triphosphate, FBL: Fibrillarin, IP: immunoprecipitation, IP-seq: immunoprecipitation se-
quencing miRNA: micro RNA, MNase: micrococcal nuclease, ncRNA: non-coding RNA, PAR-CLIP: photoacti-
vatable-ribonucleoside-enhanced cross-linking and immunoprecipitation, rRNA: ribosomal RNA, scaRNA: 
small Cajal body-specific RNA, sdRNA: small derived RNA, snoRNA: small nucleolar RNA, snoRNP: small nu-
cleolar ribonucleoprotein, snRNA: small nuclear RNA, sRNA: small RNA, TPM: tags per million, tRNA: trans-
fer RNA. 
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ABSTRACT
High-throughput sequencing has greatly facilitated
the discovery of long and short non-coding RNAs
(ncRNAs), which frequently guide ribonucleopro-
tein complexes to RNA targets, to modulate their
metabolism and expression. However, for many ncR-
NAs, the targets remain to be discovered. In this
study, we developed computational methods to map
C/D box snoRNA target sites using data from core
small nucleolar ribonucleoprotein crosslinking and
immunoprecipitation and from transcriptome-wide
mapping of 2′-O-ribose methylation sites. We thereby
assigned the snoRNA guide to a known methylation
site in the 18S rRNA, we uncovered a novel partially
methylated site in the 28S ribosomal RNA, and we
captured a site in the 28S rRNA in interaction with
multiple snoRNAs. Although we also captured mR-
NAs in interaction with snoRNAs, we did not detect
2′-O-methylation of these targets. Our study provides
an integrated approach to the comprehensive char-
acterization of 2′-O-methylation targets of snoRNAs
in species beyond those in which these interactions
have been traditionally studied and contributes to the
rapidly developing field of ‘epitranscriptomics’.
INTRODUCTION
RNAs are extensively modified in all living organisms (1).
Recently, high-throughput approaches have been devel-
oped to map 2′-O-methylated riboses (2′-O-Me, (2)) and
nucleobases carrying the most frequent modifications, in-
cluding N6-methyladenosine (m6A, (3)), pseudouridine ( ,
(4)) and 5-methylcytosine (m5C, (5)), transcriptome-wide.
These studies have catalyzed the birth of ‘epitranscrip-
tomics’ (6) and have rekindled the interest in the functions
of RNA modifications and their relevance for human dis-
eases (7,8). Whereas 2′-O-ribose methylation has long been
implicated in the stability and structure of ribosomal RNAs
(reviewed in (9)) and m6A appears to modulate the rate of
mRNA translation (10–13), the role of most RNA modifi-
cations remains to be characterized.
The 2′-O-methylation of riboses in ribosomal RNAs
(rRNAs), small nuclear RNAs (snRNAs) and in Archaea,
transfer RNAs (tRNAs) (14–16), is catalyzed by the pro-
tein fibrillarin. Fibrillarin is part of a larger ribonucle-
oprotein (snoRNP) complex whose protein components
in mammals and yeast are: FBL (fibrillarin)/Nop1 (17),
SNU13/Snu13 (18), NOP56/Nop56 and NOP58/Nop58
(19). As summarized in (20), it is generally accepted that the
snoRNP complex assembles sequentially. SNU13/Snu13
initially binds the guide RNA, leading to the folding
of the K-turn motif, and the subsequent binding of the
NOP56/Nop56:NOP58/Nop58 heterodimer. This complex
helps position the guide RNA in its active conforma-
tion and is completed by the binding of FBL/Nop1, the
snoRNP component responsible for the 2′-O-methylation
enzymatic activity. As we here focus on human snoRNA,
to simplify reading we use hereafter the corresponding
nomenclature. The guiding C/D-box small nucleolar RNAs
(snoRNAs) (in Archaea small RNAs) take their names
from conserved C/C’ (RUGAUGA, R = A or G) and
D/D’ (CUGA) boxes. Molecules with more complex struc-
ture, which can include additional H/ACA boxes and sig-
nals that direct their localization to Cajal bodies (there-
fore called small Cajal body-associated RNAs or scaR-
NAs (21)) have also been identified and are essential for
the modification and proper functioning of snRNAs. The
C/C’ and D/D’ boxes are important for snoRNA biogene-
sis and for the interaction with RNA binding proteins (22).
‘Anti-sense’ elements located upstream of the D and/or
D’ boxes, base-pair with the targets. The target nucleotide
that pairs with the fifth nucleotide of the anti-sense ele-
ment acquires the 2′-O-Me mark. Base-pairing adjacent to
the target site can further enhance 2′-O-methylation (23).
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Many studies have investigated snoRNA-guided modifica-
tions, particularly in yeast (24–27). As a result, features that
define snoRNA target sites have been identified and incor-
porated into computational methods for snoRNA target
prediction (28,29). They include a high complementarity to
the 3′ end of the anti-sense box, with no more than one mis-
match over at least seven nucleotides, and no bulges (29). A
few snoRNAs including U3, U8, U13 have been found to
be essential for the processing of rRNA precursors in mul-
tiple species, whereas U14 functions in both guiding 2′-O-
methylation as well as rRNA precursor processing (30–33).
Until the introduction of the crosslinking, ligation and
sequencing of hybrids (CLASH) (34), experimental char-
acterization of snoRNA target sites was laborious and ad-
dressed only a few sites at a time (35). Progress on method
development was further driven by the need to general-
ize target identification approaches to other guide RNAs,
such as the miRNAs (36). Interestingly, miRNA–target hy-
brids are produced by the action of endogenous ligases
and can be obtained through crosslinking and immuno-
precipitation (CLIP) of Argonaute proteins, without a spe-
cific ligation step (37). MiRNA targets inferred from the
chimeric reads obtained with CLIP seem to behave more
as canonical miRNA targets, responding more strongly
to miRNA transfection, than CLASH-determined targets
(38). Whether snoRNA–target chimeras can also be ob-
tained from the CLIP of core snoRNPs has not been in-
vestigated.
In parallel with the capture of snoRNA–target interac-
tions, efforts were undertaken to map 2′-O-methylated ri-
boses in ribosomal RNAs, also in high-throughput (2). Tak-
ing advantage of the resistance of 2′-O-methylated riboses
to alkaline hydrolysis, the RiboMeth-seq method was used
tomap 54 annotated and 1 predicted 2′-O-methylated site in
Saccharomyces cerevisiae and is now applied to the profiling
of rRNA modifications in human cells as well (39).
Studies from various groups have recently expanded the
set of human snoRNAs, beyond those that are catalogued
in snoRNAbase (https://www-snorna.biotoul.fr/ (40)) (41–
44). Taking advantage of the processing pattern that most
C/D-box snoRNAs seem to follow (42) and of the small
RNA sequencing data sets generated by the ENCODE con-
sortium, we have recently constructed an updated catalog
of human snoRNAs (44). Interestingly, in data sets from
both small RNA sequencing and from core snoRNP CLIP
we reproducibly identified snoRNA-like sequences which
contained only a subset of the C/D box snoRNA-specific
sequence elements. For most snoRNA-like molecules we
could not predict target sites.
Given the surge in data sets pertaining to snoRNA inter-
actions, we here sought to provide relevant computational
analysis methods. First, we developed a model to identify
chimeric sequences, composed of a C/D box-containing
RNA and a corresponding target part, among the reads
obtained by CLIP of core C/D-box snoRNPs. To fur-
ther enable the functional characterization of the chimera-
documented interactions, we developed a model to identify
sites of 2′-O-Me fromRiboMeth-seq data (2). Our data sup-
ports the concept that some rRNA sites are only partially
methylated (39) and indicates that some of the snoRNAs
which are not known to guide 2′-O-methylation interact
with sites whose methylation is guided by other snoRNAs.
Interactions with strong chimeric read support outside of
the canonical snoRNA targets, do not seem to lead to 2′-O-
ribosemethylation that can be detectedwithRiboMeth-seq.
This suggests that the sensitivity of RiboMeth-seq is low or
that C/D box snoRNA interaction with non-canonical tar-
gets may serve yet uncharacterized functions.
MATERIALS AND METHODS
CLIP of snoRNP core proteins
To identify chimeric snoRNA–target reads, we analyzed
five CLIP data sets that were published before (42): two
NOP58-CLIP (Gene Expression Omnibus (GEO) acces-
sion numbers GSM1067861 and GSM1067862), 1 NOP56-
CLIP (GEO accession # GSM1067863) and 2 FBL-CLIP
(GEO accession # GSM1067864 and GSM1067865). We
also generated an additional FBL-CLIP data set with the
protocol described in (45) (GEO accession GSE77027).
Identification of snoRNA–target chimera
SnoRNA and target sets. We obtained the most compre-
hensive annotation of human snoRNA sequences, genome
coordinates and known or predicted targets from the hu-
man snoRNA atlas that was recently published (44). We
downloaded the sequences of known snoRNA targets
(rRNA and snRNA) from the snoRNA database (40) and
we further obtained tRNA sequences fromGtRNAdb (46).
We added one tRNA sequence per codon to the set of pu-
tative snoRNA targets. The database of putative snoRNA
targets thus consisted of the GRCh37 version of the hu-
man genome assembly, augmentedwith rRNA, snRNAand
tRNA sequences.
Computational analysis of chimeric reads
Analogous to a previous study that developed a strategy
to uncover chimeric miRNA–target reads from Argonaute-
CLIP data (37), we here developed a method that uses
snoRNA-specific information to identify snoRNA–target
chimera in core snoRNP CLIP data sets. The challenge is
that the very low frequency of chimeric reads in CLIP data
sets and the short length of the snoRNA and target parts in
the typically short reads obtained from CLIP can lead to a
high rate of false positive chimeras, making it necessary to
use additional information, such as the specific pattern of
hybridization of the guide RNA to the target.
Read selection. We carried out an initial annotation of
CLIP data sets with the CLIPZ web server (47), which pro-
vides as output genome-mapped reads with their respec-
tive annotations, as well as the unmapped reads. Because
we look for snoRNA–target interactions that take place
within the snoRNP complex, we expect that target sites are
also captured on their own in the core snoRNP CLIP, just
as miRNA targets are captured in Argonaute-CLIP (48).
Thus, to reduce the search space, we used clusters of at least
two overlapping genome-mapped reads as putative target
regions. To have sufficiently long snoRNA and target parts
in the chimeric reads, we only used unmapped reads longer
than 24 nucleotides.
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Detection of snoRNA subsequences in unmapped reads.
To speed up the identification of snoRNA subsequences
within unmapped reads we first generated all possible sub-
sequences of 12 nucleotides in length (‘anchors’) from all
snoRNAs. We then searched the unmapped reads for ex-
act matches to any of these anchors and, when a match
was found, we carried out the local alignment of the re-
spective snoRNA to the unmapped read with the swalign
python package (https://pypi.python.org/pypi/swalign) (pa-
rameters for a match = 2, mismatch = −5, gap opening =
−6, gap extension = −4). For each chimeric read, we re-
tained only the snoRNA(s) with the best local alignment
score. To evaluate the significance of the alignment scores,
we applied the same procedure to shuffled reads. For most
of the reads, the score of the alignment with the snoRNA
presumed to be contained in the read was much higher
compared to the score of aligning the snoRNA to a shuf-
fled version of the read (Supplementary Figure S1A). Thus,
as it appears that many unmapped reads indeed contain
snoRNA subsequences, we split chimeric reads into the part
that could be aligned to a snoRNA (the ‘snoRNA frag-
ment’) and the rest of the read (‘putative target fragment’).
All reads with a putative target fragment of at least 15 nu-
cleotides were considered candidate chimeras which we an-
alyzed further as described below.
Annotation of putative target fragments extracted from
chimeric reads
The search space for putative target fragments consisted
of CLIPed sites as well as rRNA, snRNA and tRNA se-
quences, which we explicitly included because the refer-
ence genome assembly may not contain all of the repeti-
tive loci of these RNAs. As the PAR-CLIP protocol yields
reads in which C nucleotides are incorporated at the sites of
crosslinked U’s, before carrying out the mapping of the pu-
tative target fragments we generated single-point variants
of the reads, with one C nucleotide changed to a U (37).
For the mapping, we used Bowtie2 (49) in the local align-
ment mode with the following command line parameters:
-f -D100 -L 13 -i C, 1 –score-min C, 30 –local -k 10. For
reads that mapped to multiple genomic loci, we checked
whether at least one of these loci corresponded to a canon-
ical snoRNA target, rRNA or snRNA. If so, we kept only
the canonical locus. Otherwise, we kept all putative target
loci. The statistics for each experimental data set can be
viewed in Supplementary Table S1.
Training a model of snoRNA–target interaction
To better distinguishing bona fide snoRNA–target interac-
tions captured in chimeras from false positives, we devel-
oped an additional model as follows. We extracted putative
target sites that were captured in multiple chimeras with the
same snoRNA and had a PLEXY-predicted energy of in-
teraction (28) lower than -12 kcal/mol. From the combined
CLIP experiments we identified 362 such sites in the 28S
and 18S ribosomal rRNAs. 67 of these are known to un-
dergo 2′-O-ribose methylation (we called these ‘positives’),
whereas for the remaining 295 sites a modification is not
so far known to occur (‘negatives’). For each site, we cal-
culated the features described below and trained a model
to predict the class (‘positive’ or ‘negative’) of sites in the
28S rRNA. We evaluated the performance of the model us-
ing the the known modification sites on the 18S rRNA as
true positives and all other sites in the 18S rRNA as true
negatives. As the performance was high, we combined the
two data sets and retrained a model for the comprehensive
identification of snoRNA–target interactions.
Feature definition and computation
Predicted energy of snoRNA–target interaction. PLEXY
is a tool for the transcriptome-wide prediction of C/D
box snoRNA targets. It uses nearest-neighbor energy pa-
rameters to compute thermodynamically stable C/D-box
snoRNA - target RNA interactions (28,50), but applies ad-
ditional rules to further reduce the false positive rate. For
each putative target fragment that mapped to the database
of putative targets (see section SnoRNA and target sets)
we extracted a 50 nucleotides long sequence centered on
the target part of the chimeric read, and calculated its in-
teraction energy with the snoRNA also identified from the
chimeric read. PLEXY also assigns the position of the
snoRNA-induced modification and we kept this informa-
tion for further analyses. To assess the value of the PLEXY
score in identifying bona fide interactions, we shuffled the
snoRNA associated with each target part in a chimeric read
and repeated the calculation.
Target site accessibility. Known snoRNA–target site in-
teractions involve perfect base-pairing of the nucleotides at
the 3′ end of the anti-sense box, which is anchored at the
D box. This interaction region defines the 5′ end of the tar-
get site. Therefore, we defined the accessibility of the target
region as the probability that the 5′-anchored 21 nts-long re-
gion in the target is in single stranded conformation within
an extended region of 30 nucleotides upstream and 37 nu-
cleotides downstream of 5′ end of the putative site. We com-
puted this value with CONTRAfold (51).
Nucleotide content of flanking regions. We defined the
‘Flanks A content’ as the proportion of adenines within the
67 nts-long region defined above. We similarly computed
frequencies of other nucleotides. Because the frequency of
adenines was most predictive of true interaction sites (Sup-
plementary Figure S2) we only used this feature in the
model.
Model training
The histograms constructed separately for the positive and
negative sites in the 28S and 18S rRNAs indicated that the
features described above are informative for distinguish-
ing positive from negative sites (Figure 1) and we therefore
trained a generalized linear model (GLM) with the logit
link function (logistic regression) using these features, with
the Statsmodels python library (52). We built the model
based on all 18S rRNA and 28S rRNA sites. The code that
we used to extract putative snoRNA–target interactions
from CLIP data can be obtained from the github (https:
//github.com/guma44/snoRNAHybridSearchPipeline) and
additional information is available on the accompanying
web site (http://www.clipz.unibas.ch/snoRNAchimeras).
 at U
niversity of Basel/ A
284 U
PK
 on January 3, 2017
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
34
4 Nucleic Acids Research, 2016
Figure 1. Features that are relevant for the identification snoRNA–target interactions based on chimeric reads. Distributions of (A) the interaction energy
calculated with PLEXY (28), (B) the target site accessibility calculated with CONTRAfold (51) and (C) the A nucleotide composition of the neighborhood
of positive (known) and negative (captured in chimeras but unknown) snoRNA interaction sites. (D) Correlation between features used for model training
and the indicator function, taking the value of −1 for negative and 1 for positive sites. (E) Receiver operating characteristic (ROC) curve and (F) Precision-
Recall (PR) curve constructed based on snoRNA target predictions in 18S rRNA with the model trained on 28S rRNA target sites.
Annotation of modification sites
We annotated the biotypes of the targets in which predicted
modification sites resided based on the ENSEMBL version
75 (53) and the RMSK table from University of California
Santa Cruz genome browser (54), for the repeat elements.
From the known interactions that we retrieved with our
model from chimeric reads, we separately extracted those
that involve the anti-sense elements at the D and D’ boxes
and constructed profiles of coverage of the corresponding
snoRNAs by fragments from chimeric reads, relative to the
position of the D box. As shown in Supplementary Figure
S1B and C, the appropriate anti-sense elements were cap-
tured preferentially in chimeric reads, although other parts
of the snoRNAs have also been ligated with some frequency
to the targets.
RiboMeth-seq
Preparation and sequencing of RiboMeth-seq libraries. The
principle behind RiboMeth-seq is that nucleotides with a
2′-O-Me ribose are resistant to alkaline hydrolysis. Thus,
products of partial alkaline hydrolysis should not start or
end at 2′-O-Me sites, leading to an underrepresentation of
these positions among read starts and ends. The read starts
and ends thus provide a negative image of the methylation
landscape (2).We carried out RiboMeth-seq experiments in
HEK 293 cells, using either total RNA or poly(A)-enriched
RNA from either the nucleus or cytoplasmic fractions. We
also carried out the alkaline hydrolysis for different time in-
tervals of 8, 14 or 20 min. The samples that we prepared
were as follows:
RiboMethSeq HEK totalRNA 8min
RiboMethSeq HEK totalRNA 14min
RiboMethSeq HEK totalRNA 20min
RiboMethSeq HEK polyARNA 8min
RibomethSeq HEK cytoplasmic1 14min
RibomethSeq HEK cytoplasmic2 14min
RibomethSeq HEK nuclear1 14min
RibomethSeq HEK nuclear2 14min
We extracted total RNA with TRI Reagent (Sigma)
and prepared the mRNA with the Dynabeads mRNA DI-
RECTKit (Life Technologies), fromHEK293 cells accord-
ing to themanufacturer’s instructions. Formapping of 2′-O-
methyl sites in rRNA we used 1 g of total RNA as start-
ing material. To explore the existence of 2′-O-methyl sites in
mRNAs, we used poly(A)-selected RNA (200 ng). In both
protocols, the RNA was partially degraded under alkaline
conditions in a sodium carbonate/bicarbonate buffer at pH
9.2 for 14 min and then put on ice. Samples were sepa-
rated parallel to a low molecular weight marker ladder (10–
100 nt) on a 15% denaturing polyacrylamide gel for 1 h at
1400 V and 20 W. The gel was stained with GR Green nu-
cleic acid stain (Excellgen) for 3 min and fragmented RNA
ranging from 20 to 40 nt was cut out from the gel and ex-
tracted overnight in 0.4 M NaCl. The RNA was precipi-
tatedwith 1l of co-precipitant (GlycoBlue) in 75% ethanol
at −20◦C for 2 h and then centrifuged at maximum speed
for 10 min at 4◦C. The RNA pellet was washed twice with
70% ethanol and air-dried. The pellet was dissolved in wa-
ter, the RNA was dephosphorylated with FastAP alkaline
phosphatase (Thermo Scientific) at 37◦C for 30 min and
the enzyme was heat-inactivated at 75◦C for 10 min. Subse-
quently, the RNA was phosphorylated with polynucleotide
kinase (Thermo Scientific) in the presence of 1 mM ATP
at 37◦C for 1 h and then extracted with phenol-chloroform
and precipitated in 80% ethanol, washed with 70% ethanol
twice and air-dried. The pellet was dissolved in 8 l mix
(4 l H2O, 1 l 10× truncated T4 RNA Ligase 2 buffer,
1 l 100 uM 3′ rApp-adapter (5′ adenylated 3′ adapter,
5′-App-TGGAATTCTCG GGTGCCAAGG-amino-3′), 2
l 50% DMSO), denatured at 90◦C for 30 s and chilled
on ice. Next, RNasin Plus RNase inhibitor (Promega) and
 at U
niversity of Basel/ A
284 U
PK
 on January 3, 2017
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
35
Nucleic Acids Research, 2016 5
T4 RNA Ligase 2 truncated were added to a final con-
centration of 2 U/l and 30 U/l, respectively, and the
reaction was incubated at 4◦C for 20 h over night. The
next day, 1 l of RT primer (100 M; 5′-GCCTTGGCAC
CCAGAGAATTCCA-3′) was added (for quenching of re-
maining 3′ adapter molecules, preventing adapter dimers
ligation in the next step), the samples were heated at 90◦C
for 30 s, at 65◦C for 5 min, then placed on ice. A 5′-adapter
ligation mix was then directly added to the sample (1.5 l
10 mM ATP, 1 l 100 uM 5′ RNA Adapter RA5 (Illumina
TruSeq RNA sample prep kit), 1 l T4 RNA Ligase 1 (20
U/l), 0.5 l RNasin Plus RNase inhibitor (40 U/l) and
reactions were incubated at 20◦C for 1 h and 37◦C for 30
min. The RNA was then directly reverse transcribed in a 30
l reaction by adding dNTPs to 0.5 mM, DTT to 5 mM,
1× SSIV buffer, RNAsin to 2 U/l and 1 l Superscript IV
reverse transcriptase (Life Technologies). The sample was
incubated at 50◦C for 30 min and inactivated at 80◦C for
10 min. 5 l of the resulting cDNA was then used in a pi-
lot polymerase chain reaction (PCR) reaction. To this end,
aliquots were taken from reactions at every second cycle be-
tween 12 and 22 cycles and analyzed on a 2.5% agarose gel.
The number of cycles causing a first visible amplification
was chosen for a large scale PCR (10 l cDNA in a 100 l
reaction). The PCR product was ethanol precipitated and
run along a 20 bpmarker on a 9%non-denaturing polyacry-
lamide gel in TBE for 1 h at 250 V, 20 W. The gel was dis-
mantled and stained for 3 min with GR Green. PCR prod-
ucts between 125 and 175 bp were cut out, the gel piece
was mashed and DNA was eluted overnight into 400 l
of H2O. The supernatant was separated from the gel par-
ticles in a SpinX filter column (Costar), NaCl was added to
0.4 M, DNA was ethanol precipitated, the pellet washed in
75% ethanol and dissolved in 20 l H2O. Libraries were se-
quenced on an Illumina HiSeq-2500 deep sequencer (GEO
accession:GSE77024). Their summary can be found in Sup-
plementary Table S2.
Mapping of RiboMeth-seq reads. We obtained
∼50 million reads for each of the RiboMeth-seq
samples. We removed adaptors with Cutadapt (–
minimum-length 15, other parameters left with
default values) (55) and mapped the reads with
STAR (parameters: –outFilterMultimapNmax
20 –outFilterMismatchNoverLmax 0.05 –
scoreGenomicLengthLog2scale 0 –outSAMattributes
All) (56) to a human GRCh37 assembly version-based
transcriptome composed of rRNAs, snRNAs, tRNAs and
snoRNAs (see SnoRNA and target sets section) as well as
to lincRNAs, miscRNAs, and all unspliced protein coding
genes (obtained from GRCh37 version of ENSEMBL,
http://grch37.ensembl.org/index.html (53)).
Computation of the RiboMeth-seq score. For each target
of interest such as the 18S rRNA, we calculated the log2
normalized (to a total library size of 106 reads) profile of
cleavage positions. We used separately the 5′ and 3′ ends of
the reads, as both ends are determined by alkaline hydroly-
sis. We then calculated the angle defined by the log2 cover-
age values at positions−1, 0 and +1 for each position along
the RNA. An angle of 180◦ indicates that the frequency
of cleavage at the three adjacent positions is identical, 0◦
indicates that the central position has very high coverage
compared to the neighboring positions (and is therefore not
protected from cleavage) and 360◦ indicates that the cen-
tral position has no coverage (and therefore it is protected
from cleavage) compared to the neighboring positions. As
a RiboMeth-seq score we took the average angle computed
based on 5′ and 3′ read ends. We used a score threshold
of 290◦ for predicting sites in individual RiboMeth-seq ex-
periments, favoring slightly recall over precision. Detailed
statistics for individual experiments can be found in Supple-
mentary Table S2. Finally, we used putative 2′-O-Me sites
that had a score above the threshold in at least one experi-
ment and calculated their average score across the seven ex-
periments. To determine a threshold for this average score
and then compute the PR curve and Matthews correlation
coefficient, we included among the positives the 19 sites that
were did not score above the threshold in any individual ex-
periment, but are known to undergo methylation. This re-
sulted in a set of 105 known sites in the 18S and 28S rRNAs.
Validation of 2′-O-methylation sites with RTL-P
Similar to the classic primer extension assays (57), the ‘Re-
verse Transcription at Low deoxy-ribonucleoside triphos-
phate (dNTP) followed by polymerase chain reaction’
method (RTL-P, (58)) takes advantage of the observation
that cDNA synthesis through a 2′-O-Me nucleotide is im-
paired when dNTPs are limiting. However, RTL-P is sim-
pler and more sensitive than primer extension assays. RTL-
P consists of a site-specific primer extension by reverse
transcriptase at a low dNTP concentration and a semi-
quantitative PCR amplification step, followed by agarose
gel electrophoresis to obtain ratios of PCR signal intensities.
To increase sensitivity and reproducibility, we implemented
a real-time PCR (qPCR) step to facilitate the analysis of the
signal intensities (qPCR parameters and primer sequences
are shown in Supplementary Table S3).
Validation of 2′-O-methylation at G2435 in 28S with mass
spectrometry
The rRNA fragment isolation for mass spectrometry anal-
ysis (MS) was adapted from (59). The isolated fragment
was treated with RNase T1 to yield a specific digestion pat-
tern and dephosphorylated prior to LC–MS/MS analysis.
As reference we used 11-nts long synthetic RNA oligonu-
cleotides identical in sequence to the 28S rRNA around the
G2435 site. 20 pmol of the unmodified synthetic UCCU-
GAGAGAU as well as the 2′-O-methylated synthetic vari-
ant UCCUG*AGAGAU (the methylated G is indicated by
*) were subjected to RNase T1 digestion and dephosphory-
lation.
Samples were analyzed on a LTQ-Orbitrap Elite mass
spectrometer (Thermo Fisher Scientific) using a targeted
LC-MS/MS workflow as described recently (60). UCCUG
and UCCUG* specific MS assays were generated from the
synthetic RNA oligonucleotides and applied to all samples.
Data analysis was carried out using the Qual Browser tool
of the Xcalibur software (version: 3.0.63). Full details of
the sample preparation and LC-MS/MS experiment are de-
scribed in Supplementary Figure S3.
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RESULTS
Crosslinking and immunoprecipitation of core snoRNPs cap-
tures snoRNA–target site chimeras
Although miRNAs and snoRNAs differ entirely in their
function, they share the ability to guide ribonucleopro-
tein complexes to target RNAs. Thus, by analogy with
miRNAs (37), we hypothesized that chimeric molecules,
composed of snoRNAs and their targets, are captured in
CLIP experiments that target one of the core snoRNP
proteins. Therefore, we designed a method to identify
snoRNA–target chimeric reads from among the unmapped
(to genome or transcriptome) reads obtained in six photore-
active nucleoside-enhanced (PAR)-CLIP experiments that
targeted one of the NOP58, NOP56 and FBL proteins. We
found that on average, ∼10% of the reads that were not
mapped to the genome or transcriptome had at least a 12-
nt match to a snoRNA. However, only for ∼half of these
reads was the remaining, putative target part of the read,
longer than 15 nucleotides. Because multi-family snoRNAs
have very low expression in the HEK 293 cells, most of the
putatively chimeric reads yielded a high-scoring alignment
to a single snoRNA, and only ∼20% aligned to multiple
snoRNAs. A summary of the data obtained in all of these
experiments is shown in Supplementary Table S1. To deter-
mine whether the apparent snoRNA–target chimera do re-
flect real interactions, we randomized the snoRNAassigned
to each target fragment in the chimeras and calculated the
predicted energies of interaction of the real and randomized
pairs of molecules with PLEXY (28). Although the interac-
tion energy predicted for the presumed chimeras was sig-
nificantly lower compared to randomized sequence pairs,
the difference between the average PLEXY energies was
relatively low (∼1.2 kcal/mol, Figure 2A). This indicated
that that a more sophisticated approach is needed to reli-
ably identify snoRNA–target interactions from these data,
which likely contain a large number of false positives.
Amodel to identify high-confidence snoRNA–target chimeras
For training a model to predict snoRNA–target interac-
tions, we selected presumed snoRNA–rRNA chimeras with
low predicted energy of interaction (<−12 kcal/mol), sep-
arated them into those containing ‘positive’ target sites
(known from previous studies) and those containing ‘neg-
ative’ target sites (not known to undergo snoRNA-guided
methylation) and compared the distributions of features
that have been found to play a role in other small RNA-
guided interactions (61) between the two sets. The PLEXY
interaction score (28) discriminated best these two data sets
(as shown in Figure 1A and D). However, known snoRNA
target sites also reside in structurally accessible regions (Fig-
ure 1B), rich in adenines (Figure 1C). We used chimeric
reads involving the 28S rRNA to train a generalized linear
model (GLM) based on these features and then tested the
model on chimeric reads involving the 18S rRNA. The area
under the receiver operating characteristic (ROC) curve was
∼85%, the model being able to recall 70% of the known in-
teraction sites with 65% precision (Figure 1E and F). We
then combined the sites in the 28S and 18S rRNAs, re-
trained the model, and found that at a score threshold of
0.15 we obtained good performance in predicting rRNA
modification sites, with a Matthews correlation coefficient
(MCC) of ∼0.75, precision of 0.75 and recall value of 0.74
(Figure 2B–D). Our predictions finally consisted of putative
interactions that were supported by chimeric reads from at
least two experiments and had a minimum score of 0.15.
For completeness, we have also predicted interactions in in-
dividual data sets and show the overlap of sites obtained in
pairs of experiments in Supplementary Figure S4.
Chimeric reads reveal novel C/D box snoRNA target sites
within structural RNAs
We applied the derived model to the full chimeric read
data and identified 980 putative interactions, involving 852
unique target sites. We focused on the snoRNA interactions
with structural RNAs, including not only the rRNAs, but
also snRNAs, tRNAs and the snoRNAs themselves. Only
one of the 2′-O-Me sites in rRNAs that have been mapped
so far is is ‘orphan’, meaning that its guide snoRNA is
unknown. Our data indicates that this modification, lo-
cated at position A1383 in the 18S rRNA (62), is guided
by SNORD30 (Figure 3A), a snoRNA which was reported
to guide the 2′-O-methylation at position A3804 in 28S
rRNA (63). The chimeric reads also revealed 35 potentially
novel 2′-O-Me sites in rRNAs (13 in 18S rRNA, 21 in 28S
rRNA and 1 in 5.8S rRNA), some of which were found
in interaction with multiple snoRNAs, thus correspond-
ing to 40 novel interactions. Eleven of the 40 interactions
involve snoRNAs that have been so far classified as ‘or-
phan’ (Supplementary Table S4). As an example, a snoRNA
of unknown family (snoID 372) was found in three exper-
iments in interaction with the 28S rRNA (predicted en-
ergy of interaction of −24.8 kcal/mol), in which it may
guide the modification at position 4953 (Figure 3B). Sim-
ilarly, in two experiments we found the recently uncovered
snoID 0701 (family unknown) orphan snoRNA, which has
low but broad expression across tissues (44), in a very sta-
ble (−28.2 kcal/mol) interaction with the 28S rRNA. This
snoRNA is predicted to guide the 2′-O-methylation at posi-
tion U2756 (Figure 3C).
SnRNAs are also known targets of scaRNA-guided 2′-O-
methylation. Of the nine such sites that are known, we were
able to recover four over our prediction threshold. Addi-
tionally, we identified chimeric reads of the SNORD23, a
snoRNA that is currently considered orphan, with the U6
snRNA (Figure 3D). In previous work (42), we have studied
themethylation pattern of this snRNAby primer extension.
We found evidence of 2′-O-methylation at positions 60, 62
and 63 of U6, but not at position 64, which is predicted to
be modified as a result of the interaction with SNORD23.
Thus, the significance of this interaction, supported by 11
reads in our data, remains to be determined.
Additionally, we identified three apparent interac-
tions of snoRNAs with other snoRNAs (SNORD5 with
SNORD56, SNORD50 with SNORD57 and SNORD34
with SNORD38A), as well as an intra-molecular chimera
of SNORD4B. The predictions are summarized in Supple-
mentary Table S4 and all alignments of putative chimeric
reads to putative target sites and snoRNAs can be viewed
at http://www.clipz.unibas.ch/snoRNAchimeras/.
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Figure 2. Characterization of the model for inferring snoRNA–target interactions from chimeric reads. (A) Empirical cumulative distribution function of
the interaction energy estimated with PLEXY between target fragment and snoRNA found in the chimera (’Real chimeras’) or between target fragment
and a randomly assigned snoRNA (’Shuffled snoRNA’). P-value from the Mann–Whitney U test is also shown. (B) Metrics illustrating the performance
of the method, as a function of the minimum average probability of the considered sites from the 18S and 28S rRNAs. (C) Precision-Recall curve for the
method. (D) Matthews correlation coefficient (MCC) as a function of the minimum average probability of the considered sites.
Figure 3. Schematic representation of snoRNA–target interactions that are predicted based on chimeric reads fromCLIP experiments. For each interaction,
the snoRNA sequence is shown at the top and the target sequence at the bottom of the panel. ‘/’ indicates that only part of the sequence is shown, for
readability. Regions of both snoRNAs and targets that are represented in the chimeric reads are encompassed in blue boxes. Indicated are also the presumed
C/C’ and D/D’ boxes as well as the number of chimeric reads supporting each of the interactions. PLEXY-predicted sites of 2′-O-methylation are marked
by ‘m*’ and the previously mapped site is labeled with ‘m’.
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Redundant targeting of known sites of 2′-O-ribose methyla-
tion by multiple snoRNAs
One of the main open questions in the snoRNA field con-
cerns the targets and functions of the 330 orphan snoR-
NAs, which belong to 219 families (44). As mentioned in
the introduction, some of these snoRNAs are involved in
pre-rRNA processing. Interestingly however, the chimeric
read data shows that SNORD118, also known as U8, a
snoRNA which is necessary for the proper maturation of
5.8S and 28S rRNAs (31), interacts with the region of the
28S rRNA where the SNORD80 is known to guide the
modification of G1612. The evidence for this interaction is
very strong, chimeras having been captured in six distinct
experiments (Figure 4). Although the base-pairing between
SNORD118 and the putative target site is not as extensive
as that of the SNORD80 snoRNA, it still includes 10 con-
secutive base-pairs, two of which are G-U base pairs. This
example suggests that some snoRNAs are capable of inter-
acting with sites whose 2′-O-methylation is guided by other
snoRNAs. We detected fragments from 66 orphan snoR-
NAs in chimeric reads.
Identification of snoRNA-guided 2′-O-Me sites with
RiboMeth-seq
Surprisingly, ∼300 predicted interaction sites mapped to
loci encoding protein-coding genes. To evaluate whether
these sites could undergo 2′-O-methylation, we imple-
mented a high-throughput version of the recently devel-
oped RiboMeth-seq method (2). To be able to capture
non-canonical targets, we carried out seven experiments,
six using total RNA, which contained both the canonical
rRNAs targets as well as other RNA species, and one us-
ing poly(A)+ RNAs, which was thereby strongly enriched
in mRNAs. Two of the total RNA samples were prepared
from total cell lysate, two from the nuclear fraction and two
from the cytoplasmic fraction.
2′-O-Me sites were previously identified fromRiboMeth-
seq by comparing the number of reads ending at a particular
position in the target with the average number of reads end-
ing at the flanking regions (‘score A’ in (2)). Reasoning that
2′-O-methylation of adjacent nucleotides is very rare and
that 2′-O-Me positions should yield much fewer cleavage
events compared to the unmethylated adjacent nucleotides,
we here tested additionally another score. Specifically, at
each position of a target of interest (e.g. 18S rRNA), we
evaluated the shape (angle) of the trough defined by the log2
normalized read coverage at the specific position and the
immediately adjacent positions (Figure 5A). We found that
this score yields a higher precision compared to the ‘score
A’ proposed before (2) (Figure 5B and C) and a very high
Matthews correlation coefficient in classifying the sites (Fig-
ure 5D).
Applying this method to the combined RiboMeth-seq
data, we identified 168 2′-O-Me sites, 80 of which were
known. These included 32 out of the 45 known 2′-O-Me
sites in 18S rRNA (71%), 44 out of the 60 in 28S rRNA
(73%), the known site at position 75 in 5.8S rRNA, 2 sites
in the U6 snRNA and one site in U1 snRNA. Figure 6
shows the location of previously known 2′-O-methylation
sites in the 18S and 28S rRNAs, as well as the corresponding
chimeric read andRiboMeth-seq evidence that we obtained
here for these rRNAs. The 88 novel sites weremostly located
in canonical snoRNA/scaRNA targets––snRNA, rRNAs
and tRNAs––34 being located in other RNA species. Al-
though both the chimeric read method and RiboMeth-seq
identified the majority of known 2′-O-Me sites, with com-
parable sensitivity (∼70%), none of the 34 novel target sites
in structural RNAs that were found in chimeric reads had a
RiboMeth-seq score above the threshold.
PositionG2435 in the 28S rRNA, captured in interaction with
SNORD2, is partially methylated
To assess whether the limited sensitivity of RiboMeth-seq
could be a reason for the limited validation of sites that are
reproducibly captured in chimeric reads, we investigated in
depth the predicted SNORD2-guided 2′-O-methylation of
position G2435 in the 28S rRNA. This interaction was cap-
tured in four CLIP experiments (Figure 7A).
We applied the recently published method ‘Reverse Tran-
scription at Low deoxy-ribonucleoside triphosphate con-
centrations followed by polymerase chain reaction’ (RTL-
P) (58), which we then followed with qPCR, to improve
quantification. After showing that the method yields the ex-
pected results on a positive (position A1031 in the human
18S rRNA) and a negative control (U1991 in 28S rRNA)
(Supplementary Figure S5), we tested position G2435 in
28S rRNA.We found that the unanchoredMeU-RT primer
yielded significantly less cDNA and hence PCR product
than the anchored MeA-RT primer at low dNTP concen-
trations (Figure 7B), indicating that the site indeed carries
a 2′-O-Me modification.
To unambiguously show that the RT stoppage at G2435
is due to 2′-O-methylation, we applied targeted mass spec-
trometry (60). Figure 7C shows the extracted ion chro-
matograms of specific UCCUG* fragments that were mea-
sured in 28S rRNA as well as in a control sample.Wemanu-
ally checked the identities of the employed fragments using
the control sample (Supplementary Figure S3A) and found
that they matched those obtained from the HEK rRNA
(Supplementary Figure S3B), confirming the presence of
UCCUG* in the HEK sample. The LC-MS analysis also
identified the unmodified fragment UCCUG from HEK
rRNA (Supplementary Figure S3C), albeit at a lower level
thanUCCUG* (Supplementary Figure S3D). These results
show that the G2435 28S rRNA site identified among the
chimeric reads is predominantly 2′-O-methylated.
mRNAs captured in chimeras with snoRNAs do not show ev-
idence of 2′-O-methylation
Finally, we wondered whether some of the chimera-
supported interactions that did not reside in the typi-
cal snoRNA targets, particularly those annotated as be-
ing located in mRNAs, were also below the sensitivity
of RiboMeth-seq. We therefore applied RTL-P to four
mRNA-annotated sites, located in APP, CCDC93, DHFR
and ZC3H12C transcripts, but did not find evidence of 2′-
O-methylation (data not shown).
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Figure 4. Similar to Figure 3, representation of the data supporting the interaction of both SNORD80 and SNORD118 with the 28S rRNA, around the
known position of 2′-O-methylation at G1612.
Figure 5. Analysis of RiboMeth-seq data. (A) Strategy for evaluating the
RiboMeth-seq data. The score was calculated based on the normalized
log2 coverage of a position and of its immediately adjacent neighbors by
RiboMeth-seq reads. A large score indicates stronger depletion of the po-
sition by 3/5 ‘ ends of reads and thus resistance to alkaline hydrolysis. (B)
Example of a normalized log2 coverage profile along 28S rRNA and cal-
culated scores (Angle and Score A). With red dashed lines positions of
known 2′-O-methylation sites are indicated. The red rectangles indicates
regions where no 2′-O-methylation has been mapped, which is also pre-
dicted by the angle score but not by score A. (C) Example of Precision-
Recall curves obtained for the two scoringmethods applied to rRNAs from
the RiboMethSeq HEK totalRNA 8min experiment. (D) Matthews cor-
relation coefficient (MCC) plot of average RiboMeth-seq score indicating
the optimal angle score.
DISCUSSION
High-throughput sequencing of samples prepared from
cells that underwent various treatments have enabled the
characterization of transcriptomes at ever increasing depth
and resolution. This lead to the realization that the non-
coding transcriptome is as large as the protein-coding frac-
tion (64). New members of all classes of RNAs, includ-
ing miRNAs and snoRNA have also been discovered (65,
66). The large number of novel molecular species increased
the need for functional characterization methods, ideally in
high-throughput. The aim of our study was to provide such
methods for a specific class of non-coding RNAs, the C/D-
box snoRNAs.
Figure 6. Location of snoRNA interaction sites and 2′-O-ribose methy-
lation in the (A) 18S and (B) 28S ribosomal subunits. 2′-O-Me positions
that are known from literature are shown as black bars. Interaction sites
identified from chimeric reads are shown as blue bars, with their associ-
ated probabilities. The gray area indicates the score threshold that we used
to extract the high-confidence sites from chimeric reads. The locations of
2′-O-Me sites identified with RiboMeth-seq are shown with red lines and
dots.
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Figure 7. SNORD2-guided 2′-O-methylation of G2435 in the 28S rRNA (A) Schematic representation of the predicted interaction, which is supported by
28 chimeric reads (see also legend of Figure 3). (B) Confirmation of the G2435 2′-O-methylation by RTL-P followed by agarose gel analysis and followed
by qPCR analysis. Error bars represent the standard deviation of the mean, and the P -value of the t-test computed over three replicate experiments,
each with three technical replicates is indicated. (C) Targeted LC-MS/MS analysis of UCCUG*, confirming the 2′-O-methylation at G2435. A synthetic
RNA oligonucleotide control (on top) and fragment A2416-G2461 from 28S rRNA (at the bottom) were digested with RNase T1 and specific transitions
measured by targeted mass spectrometry.
We have combined two high-throughput approaches,
the first aiming to identify direct interactions between
snoRNAs and targets and the second to map sites of 2′-
O-methylation transcriptome-wide. The first approach is
based on the observation that chimeric reads, resulting from
the ligation of a guide RNA to its target by endogenous
ligases, are generated during CLIP (37). Whether CLIP of
core snoRNP proteins can be used to identify snoRNA tar-
gets has not been investigated so far. Due to the low fre-
quency of chimeric sequences (less than a percent of the
reads (37)), the large ‘background’ of CLIP (48), and the
short length of the snoRNA and target fragments that are
captured, a snoRNA-centric analysis, taking into account
the specific base-pairing pattern of snoRNAswith targets, is
necessary.We found that amodel that uses the predicted en-
ergy of interaction between the snoRNA and target, the ac-
cessibility of the target site and the A nucleotide context of
the regions flanking the putative site, can identify over 70%
of the known 2′-O-Me sites in rRNAs, with similar speci-
ficity. The model assigns SNORD30 as guide for the ‘or-
phan’ A1383 site in the 18S rRNA, and identifies an inter-
action between the SNORD118 snoRNA, so far known to
be involved in pre-rRNA processing (31), with G1612 in the
28S rRNA,whosemethylation is guided by SNORD80. The
multi-copy nature of many of the ‘orphan’ snoRNAs, other
homologies that they have in the genome, and the presence
of crosslinking-induced mutations in the CLIP data pose
substantial challenges to the identification of their targets
and will benefit from an increase in the length of the reads
generated with CLIP.
The model also predicted 40 novel interactions with
rRNAs as well as many outside of structural RNAs. To
evaluate 2′-O-methylation at these sites we implemented the
RiboMeth-seq method (67). Although with this method we
were able to recover the majority of known methylation
sites, we did not find support for 2′-O-methylation of any
novel sites in rRNAs. To determine whether these results
are partly due to the limited sensitivity ofRiboMeth-seq, we
used low-throughput methods to evaluate 2′-O-methylation
at position G2435 site in the 28S rRNA, which was sup-
ported by chimeric read data from four experiments. Both
RTL-P and mass spectrometry provided evidence for 2′-O-
methylation at this site. These data, as well as a closer in-
spection of the RiboMeth-seq scores of this site in indi-
vidual experiments, indicate that the site is only partially
methylated. The cause and consequences of partialmethyla-
tion at rRNA sites will be fascinating topics for future stud-
ies, as the evidence for partial and cell type-specific methy-
lation of rRNAs is mounting (39,44). Of note, the interac-
tion of SNORD48 with C1868 in the 28S rRNA, presumed
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to lead to the observed partial methylation of this site (39)
was also captured in our chimeric read data. Another pos-
sibility to consider is that the CLIP-derived chimera pro-
vide evidence for snoRNA-rRNA interactions that are rel-
evant for rRNA processing but not 2′-O-methylation. In-
deed, it has been proposed that the ancestral function of
snoRNAs was in rRNA processing, a function that is still
preserved in the U3, U8, U13, and U14 snoRNAs (26,30–
32,68,69). Because the corresponding snoRNA-interacting
sites may also need to be structurally accessible and have
low-energy interaction with the snoRNAs, and because the
D/D’ box sequences are short and not perfectly conserved
in sequence, our method may misclassify these sites as 2′-
O-methylation sites. Because PLEXY enforces the snoRNA
interaction with the target to take place close to already an-
notated D boxes, we do not expect such cases in our final
list of candidates. However, a careful inspection of the hy-
brids and chimeric read alignments that we provide on the
accompanying web site should help identify these cases.
Although the chimeric read data suggested some interac-
tions of snoRNAs with mRNAs, we were not able to val-
idate these with RiboMeth-seq. This could be due to the
much lower expression of themRNAs compared to rRNAs,
which makes the reliable detection of troughs in read cov-
erage difficult. However, the RTL-P method also failed to
provide evidence of 2′-O-methylation at mRNA sites (not
shown). Thus, these sites may be the result of spurious lig-
ation events. Alternatively, the snoRNA interaction with
these sites may have other outcomes than 2′-O-methylation.
Consistent with this hypothesis, a recent study that analyzed
globally RNA–RNA interactions also found many interac-
tions of snoRNAs with mRNAs and further demonstrated
a function of SNORD83B in controlling the level of its tar-
get mRNAs (70).
Finally, RiboMeth-seq revealed a few high-confidence
sites for which we did not find any corresponding chimeric
reads. The low rate of capture of interactions in the chimeric
reads may account for this observation. Alternatively, the
RiboMeth-seq-documented sites may be resistant to alka-
line hydrolysis for reasons other than 2′-O-Me. Support-
ing this latter hypothesis, these sites are generally located in
rRNAs or snRNAs, molecules that are extensively modified
and highly structured. In contrast to the known modifica-
tion sites in rRNAs, which do not exhibit any nucleotide
bias, the new sites recovered by RiboMeth-seq show a
strong G-bias (not shown). This could again indicate that
these sites are spurious or that modifications are intro-
duced at these sites by specific enzymes such as the trans-
fer RNA methyltransferase 7 protein (71). Interestingly, a
recent study reported that G3771 in the 28S rRNA is 2′-
O-methylated, guided by SNORD15A (39). Although we
also find strong evidence for the methylation of this site in
our RiboMeth-seq data, we did not find chimeric read ev-
idence for SNORD15A acting as guide at this site. Rather,
our chimeric read data supports a previous prediction (72)
that SNORD15A guides the methylation at A3764 in the
28S rRNA.
Our study thereby provides computational methods that
enable themapping of snoRNA–target interactions in high-
throughput. We believe that the application of these two
complementary and high-throughput approaches, namely
interaction capture via CLIP-seq and RiboMeth-seq will
accelerate the accurate assignment of snoRNA guides to
already mapped as well as newly discovered sites of 2′-O-
methylation across cell types. This is especially relevant for
studying the landscape of rRNAmodification, which seems
to be much more dynamic than anticipated, and for ex-
tending the study of snoRNA-guided methylation beyond
species such as yeast and human.
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 4.1 Abstract 
Small nucleolar RNAs (snoRNAs) are a class of non-coding RNAs that guide the post-transcriptional pro-
cessing of other non-coding RNAs (mostly ribosomal RNAs), but have also been implicated in processes 
ranging from microRNA-dependent gene silencing to alternative splicing. In order to construct an up-to-
date catalog of human snoRNAs we have combined data from various databases, de novo prediction and 
extensive literature review. In total, we list more than 750 curated genomic loci that give rise to snoRNA 
and snoRNA-like genes. Utilizing small RNA-seq data from the ENCODE project, our study characterizes the 
plasticity of snoRNA expression identifying both constitutively as well as cell type specific expressed snoR-
NAs. Especially, the comparison of malignant to non-malignant tissues and cell types shows a dramatic per-
turbation of the snoRNA expression profile. Finally, we developed a high-throughput variant of the reverse-
transcriptase-based method for identifying 2’-O-methyl modifications in RNAs termed RiM-seq. Using the 
data from this and other high-throughput protocols together with previously reported modification sites 
and state-of-the-art target prediction methods we re-estimate the snoRNA target RNA interaction network. 
Our current results assign a reliable modification site to 83% of the canonical snoRNAs, leaving only 76 
snoRNA sequences as orphan. 
 4.2 Introduction 
Currently there are two known high-throughput methods that can be used to study 2’-O-ribose-
methylation transcriptome-wide: CLIP-seq and RiboMeth-seq. CLIP-seq captures direct snoRNA-target in-
teractions and RiboMeth-seq enables the identification of actual 2’-O-methyl modifications. Both of these 
methods were extensively described in CHAPTER 3. 
In this chapter of the thesis I would like to address only the part that I have contributed to the study “An 
updated human snoRNAome”, which is the new experimental method that we named RiM-Seq. We ap-
plied RiM-Seq to validate computationally predicted sites of 2’-O-methylation. We began the development 
of RiM-seq before we adapted RiboMeth-seq to validate 2’-O-methylation sites and CLIP-seq to identify 
chimeras. RiM-Seq can be viewed as another, supplemental method to confirm 2’-O-methylation sites tran-
scriptome-wide because its principle is different from those of RiboMeth-seq and CLIP-seq. RiM-Seq is es-
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sentially a high-throughput variant of the low-throughput reverse-transcriptase-based protocol which we 
used in the form of primer extension assays to validate individual 2’-O-Me’s in various targets in CHAPTER 2.  
 4.3 RiM-seq 
To validate predicted 2’-O-methylated residues transcriptome-wide we developed a high-throughput se-
quencing-based variant of the well-established, low-throughput reverse transcriptase-based protocol [156], 
which is usually coupled with polyacrylamide gel analysis. The method is based on the observation that 
cDNA synthesis is noticeably impaired in the presence of a 2’-O-methylation when deoxynucleoside tri-
phosphate fragments (dNTPs) are limiting [156, 157] (FIGURE 4.1). This gives rise to a characteristic pattern 
of gel banding immediately preceding the 2’-O-Me, with strong bands at low dNTP concentrations 
(0.004mM) [157] becoming weaker with increasing concentrations of dNTPs (CHAPTER 2). These stoppages, 
which correspond to 2’-O-methylation sites, will generate read ends when RNA fragments are reverse-
transcribed under different dNTP concentrations, ligated to adapters and sequenced. 2’-O-methyl positions 
can be subsequently identified by calculating the “stoppage ratio” of reads starting at a given position (5’ 
ends) to the reads that cover that position (readthrough reads + 5’ ends) and comparing this ratio between 
samples generated with low and normal, high dNTP concentrations.  
 
 
Figure 4.1 RiM-seq protocol. RNA is reverse transcribed under high (left) or low (right) dNTP concentration. When the dNTP concentration is low, 
reverse transcription in impaired in the presence of a 2’-O-methylation site.  
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Figure 4.2 RiM-seq readout. Plot of three log2 stoppage ratios along a fragment of 28S rRNA obtained from samples prepared with four different 
concentrations of nucleotides during primer extension (G1 being the highest dNTP concentration, G4 the lowest): concentration 4 to concentration 
1 (G4/G1), concentration 3 to concentration 1 (G3G1) and concentration 2 to concentration 1 (G2G1). Dashed lines indicate known 2’-O-
methylation sites from snoRNABase [95].  
 
FIGURE 4.2 depicts a region of the 28S rRNA with sites of 2’-O methylation that were identified with RiM-
Seq. Dashed lines indicate known 2’-O-methylation sites from the snoRNA-LBME-db [95]. G1 represents the 
stoppage ratio of the control sample that was reverse transcribed under normal dNTP concentrations 
(500µM), G4 represents the stoppage ratio of the sample that was reverse transcribed under the lowest 
dNTP concentrations (0.4 µM) (see TABLE 4.1). G2, G3, and G4 samples generated significantly more RT 
stoppages at 2’-O-methylation positions compared to the G1 control, which resulted in an increase of reads 
starting at this positions (5’ends). Also evident is that the stoppage ratio is correlated with the RT-dNTP 
concentrations as would be expected.  
 4.4 Methods 4.4.1 RiM-seq library preparation and sequencing protocol 
Total RNA was extracted with TRI Reagent (Sigma) and mRNA was prepared with the Dynabeads mRNA 
DIRECT Kit (Life Technologies), both from HEK293 cells according to the manufacturer’s instructions. For 
mapping of 2’-O-methyl sites in rRNA, 5µg of total RNA was used as starting material, whereas for mapping 
2’-O-methyl sites in mRNA, 1µg of poly(A)-selected RNA was used. In both protocols, the RNA was degraded 
under alkaline conditions in a sodium carbonate/bicarbonate buffer at pH 9.2 for 5 minutes, put on ice and 
purified with RNeasy clean-up columns (QIAGEN). The sample was eluted in 12µl of water and dephosphor-
ylated in a 14µl reaction volume using FastAP (life technologies) according to manufacturer's instructions 
(1.4µl FastAP buffer, 0.6µl RNasin Plus RNase Inhibitor (Promega), 1µl FastAP). 1µl of 40µM 3’ RNA-adapter 
(5’ 5’-p-UGGAAUUCUCGGGUGCCAAGG-amino-3) were added and the sample was denatured at 70°C for 2 
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minutes and then transferred on ice. A ligation mixture (5µl 10x NEB Ligase 1 buffer, 12 µl DMSO (50%), 
16µl PEG 8000 (50%), 0.5µl RNasin Plus RNase inhibitor, 2µl T4 RNA Ligase 1 (30 U/µl)) was added and the 
sample was incubated 2 hours at 25°C. The sample was purified using RNeasy clean-up kit (QIAGEN) and 
eluted in 48µl H2O. For reverse transcription, 1µl of 10µM RT primer (5’-GCCTTGGCAC CCAGAGAATTCCA-3’) 
was added to 9µl of the RNA sample and the mixture was incubated at 72°C for 2 minutes and then cooled 
down on ice for 2 minutes. The reverse transcription reactions were set up as follows in TABLE 4.1: 
 
Table 4.1 Reverse transcription conditions used in RiM-seq. G1-G4 (high dNTP conc-low NTP conc) are the different conditions used in RT.  
 
Condition G1 G2 G3 G4 
dNTP Concentration 500µM 5µM 2µM 0.4µM 
10mM dNTP Mix 1µl - - - 
0.1mM dNTP Mix - 1µl 0.4µl - 
0.01mM dNTP Mix - - - 0.8µl 
Water 1µl 1µl 1.6ul 1.2µl 
5x First Strand Buffer 4µl 4ul 4µl 4µl 
100mM DTT 2µl 2µl 2µl 2µl 
RNase Inhibitor 1µl 1µl 1µl 1µl 
SuperScript III 1µl 1µl 1µl 1µl 
SubTotal 10µl 10µl 10µl 10µl 
Total 20µl 20µl 20µl 20µl 
 
The reaction was incubated at 42°C for 20 min, 50°C for 20 min, and 55°C 20 min and then 4°C for at least 
one minute. Excess RT primers were digested by adding 3µl of ExoSAP-IT (Affymetrix) and incubated at 37°C 
for 12 minutes. The enzyme was inactivated by incubation at 80°C for 15 minutes. Subsequently the RNA 
was degraded by adding 2µl of RNase H (NEB) and incubating at 37°C for 15 minutes. The RNase H was inac-
tivated by incubation at 65°C for 20 minutes and the sample placed on ice. 
The cDNA (25µl) was cleaned up using 50µl of Agencourt AMPure XP beads (BECKMAN COULTER) with 25µl 
of isopropanol. The mixture was mixed well and incubated 5 minutes at room temperature. The beads were 
collected on a magnet and washed twice with 80% ethanol. The beads were dried on the magnet for 10 
minutes and the cDNA was eluted in 20 µl of H2O. 
To each sample 1µl of 40µM 5’-DNA adapter (5’-p-GATCG TCGGA CTGTA GAACT CTGAA C-amino-3’) was 
added and the samples were denatured at 75°C for 2 minutes and then transferred on ice. 39.5µl of the 
following ligation mix were added to every sample: 6µl 10X NEB Ligase 1 Buffer, 4.5µl DMSO (50%), 27µl 
PEG 8000 (50%), 2µl T4 RNA ligase 1 (30U/µl) and the mixture was vortexed and incubated at room tem-
perature overnight. The cDNA (60µl) was again cleaned up adding 120µl of Agencourt AMPure beads with 
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30µl of isopropanol by incubating the mixture 5 minutes and collecting the beads on a magnet. The beads 
were washed twice with 80% ethanol and dried 10 minutes on the magnet. The cDNA was eluted in 60µl of 
H2O. 
5µl of the resulting cDNA were then used in a pilot PCR reaction. To this end, aliquots were taken from re-
actions at every second cycle between 12 and 22 cycles and analyzed on a 2.5 % agarose gel. The number of 
cycles causing a first visible amplification was chosen for a large scale PCR (10µl cDNA in a 100µl reaction). 
The PCR product was then cleaned up with the QIAquick PCR Purification Kit (QIAGEN) followed by a clean-
up with Agencourt AMPure XP beads according to manufacturer’s instructions. The PCR product was eluted 
in 25µl of H2O. Libraries were sequenced on an Illumina HiSeq-2500 deep sequencer. 
 4.4.2 Read mapping and 2’-O-methylation sites extraction 
 
We obtained ~40 million reads for each of the RiM-seq samples G1-G4 (four different dNTP concentra-
tions). The adapter was cut with Cutadapt (--minimum-length 15, and other parameters set to default) 
[186] and we mapped the reads with STAR [187] (additional parameters: --outFilterMultimapNmax 20 --
outFilterMismatchNoverLmax 0.05 --scoreGenomicLengthLog2scale 0 --outSAMattributes All) to the RNA 
transcriptome composed of rRNAs and snRNAs. Mapped reads were used to calculate coverage and the 5’ 
ends of the reads were used to identify locations where the reverse transcription reaction had stopped. 
Putative 2’-O-methylation sites were detected with the following procedure: For each sample a stoppage 
ratio was calculated as the ratio between the number of reads starting at given position (reads with 5’ end 
at that position) and the number of reads covering a specific position (reads with 5’ end at that position + 
readthrough reads). To avoid division by 0 a pseudocount was added to both coverages. For each condition 
(G1-G4) a fold change was calculated as log2 of the ratio between the stoppage ratio at that concentration 
and the stoppage ratio in the control sample (G1). This gave three log2 ratios corresponding to decreasing 
concentrations of nucleotides: concentration 4 to concentration 1 (G4/G1), concentration 3 to concentra-
tion 1 (G3G1) and concentration 2 to  
 
 
 
  
Figure 4.3 Plot of the log2 G4-to-G1 stoppage ratios  (see the text for details) along the 18S 
rRNA (blue line) with local background calculated (red line). Dashed lines indicate 2’-O-
methylation sites from snoRNABase. 
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concentration 1 (G2G1). Because the stoppage ratio seems to be strongly region-specific, we subtracted the 
local background defined as the mean stoppage ratio in the neighborhood of a given position (+/- 5 nucleo-
tides, excluding the central position) see FIGURE 4.3 and FIGURE 4.4. According to the reverse transcription 
protocol there should be an increase in sample to control ratio with decreasing nucleotide concentration 
and this pattern was used as a first filtering step. As there is no indication that the ratio should increase 
linearly, we required that there is increase in log2 ratio going from G2/G1 to G3/G1 and from G3/G1 to 
G4/G1 i.e. G2/G1 < G3/G1 < G4/G1. Thus, only positions with increased ratios were kept for further analysis 
(FIGURE 4.2). We used as a score the log2 ratio between lowest and control concentration (G4/G1). The 
threshold for the G4/G1 ratio was deduced from the Matthews coefficient plot and is 3.63 (FIGURE 4.5). 
 
 
However, at this threshold only a small number of putative target sites we found and the recall of known 
rRNA sites was only 0.47 (precision 0.56, FIGURE 4.6). Because this experiment is used to validate computa-
tional predictions rather than discover stoppage sites de novo, we lowered the threshold to 2.0, where the 
precision is low but recall is ~70%. 
 
  
Figure 4.4 Plot of the G4-to-G1 log2 stoppage ratio along the 18S rRNA with local background 
subtracted. Dashed lines indicate 2’-O-methylation sites from snoRNABase. 
Figure 4.5 Matthews correlation coefficient plot for the G4/G1 ratio 
calculated on 18S and 28S rRNAs. 
Figure 4.6 ROC curve and PR curve calculated for G4/G1 ratio as a score on 
18S and 28S rRNAs. 
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4.5 Discussion of the RiM-seq method 
The RiM-seq approach to detect 2’-O-methylation sites is based on a well-known procedure often used in 
primer extension assays. As such, it preserves all the advantages and drawbacks of this method. The main 
advantage of the method is its simplicity: it is easy to conduct and fairly easy to analyze. However, false 
positives can be generated by pausing induced by other types of modifications (although with much lower 
rate), by degradation of RNA at sensitive sites and by the secondary structure of the RNA [201]. One way to 
deal with this problem when performing gel analysis is to compare the results to those obtained with un-
modified RNA [201]. This, however, is not possible with the high-throughput approach. There is also great 
variability in the log2 ratio of the stops - some of them very clear and some not visible at all. Additionally, 
there is a contribution of so called shading to the false negative rate. This corresponds to the situation 
when two sites are in close proximity and one of them cannot be reached due to strong pausing at the oth-
er site. The ROC curve calculated for rRNAs indicates that the approach allows one to distinguish between 
methylated and non-methylated sites. However, the precision-recall (PR) curve shows that this method 
does not have both high precision and recall (FIGURE 4.6). Nonetheless, we present this method as an alter-
native high-throughput method for the validation of computationally predicted sites of 2’-O-methylation, 
complementing the known approaches CLIP-seq and RiboMeth-seq (described in CHAPTER 3).  
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 5.1 Introduction 
Small nucleolar RNAs (snoRNAs) are well-characterized non-coding RNAs that localize in eukaryotic and 
archeal nucleoli where they primarily guide chemical modifications of target RNAs. These are mainly ribo-
somal RNA (rRNA) and small nuclear RNA (snRNA) [166], but other RNA species can also undergo snoRNA-
guided modification [177], and the spectrum of snoRNA targets is not entirely characterized. Based on se-
quence and structural features, snoRNAs can be divided into the C/D box snoRNAs, which guide 2’-O-
methylation, and H/ACA box snoRNAs, which guide pseudouridylation of their target RNA. During their 
biogenesis, which involves processing from excised and debranched introns by exonucleolytic trimming [75, 
202], snoRNAs associate with evolutionary conserved proteins to form the enzymatically active small ribo-
nucleoprotein complex (snoRNP). The core proteins of the C/D box snoRNP are 15.5K, NOP56, NOP58, and 
Fibrillarin [74, 104, 105], the latter being the enzyme that catalyzes the site-specific transfer of a methyl 
group from S-adenosylmethionine onto the 2’-hydroxy group of the ribose. The target site specificity is 
defined by a 6-20 nucleotides-long region known as the anti-sense box and located upstream of the D or D’ 
box of the snoRNA, which pairs with the target site. The target nucleotide that pairs with the 5th nucleotide 
upstream of the D box undergoes methylation [109-111]. Computational prediction of snoRNA targets also 
makes use of these properties. The number of target sites that can be predicted based on these principles 
in the entire genome vastly exceeds the number of sites where modifications have been described. Howev-
er, additional determinants seem difficult to uncover [73, 102, 107, 173]. Furthermore, a considerable 
number of C/D box snoRNAs that carry the conserved C/C’ (RUGAUGA, R = A or G) and D/D’ (CUGA) boxes 
remain “orphan”, without a known RNA target [203, 204]. Recent studies have described atypical charac-
teristics and expression patterns of orphan snoRNAs, as well as unexpected associations with RNA-binding 
proteins, which suggest that snoRNAs may have a broader set of functions than currently known [94, 205]. 
 
Among the orphan snoRNAs, a cluster located on chromosome 15q11-13 has been extensively studied due 
to their association with the Prader-Willi syndrome (PWS), a congenital disease marked by excessive appe-
tite and morbid obesity as well as mental and growth retardation. The molecular basis of PWS is unknown, 
but genome analysis of a number of patients as well as studies in animal models implicate the loss of pa-
ternal expression of maternally-imprinted chromosome 15q11-13 genes - caused by non-inherited dele-
tions, uniparental disomy, or imprinting defects - as the cause of PWS [206]. The chromosome 15q11-13 
locus comprises multi-copy snoRNAs and several protein-coding genes, but the latter do not appear to con-
tribute to the development of the syndrome [206, 207]. The snoRNAs SNORD64, SNORD107, SNORD108, 
SNORD109A, SNORD115, and SNORD116 are processed from the introns of a non-protein coding transcript 
(U-UBE3A-ATS) that is transcribed from this locus [208]. SNORD115 and SNORD116 are multicopy (47, and 
29, respectively) snoRNAs, well-conserved in mammals [209, 210], highly expressed in the brain [211]. Ini-
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tially, SNORD115 seemed a good candidate PWS gene, because it has a striking complementarity to the 
serotonin receptor 2C pre-mRNA, whose splicing it may regulate, potentially contributing to the develop-
ment of obesity [92, 212]. However, other studies in human [213] and mouse [214] essentially ruled 
out  SNORD115 as a main contributor to PWS. In particular, Runte and colleagues [213] demonstrated that 
family members of Angelman syndrome patients who carried paternal deletions of the whole SNORD115 
cluster did not exhibit an obvious clinical phenotype. Genetic studies have described several microdeletions 
in the 15q11-13 locus in PWS patients and the data are notably in favor of the interpretation that paternal 
deficiency of SNORD116 alone is sufficient to cause the key manifestations of the PWS phenotype [98, 99, 
215, 216]. The question whether other genes in the region, particularly the lncRNA IPW116 that hosts 
SNORD116, may aggravate the PWS phenotype, remains open [217, 218].  
 
In mouse, the PWS locus is located on chromosome 7. Based on the findings that implicated SNORD116 in 
the pathogeny of PWS in humans, two groups generated mouse models of the disease by deleting the PWS 
critical region (PWScr) that spans the Snord116 cluster and IPW exons A1/A2, B and C [219, 220]. Previously 
mouse models of PWS had mostly larger deletions of several paternally-expressed, imprinted genes [221-
224]. Mice that inherited the deleted allele maternally (PWScrm−/p+) showed no phenotypic abnormalities 
and were indistinguishable from wild-type (wt) littermates. However, mice that inherited the allele pater-
nally (PWScrm+/p−) displayed postnatal growth retardation, delayed sexual maturation, increased anxiety, 
motor learning deficit, hyperphagia, and hyperghrelinemia, thus recapitulating a subset of the PWS symp-
toms [219, 220] (FIGURE 5.1). Features of human PWS that were not observed in the mouse models are 
hypotonia, obesity, and decreased sensitivity to pain. The authors of the respective studies argued that the 
PWS may have species-specific components [220]. 
 
 
 
Figure 5.1 Growth Differences among PWScrm+/p− and PWScrm+/p+ siblings. Representative pair of mice from the same litter at postnatal day 10 
(129SV x C57BL/6 genetic crosses). Figure from [219]. 
 
Although a general consensus that PWS is caused primarily by the lack of SNORD116 expression has seem-
ingly been reached, the molecular function of SNORD116 has remained elusive. Mouse Snord115 and 
Snord116 yield a variety of processed snoRNAs (psnoRNAs) and some studies suggested that they modulate 
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alternative splicing of multiple transcripts [122, 128]. MiRNA-like functions have also been attributed to 
snoRNA-derived fragments (reviewed in [94]). The question of which type of molecule is predominantly 
generated from the Snord115 and Snord116 loci has been addressed in a few studies, with the conclusion 
that it is a classical C/D box-containing snoRNA [225] that associates with core C/D box snoRNP proteins 
[93]. Furthermore, incorporation of psnoRNA-type products into Argonaute 2 proteins in human cells was 
very limited [177], arguing against a miRNA-like role for psnoRNAs in human.  
 
Yin and colleagues also described a long non-coding RNA (lncRNA), sno-lncRNAs, derived from the 
SNORD116 locus and demonstrated its involvement in PWS pathogenesis [205]. Interestingly, the ends of 
this sno-lncRNA correspond precisely to two SNORD116 that are embedded in the same intron. Generation 
of the sno-lncRNA likely involves the snoRNP biogenesis machinery, which would explain why these tran-
scripts are found complexed to snoRNP proteins. It has been proposed that these interactions stabilize the 
sno-lncRNAs by inhibiting exonucleolytic degradation [205]. Interestingly, five sno-lncRNAs are generated 
from the PWS locus, each containing multiple binding sites for the splicing regulator RBFOX2. It has been 
suggested that the sno-lncRNAs act as molecular sinks, titrating RBFOX proteins in specific cells and thereby 
inducing subtle alterations in the splicing of RBFOX-regulated exons. Given that the expression of sno-
lncRNAs was found to be highest in pluripotent stem cells [225], RBFOX-dependent splicing alterations are 
expected in the early embryonic development of PWS patients. 
 
In this study we use a broad set of assays to evaluate possible functions for SNORD116 snoRNAs in the 
brain, the tissue in which they are most highly expressed. We first considered that Snord116 or sno-
lncRNAs from the PWS region may alter patterns of splicing of Rbfox2-regulated targets in brain, as they 
appear to do in stem cells and ovarian carcinoma PA1 cells [205]. Analyzing the impact of Snord116-
deletion (in PWScrm+/p- compared to wt mice) on alternative splicing in the brain with mRNA-seq, we found 
neither substantial changes in splicing nor an enrichment in splicing changes in Rbfox2 targets compared to 
other genes. Next we re-evaluated the possibility that these snoRNAs have a canonical function, compre-
hensively mapping 2’-O-methylated riboses in wt mice and PWScrm+/p− mice that do not express Snord116 
with the RiboMeth-Seq method [65]. We identified several promising targets sites that appear to be differ-
entially methylated in the two conditions. To determine whether these could be direct targets of Snord116 
snoRNAs, we then performed snoRNP-Crosslinking and Immunoprecipitation (CLIP) experiments in several 
neuronal cell lines as well as in mouse primary neurons (cerebellar granule cells). Although we recapitulat-
ed previous findings that Snord116 snoRNAs associate with the snoRNP machinery, especially in primary 
neurons, we were not able to identify guide RNA-target hybrids in these data sets, even though hybrids of 
other, canonical snoRNAs, could be identified. At this point, the data that we obtained indicates that in 
neurons, Snord116 snoRNAs do associate with core snRNPs and generate primarily typical snoRNA tran-
scripts. However, a guide function of these snoRNAs in the brain remains elusive. The 2’-O-methylation 
patterns in the brain tissue of PWScrm+/p− mice are similar to those in wt mice with some notable differ-
ences, which will be validated with mass spectrometry. The mechanistic basis of these differences in meth-
ylation will have to be determined. 
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5.2 Results 5.2.1 PWScr deletion does not affect alternative splicing of Rbfox2-regulated targets in mouse brain 
To learn about the Rbfox2 association with the snoRNAs, we reanalyzed the data from [226] where binding 
sites of Rbfox1/2/3 in mouse brain were globally mapped with HITS-CLIP. We reproduced the observation 
that Rbfox proteins bind extensively to RNAs derived from the snord116 locus [205], specifically to binding 
sites that are located between the snoRNAs in the sno-lncRNA (FIGURE 5.2). 
 
Figure 5.2 Rbfox binding in the Snord116 locus. The Snord116 copies are indicated with light blue triangles at the top of the panel. Densities of 
reads from the Rbfox1-3-HITS-CLIP experiments mapped to the negative strand of the chromosome are shown with dark blue. 
 
To determine whether targets of the Rbfox proteins respond to the loss of Snord116 expression, we first 
used the site extraction tool that is implemented in the CLIPZ web server (www.clipz.unibas.ch) to obtain 
Rbfox1-3 binding sites, which are enriched in reads compared what is expected based on the mRNA level 
expression of the genes [227]. Asking whether Rbfox targets (transcripts for which significantly enriched 
sites were identified in at least 6 of the 8 HITS-CLIP experiments) are differentially expressed in the knock-
out mouse samples, we found this not to be the case (FIGURE 5.3).  
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Figure 5.3 Distribution of expression changes of HITS-CLIP-determined Rbfox targets in PWScrm+/p− compared to wt mice. 
 
We used the rMATs analysis tool [228] to determine whether the deletion of Snord116, which is predicted 
to prevent the “sponging” of the Rbfox proteins, leads to changes in the splicing of Rbfox targets. The dis-
tributions of percent spliced in (PSI) scores of individual exons/introns indicate that there is no global shift 
in splicing (FIGURE 5.4). Nevertheless, we examined the 24 high confidence events (p-value < 0.01) with |PSI 
difference| of at least 0.3 (FIGURE 5.5) and found that only one (Enah) of these, corresponding to the ena-
bled homolog gene (ENAH) with role in cytoskeleton remodeling, is an Rbfox target. The exons of Rbfox 
targets that were identified in [205] changed very marginally in the PWScrm+/p− compared to wt mice, argu-
ing against a Rbfox-sponging effect of the snoRNAs in the mouse brain (FIGURE 5.4). We also investigated all 
putative exon inclusion/exclusion events by sashimi plots (data not shown) but did not find any meaningful 
differences between PWScrm+/p− and wt mice.  
 
 
Figure 5.4 (A) Exon inclusion/exclusion rates in wt and PWScrm+/p− mice. (B) Exon inclusion/exclusion rates in genes identified in [205]. 
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Figure 5.5 Scatterplot of PSI scores of all possible Skipped Exons (SE) in PWScrm+/p− and wt brain samples. Red dots indicate the significant SE events 
(p-value<0.01, in a likelihood-ratio test evaluating whether the difference of the mean PSI values between two sample groups exceeds a user de-
fined threshold which was set of 0.0001) that have an absolute average inclusion difference > 0.3. 
 5.2.2 Snord116 expression in neuronal samples  
It is well established that the imprinted snoRNAs from the PWS locus show highest expression in the brain 
in human as well as in mouse [211]. However, to identify a good cellular system for studying Snord116 
function, particularly with CLIP, we first re-assessed the expression of these snoRNAs in several neuronal 
cell lines as well as brain tissue. We carried out northern blots in two mouse neuroblastoma cell lines N1E-
115 and N2A and the human neuroblastoma cell line SH-SY5Y. Simultaneously we also probed for the ex-
pression of Snord116 in mouse brain (C57BL/6JRj). 
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Figure 5.6 Northern blots depicting the expression of Snord 116 (left) and Snord 115 (right) in mouse neurons, total mouse cerebellum, differenti-
ated and undifferentiated N1E-115 cells. 
 
FIGURE 5.6 depicts the expression of Snord115 and Snord116 in mouse cerebellum, mouse cerebellar neu-
rons, undifferentiated and differentiated N1E-115 cells (for differentiation see Methods) determined with 
northern blotting. We found that both snoRNAs have a higher expression in primary cells (total cerebellum 
and cerebellar neurons) compared with the N1E-115 cell line. Differentiation of N1E-115 cells, although 
successfully realized (SUPPLEMENTARY FIGURE 5.1), does not substantially increase the expression of these 
snoRNAs. Results for the fibroblast cell line used as a negative control are also shown. We also assessed the 
expression of Snord116 in the mouse N2A (FIGURE 5.7A and B) and human SH-SY5Y neuroblastoma cell lines 
(FIGURE 5.7C). Differentiation of both of these cell types into neuron-like cells by means of bovine serum 
albumin (BSA) and/or retinoic acid addition slightly increases the Snord116 expression.  
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Figure 5.7 Northern blots depicting expression of Snord116/SNORD116 in (A) undifferentiated N2A cells, (B) in differentiated N2A cells, and (C) in 
undifferentiated and differentiated SH-SY5Y cells. In every blot Snord116 expression was also probed in mouse brain, as a positive control 
 
These results showed that Snord116 expression is much higher in primary neurons than in neuronal cell 
lines, including those in which differentiation towards neuron-like cells was performed. This indicates that it 
is unlikely to find a substitute model cellular system for studying Snord116 function, and primary neurons 
should be used. 
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5.2.3 RiboMeth-seq in wt mice and PWScrm+/p− mice 
 
 
Figure 5.8 Northern blot depicting Snord116 expression in brain tissue from wt and PWScrm+/p− mice (ko). 
 
SNORD116 being highly expressed in the brain, their role could be to sequester the core snoRNA proteins, 
thereby affecting the levels of rRNA 2’-O-methylation in the brain. To examine this possibility as well as the 
possibility that Snord116 still has a canonical function in guiding 2’-O-methylation, we generated RiboMeth-
Seq [65] (CHAPTER 3) libraries from wt mice and from PWScrm+/p− mice, which lack Snord116 [219]. Before 
we prepared the RiboMeth-Seq libraries, we first assessed Snord116 expression in brains from two wt and 
two PWScrm+/p− (labeled as “ko“) animals in FIGURE 5.8. As expected, we confirmed the presence and ab-
sence of Snord116 expression in wt and PWScrm+/p−, respectively. 
 
We analysed the RiboMeth-seq data as described previously (Gumienny and Jedlinski et al., CHAPTER 3). 
Additionally we have calculated a score (score ‘C’) proposed in [65] to reflect the fraction of methylated 
molecules in the cell. We observed high correlation between our score (angle) and score C (FIGURE 5.9).  
 
For each putative 2’-O-methylation site a t-test on angle scores and C scores was performed to assess the 
level of difference between the sites in PWScrm+/p− and wt mice. We set a threshold of 0.01 for the p-value. 
Additionally we required that the change is in a specific direction i.e. that a site has to be present in wt and 
absent in PWScrm+/p−. To call a site “present” in a given wt sample, we used specific score thresholds (280 
for the angle score and 0.7 for the C score), which we set based on their power in accurately identifying 
known 2’-O-methylation sites in ribosomal RNAs. 
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Figure 5.9 Correlation between angle score and score C on known methylation sites. 
 
We have identified 173 and 144 differentially methylated sites for angle score and score C, respectively. To 
determine whether any of these sites could be a Snord116 site we applied the PLEXY algorithm [143] for 
predicting snoRNA targets. We found that PLEXY assigned only one site identified by angle score, located in 
the cholecystokinin gene (chr9:121494409 in mm10), to Snord116. A similar analysis applied to sites pre-
dicted by the score C identified two possible Snord116 targets: one in the adenylate cyclase (Adcy1, 
chr11:7174707 / mm10 genome assembly version from the UCSC genome server) and the other in the ring 
finger protein 14 (Rnf14, chr18:38300497 / mm10).  
 
Finally, to assess the association of these snoRNAs with core snoRNP proteins, we performed HITS-CLIP 
experiments as previously described [130], with antibodies targeting the Nop58 (for N2A and SH-SY5Y cells) 
and Fibrillarin (for N1E-115 cells and mouse neurons) proteins. To this end, the N2A and SH-SY5Y cells were 
differentiated, whereas the N1E-115 cells were left untreated, as no increase of Snord116 could be ob-
served in these cells in the northern blot. Neurons were extracted from mice, pooled, cross-linked with UV, 
and then also carried through the CLIP library preparation as described [130] (for details see METHODS). 
 5.2.4 Nop58-HITS-CLIP in SH-SY5Y cells 
Analysis of the Nop58-CLIP from SH-SY5Y cell line was performed as previously described in (Gumienny and 
Jedlinski et al., CHAPTER 3). We have performed only one experiment in this cell line. In human there are 
190 known snoRNA-target interactions of a total of 116 distinct 2’-O-methylation sites in rRNAs and small 
nuclear snRNAs. In this experiment we were able to recover 83 out of 190 interactions (44%) and 66 out of 
116 2’-O-methylations (57%). A more stringent selection of the sites based on their probability (calculated 
as described in Gumienny and Jedlinski et al., CHAPTER 3) being greater than 0.5 left 62 out of the 190 inter-
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actions (33%) and47 out of 116 distinct 2’-O-methylation sites (40%). These relatively low numbers could 
reflect both the inefficiency of capture of snoRNA-target interactions as well as the tissue specificity of neu-
rons/neuron-like cells in regard to 2’-O-methylation. 
 
Applying the same stringent threshold to sites that involved mRNAs and other RNA species that are not 
considered canonical snoRNA targets, we have found 256 putative interactions. These included 7 novel 
interactions with rRNAs, 6 of which predicted to lead to the 2’O-methylation of sites that were previously 
known to be methylated (but the guide snoRNA was not known). 6 of these methylation sites did not 
emerge from RiboMeth-seq, which may reflect either the partial coverage of RiboMeth-seq, the partial 
methylation status of these sites, or false positive sites (albeit with previous evidence in the literature). One 
interaction, at position 462 of 18S rRNA that is known to be 2’-O-methylated, seems to involve the 
SNORD116 snoRNA and has very low predicted energy of interaction (-18 kcal/mol).  
 
HITS-CLIP revealed 200 potential interaction sites that are novel and non-canonical. About half of these 
seem to involve orphan snoRNAs. Most of the target sites were located in repeats (46%) but a substantial 
fraction is located in protein coding genes (28%). In contrast to the well established snoRNAs with canonical 
targets, orphan snoRNAs were frequently found in interactions with miscRNAs (in fact with the many copies 
of Y RNA that is involved in DNA replication [229, 230]).  
 
Among the HITS-CLIP-defined sites, 15 seem to interact with SNORD116. One of these mapped to the 
NOP58 CDS. Another corresponded to a known methylation site (nucleotide 463) in 18S rRNA, which how-
ever, also interacts with SNORD14. This may explain why no significant change in methylation level could be 
inferred for this site with RiboMeth-seq. Finally, one of the putative SNORD116 interactions was with an 
tRNA and some with Alu elements. 
 
For the SNORD115 snoRNAs we only identified two putative targets, both of them in repeats (one in ribo-
somal protein L5 repeat and one in (A)n repeat), consistent with these snoRNAs being less incorporated 
into snoRNPs.  
 5.2.5 Fibrillarin-HITS/PAR-CLIPs in N1E-115 cells 
In mouse there are 136 known snoRNA-target interactions of total 90 2’-O-methylation sites (in rRNAs, 
according to snOPY database [231]). In this experiments we were able to recover 95 out of 136 interactions 
(70%) and 66 out of 90 2’-O-methylations (73%). Setting again a more stringent threshold for site probabil-
ity (determined based on the accuracy of rRNA site identification and set to 0.1), we retained 91 out of 136 
interactions (67%) and 63 out of 90 2’-O-methylation sites (70%). In this case, combined analysis of more 
replicate experiments (four as opposed to one in SH-SY5Y) resulted in increased sensitivity and also preci-
sion.  
 
In rRNA we have identified 30 new putative 2’-O-methylation sites stemming from 34 interactions. Overall, 
in mouse snoRNA-target interactions and ribosomal 2’-O-methylation are less characterized than in human 
or yeast. Thus, many of these sites are sites that are already known to be methylated in human, e.g. posi-
tion 469 of mouse 18S rRNA which is equivalent to position 468 in human.  
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We have identified 881 interaction sites located in RNAs not considered to be canonical targets of snoRNAs. 
The functional categories of the corresponding targets are similar to those inferred from the SH-SY5Y cell 
line with the exception that in N1E-115 we do not observe many target sites in misc RNAs such as Y RNAs. 
We have identified five interactions sites guided by Snord116 and one interaction site guided by Snord115. 
This pattern is is in agreement with the data that Snord116 is more efficiently captured in the CLIP experi-
ments (FIGURE 5.10 and FIGURE 5.11) 
 5.2.6 Fibrillarin-HITS-CLIP in mouse primary neurons 
We have performed several Fibrillarin-CLIP experiments in mouse primary neurons, aiming to capture 
snoRNA-target chimeric reads. Only one of these experiments yielded a number of chimeric reads that 
seemed to be meaningful and we present the analysis of these data here. In this experiment we were able 
to recover only 75 out of 136 interactions (55%) and 56 out of the 90 2’-O-methylation sites (62%). After 
application of a threshold of 0.5 (same as for the CLIP in the human cell line) the numbers decreased from 
75 to 53 and 56 to 39 for interactions and 2’-O-methylation sites, respectively. 
 
Here we have identified six novel interaction sites in rRNAs and almost 2000 putative interactions, coming 
mostly from the non-orphan snoRNAs, in other RNAs. However, in the brain tissue a substantial amount 
(34%) of guide-target interactions came from orphan snoRNAs. Out of these sites, 90 were predicted to be 
targeted by Snord116 family members and 24 by Snord115 family members. As before, there were more 
chimeric read-based predicted target sites for Snord116 than for Snord115. 
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Figure 5.10 Snapshot from the CLIPZ genome browser. Overlaid is a scheme of the PWS loci in human (upper) and mouse (bottom) with 
SNORD115/Snord115 and SNORD116/Snord116 snoRNAs loci. Green vertical lines indicate reads that were obtained from the individual CLIP exper-
iments and mapped with CLIPZ. The CLIP experiments are as follows (top to bottom): Fibrillarin-HITS-CLIP in SH-SY5Y, Fibrillarin-HITS-CLIP in mouse 
primary neurons (Replicate1), Fibrillarin-HITS-CLIP in mouse primary neurons (Replicate2), Fibrillarin-PAR-CLIP in N1E-115, Fibrillarin-HITS-CLIP in 
N1E-115. 
 
FIGURE 5.10 illustrates the capture of SNORD115/Snord115 and SNORD116/Snord116 snoRNAs in human 
and mouse CLIP experiments. Overlaid is a schematic representation of the PWS locus in human and mouse 
with its multi-copy genomic arrangements of the PWS snoRNAs. The green vertical lines overlap with the 
snoRNA loci. SNORD116/Snord116 are more efficiently captured in the CLIP experiments than 
SNORD115/Snord115 in both human and mouse cells. Remarkably, in the CLIPs performed in the SH-SY5Y 
cells and mouse primary neurons SNORD116/Snord116 were more efficiently captured than in the CLIPs 
performed in N1E-115 cells, which largely correlates with the expression levels observed in these cell lines 
and in the primary neurons (FIGURE 5.6 and FIGURE 5.7) 
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Figure 5.11 Comparison of snoRNA expression levels calculated from Fibrillarin-CLIP experiments (in primary neurons) and from small RNA-seq 
(mouse brain). Snord116 (red dots) are clearly enriched over Snord115 (blue dots) in the CLIP experiments, although they are expressed at lower 
levels in the sRNA-seq. Black dots represent all other snoRNAs. 
 
FIGURE 5.11 depicts the capture of Snord116 and Snord115 by Fibrillarin-HITS-CLIP in mouse primary neu-
rons. Snord116 are more efficiently captured than Snord115. However, canonical snoRNAs, although ex-
pressed at similar levels, represent the majority of the CLIP reads. 
 5.2.7 Combined analysis of RiboMeth-seq and CLIP-seq data 
It is important to confirm putative 2’-O-methylation sites obtained from the chimeras in CLIP with Ribo-
Meth-seq and vice versa. To this end we have intersected our mouse CLIP experiments with RiboMeth-seq. 
i.e. for each of the extracted sites obtained from the chimeric reads (irrespectively of the probability) we 
have checked if the site is also supported by RiboMeth-seq. The thresholds that we used were 0.1 for the 
probability in CLIP and 280 for the angle score in RiboMeth-seq in wt mice. FIGURE 5.12 and FIGURE 5.13 
show all the 2’-O-Me sites found in rRNAs by CLIP and RiboMeth-seq along 18S and 28S rRNAs. Several sites 
are unknown in the literature but seem to be methylated based on the RiboMeth-seq data and their guides 
identified from chimeric reads. FIGURE 5.14 shows examples of individual 2’-O-Me sites. 
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Figure 5.12 2’-O-methylation sites and CLIP interactions identified in 18S rRNA. 
 
Figure 5.13 2’-O-methylation sites and CLIP interactions found in 28S rRNA. 
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Figure 5.14 Regions of 18S and 28S rRNAs showing known as well as novel positions of 2’-O-methylation identified with RiboMeth-seq and CLIP. 
 
Taken together, using RiboMeth-seq and CLIP-seq we have recovered 73% of the known methylation sites 
in mouse. In addition to these sites we have found 15 novel 2’-O-methylation sites whose guides were ap-
parent in chimeric reads, seven of which with a high confidence (probability over 0.2). Most of these sites 
seem to interact with snoRNAs that already have assigned targets (i.e. they are not orphan snoRNAs). We 
have not found any non-canonical methylation site in the intersection of the RiboMeth-seq and CLIP-seq 
data sets. This does not exclude that non-canonical target sites exist. It is important to bear in mind that 
the formation of chimeras in CLIP experiments is very inefficient [47]. This means that chimeras involving 
targets with low expression are very difficult to capture and deeper sampling will be necessary. 
 5.2.8 Nop58-CLIP in N2A cells 
Analysis is still in progress. 
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5.3 Discussion 
PWS is a congenital disease that is caused by the loss of paternal expression of genes from the maternally 
imprinted chromosomal region 15q11-13. This region comprises multi-copy snoRNAs as well as several 
protein-coding genes. The latter do not appear to contribute to the development of the syndrome and all 
the evidence points to SNORD116 snoRNAs playing a major role in PWS. It is striking that SNORD116 snoR-
NAs display most features of canonical C/D box snoRNAs, yet targets with which these snoRNAs interact, as 
canonical snoRNAs do, have not been identified. However, their unusual but conserved multi-copy genomic 
arrangement and the high stability of SNORD116 found in the brain are indicative of an important role that 
is still to be uncovered. We here tried to examine comprehensively whether SNORD116 snoRNAs do play 
the role of guides that direct 2’-O-methylation. Advances in high-throughput analysis have greatly facilitat-
ed this effort in the recent years.  
 
First, we set out to find out whether sno-lncRNAs emerging from the PWS locus can regulate alternative 
splicing of Rbfox2-targets in the murine brain. Our analysis does not suggest that this mechanism is preva-
lent in adult mouse brain. These results are consistent with our observation, that sno-lncRNA are only faint-
ly expressed in brain tissue and neuron-derived cell lines that we tested and that mature 
SNORD116/Snord116 represent the predominant form (FIGURE 5.6, FIGURE 5.7, and FIGURE 5.8) . We then 
thoroughly examined SNORD116 expression in various cellular systems and observed that the human SH-
SHY5Y cell line exhibited a significantly higher level of expression of SNORD116 compared to the murine cell 
lines, yet still much smaller than primary murine neurons. This indicates that the function of 
SNORD116/Snord116 should be studied in primary cells. 
 
We then decided to examine a canonical function of SNORD116 by analyzing 2’-O-methylation transcrip-
tome-wide in PWScrm+/p+ wt mice and PWScrm+/p- mice, in which the SNORD116 cluster was deleted. To this 
end, we generated RiboMeth-seq libraries from brain tissue obtained from wt mice and mice carrying the 
deletion. The analysis of the 2’-O-methylation sites enabled a thorough characterization of 2’-O-Me’s in 
mouse 18S and 28S rRNA as well as in snRNA. Interestingly, the analysis of the 2’-O-methylation landscape 
in brains of wt mice and PWScrm+/p− mice with RiboMeth-seq revealed reproducible differences in some 
transcripts. One of these corresponds e.g. to the cholecystokinin triacontatriapeptide (Cck). CCK is an endo-
crine gut hormone that is released by epithelial cells in the mucosal lining of the small intestine following 
food intake and is responsible for mediating satiety by acting on CCK receptors distributed throughout the 
central nervous system, thus regulating the metabolic homeostasis [232]. Since lack of satiety linked with 
excessive eating behavior are some of the hallmarks of PWS, CCK presents a plausible target that may be 
disregulated in this disorder. We are currently validating these candidate target sites with mass spectrome-
try and RTL-P [188] in both wt and knock-out conditions. To further explore a possible guide function of 
SNORD116/Snord116 we performed snoRNP-CLIP experiments in neuronal cell lines as well as in primary 
mouse neurons and examined PWS-related snoRNA incorporation into snoRNPs. As presumed, PWS-
snoRNA-loading was particularly high in CLIPs conducted in primary neurons and the human SH-SY5Y cell 
line, while Snord116 snoRNAs were not captured in the CLIPs that were carried out in murine cell lines. In 
fact, the capture of SNORD116 by CLIP was best in the human SH-SY5Y cells, indicating that there may be a 
species-specific component regulating the loading of these snoRNAs into the snoRNP. 
 
Surprisingly, we observed that SNORD115, a C/D box snoRNA that was initially thought to be one of the key 
players in PWS, was captured only minimally in our snoRNP CLIP experiments. Although both SNORD115 
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and SNORD116 are similarly expressed in the tested cell lines and tissues, SNORD116 seem to be preferen-
tially loaded into the snoRNP complex compared to SNORD115. This observation goes along with the pro-
posed alternative role of SNORD115 in the modulation of alternative splicing of the 5-HT2C serotonin re-
ceptor, which would not require a primary binding of SNORD115 to the proteins of the snoRNP 
 
Next, we analyzed the guide RNA-target hybrids that usually form in CLIP experiments. We identified an 
extensive number of snoRNA-rRNA chimeras which allowed us to largely reconstruct the 2’-O-methylation 
landscape in 18S and 28S rRNA as well as snRNA in mouse and human, as we have previously done in hu-
man HEK cells (Gumienny and Jedlinski et al., CHAPTER 3). These results imply that the snoRNP-CLIPs are 
suitable for the further analysis of potential SNORD116-target hybrids. However, the in-depth analysis of 
the hybrids did not reveal any reliable targets neither in rRNA and snRNA nor in other RNAs. This could be 
due the fact that chimeras represent only a small fraction of all the reads that are usually obtained in CLIP 
experiments, which is a serious limitation of this method in regard to guide-target assignment for low-
abundance targets [47]. Additionally, Snord116 are captured at lower efficiency than canonical snoRNAs. As 
a result of the relatively low capture and the aforementioned limitation of the CLIP method one may miss 
out on potential Snord116-target chimeras. 
 
Taken together, we have re-evaluated here a canonical role of the PWS-associated SNORD116 snoRNAs. 
After failing to reproduce the reported impact of sno-lncRNAs on splicing modulation of Rbfox2-regulated 
targets in a mouse model that is lacking expression of the PWS critical region [219], we have extensively 
examined the role of SNORD116 in 2’-O-methylation with various high-throughput approaches. We have 
thus identified three putative 2’-O-Me sites in mRNAs with RiboMeth-seq that may be attributed to 
Snord116. These candidate sites are currently being individually validated. Intersections of the RiboMeth-
seq data with CLIP-seq data could not confirm these sites, however, we have identified 15 new 2’-O-Me’s in 
both 18S and 28S rRNA that were supported by both approaches. Hence we expand here the mouse snoR-
NA atlas by providing new 2’-O-Me sites. 
 
Uncovering unconventional targets will enable one to estimate to what extent SNORD116 participate in 
cellular networks that regulate gene expression and will therefore provide novel insights into snoRNA-
mediated gene regulation. Most importantly, identification of targets of the PWS-associated SNORD116 
would mean a major advancement towards the development of a suitable treatment. 
 5.4 Methods 5.4.1 Splicing Analysis 
Reads were mapped to the genome using the STAR aligner (version 2.5.0a) [187] with the following com-
mand: STAR --runMode alignReads --runThreadN 10 --genomeDir <genome dir> --sjdbGTFfile <annotation 
file> --readFilesIn <reads> --outFileNamePrefix <our prefix> --outSAMtype BAM SortedByCoordinate --
twopassMode Basic --alignIntronMax 200000 --readFilesCommand zcat. Then rMATs (version 3.2.0 beta) 
[228] software was used to calculate the PSI scores (Percent Spliced In) for all the different splicing events 
using the following command: python RNASeq-MATS.py -b1 
<ko_rep1.bam>,<ko_rep2.bam>,<ko_rep3.bam> -b2 <wt_rep1.bam>,<wt_rep2.bam>,<wt_rep3.bam> -gtf 
<annotation file> -o <output dir> -t single -len 63.  
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5.4.2 HITS-CLIP experiments 
HITS-CLIP was performed in the following cells: N2A( ATCC), SH-SY5Y (ATCC), and N1E-115 (ATCC), and neu-
rons extracted from mouse cerebellum (C57BL/6JRj). HITS-CLIPs in N2A and SH-SY5Y cells were performed 
as previously described using ‘mild RNase T1’ digestions conditions [130]. HITS-CLIPs in N1E-115 and neu-
rons were performed alike with the following modifications: after the overnight 3’-adapter ligation the RNA 
was not PAGE-purified and immediately carried over to the next step: before 5’-adapter ligation, the re-
verse transcription primer was added (at equimolar amounts to the the 3’- and 5’-adapter (1µl of 10µM)) to 
the reaction and annealed by denaturing at 90°C for 30 seconds, 65°C for 5 minutes, and then chilled on ice 
for at least 1 minute. Subsequently, the 5’ adapter was added and ligated at 20°C for 1 hour, followed by 
37°C for 30 minutes. The RNA was then reverse transcribed with Superscript IV (Invitrogen) according to 
manufacturer’s instructions. After pilot PCR and final PCR as described in [130], the PCR product was then 
purified using a non-denaturing 8% PAGE purification instead of using an agarose gel electrophoresis-based 
purification. 
For immunoprecipitation, antibodies were coupled to protein-G dynabeads (Invitrogen #10003D). Antibod-
ies used against endogenous proteins were α-Nop58 (sc-23705) and α-Fibrillarin (Bethyl labs A303-891A). 
After SDS-PAGE, gels were blotted onto nitrocellulose membranes to reduce the background from free 
RNAs [151]. N2A and SH-SY5Y libraries were sequenced on a HiSeq 2000 system (Illumina), N1E-115 and the 
neuron libraries were sequenced on a HiSeq 2500 system (Illumina). 
 5.4.3 Northern Blots 
Northern blots were performed as described in [177]. The probes used to detect Snord115 and Snord116 in 
N1E-115 cells and neurons/mouse brain were as follows: 
 
Snord115: Sequence (5'-3'): CCT CAG CGT AAT CCT ATT GAG CAT GAA 
Snord116: Sequence (5'-3'): TTC CGA TGA GAG TGG CGG TAC AGA 
 
The probes used to detect Snord116/SNORD116 in N2A, mouse brain, and SH-SY5Y were as follows 
 
Snord116/SNORD116: Sequence (5'-3'): TCA CTC ATT TTG TTC AGC TTT 
 
The Snord115/116 family members were manually aligned (not shown). Both Snord115 and Snord116 dis-
play highest conservation among family members near their 3’ ends. The probes were designed in a way to 
target as many of the family members as possible. 
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5.4.4 RiboMeth-seq 
RiboMeth-seq was previously described in CHAPTER 3. 
 
The following adaptations were made here for the analysis of the RiboMeth-seq data: 
 
To avoid false positives we have applied an angle score threshold of 290 for each of the experiment, as this 
seem to lead to the most accurate identification of rRNA sites (see Chapter 3). Next, for all sites that had an 
angle score above the threshold in at least one experiment, we calculated the average angle score across all 
experiments. Furthermore, to avoid noisy data coming from low expressed targets, we have also calculated 
the local coverage of the putative methylation positions and we used a threshold of at least 5 reads on av-
erage per neighboring nucleotide for a site to be considered in a given experiment. We have assessed the 
threshold for the angle score using the precision-recall (PR) curve and Matthews coefficient on ribosomal 
RNAs (FIGURE 5.15). As can be seen the optimal threshold for the averaged angle score is 290. Overall there 
are 90 known 2’-O-methylation sites listed in the snOPY database and this threshold recovers 70% of the 
known sites. We have decreased this value to 280 which has lower precision (~50%) but substantially higher 
recall (77%). Score C was computed as described in [65] and we used a score threshold of 0.7 to select pu-
tative methylation sites.  
 
 
Figure 5.15 PR curve (A) and Matthews coefficient plot (B) of the angle score. 
 5.4.5 Cell culture and differentiation 
N2A, SH-SY5Y, and N1E-115 samples, cells were grown according to the supplier’s instructions. Thirty 15-cm 
tissue culture plates were used for N2A and SH-SY5Y cells, five 15-cm tissue culture plates were used for 
N1E-115 cells. 
N2A cells were plated at 30-40% confluency and were differentiated in DMEM (Sigma #D5796), 2mM L-
glutamine (#25030024), 0.1% BSA (Sigma #A9418), and no FBS for the first day, the second day with the 
same medium including 20µM all-trans-retinoic acid (Sigma #R2625). After 48 hours of differentiation they 
were crosslinked with UV 254 nm, harvested and snap-frozen for CLIP. 
SH-SY5Y cells were plated at 30-40% differentiated in DMEM with 2mM L-glutamine and, 2% FBS, and 
20µM all-trans-retinoic acid for 48 hours, UV-crosslinked, harvested and snap-frozen. 
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N1E-115 were grown according to the supplier’s instructions. Differentiation of N1E-115 cells for Snord116 
probing was performed as follows: at approx. 50% confluency cells were washed once with prewarmed 
sterile PBS (Gibco #10010023) and the medium was changed to Neurobasal Medium (Gibco #21103-049) 
supplemented with 2mM GlutaMax (Gibco #35050-061). Cells were differentiated for 72 hours. 
N1E-115 were not differentiated for CLIP, they were grown under standard conditions and at 80% conflu-
ency they were UV-crosslinked and snap-frozen for CLIP. 
 5.4.6 Preparation of cerebellar granule cells for CLIP-experiments 5.4.6.1 Tissue dissection 
Mice (C57BL/6JRj) at P5 or P6 were used for the extraction of the neurons (cerebellar granule cells). The 
animal was decapitated, the brain removed and transferred to a 60mm dish with cold HBSS (Gibco #14175). 
HBSS was supplemented with 5ml of 1M Hepes (Gibco #15640-080) to 500 ml of HBSS. The meninges were 
removed from the cerebellum, the cerebellum and brainstem were separated from the mid- and forebrain, 
then the cerebellum was removed from the brainstem. The meninges in the cerebellar folds were removed 
as well as possible. The dissected cerebellum was transferred to a new dish and cut into 10-15 pieces. 
 5.4.6.2 Tissue dissociation 
A sterile, BSA (Sigma #A9418 4% BSA in HHBS)-coated pipette was used to to transfer the tissue pieces to a 
coated 15ml Falcon tube containing 10ml of HBSS on ice. After the tissue pieces settled to the bottom, 
most of the HBSS solution was removed, only enough HBSS was left to cover the cells. 100µl of DNase I 
(Roche #10104159001, grade II from bovine pancreas) at a concentration of 1mg/ml (in DMEM Sigma 
#D5796) and 1ml of 1x Trypsin-EDTA (Gibco #25300-054) (containing 7mM Hepes pH7.25) were added. The 
mixture was incubated for 10-15 minutes at 37°C. Subsequently, the following was added to the dissocia-
tion mixture:  
• 100µl soy bean trypsin inhibitor (Sigma #T6522, type I-S from soybean) 
• 250µl DNase I (1mg/ml in DMEM) 
• 320µl HBSS containing 4 ml/ml BSA 
The mixture was incubated for 1 minute at 37°C, then cooled on ice. The mixture was carefully triturated 
four times with a coated 1ml pipette tip (coated by pipetting 0.1% BSA und and down several times). A 
200µl pipette tip was put on top of the 1ml pipette tip, and undissociated material was further triturated 
approximately 10 times. HBSS was added to a final volume of 10ml. The cell suspension was filtered 
through a 40µm nylon mesh cell filter (BD Flacon #352349) into a 50ml falcon tube. If material from several 
pups was used, the cell suspensions were combined. Cells were centrifuged in 15ml flacons for 10 minutes 
at 250g and 4°C. The supernatant was discarded. The cell pellet was resuspended in 1ml of ice-cold HBSS 
using a coated 1ml pipette. The volume was filled up to 5ml with ice-cold HBSS. The cell suspensions were 
filtered a second time using a 40µm nylon mesh cell filter and the cells were counted. 10cm-Petri dishes 
were filled with 8ml of ice-cold HBSS. 5ml of filtered cell suspension were added per Petri dish. The cell 
suspensions were UV-crosslinked (254nm) 3x0.1J/cm2. Crosslinked cell suspensions were filled into coated 
15 ml polypropylene tubes. The plates were washed with 2ml ice-cold HBSS and remaining cells (after UV-
crosslinking cells tend to attach to the Petri-dish surface) were collected using a rubber cell scraper (BD 
Falcon #353086) and transferred to the 15 ml tube as well. Cells were spun for 10 minutes at 250g and 4°C. 
The supernatant was discarded, the cell pellets were snap-frozen at -80°C until use. 
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For the CLIP experiment that was conducted in primary neurons we extracted cells from 20 animals. The 
cell number was not determined. 
 5.5 Author’s Contributions 
DJJ contributed the most. DJJ, RG, and MZ conceived the project. DJJ co-wrote the introduction and discus-
sion with MZ, DJJ, RG, and MZ cowrote the results part. DJJ performed all experiments with help of HW 
(primary neurons extraction), RG performed all bioinformatic analyses with help of FG (alternatvie splicing 
analysis). BS provided murine brains from PWScrm+/p+ and PWScrm+/p- mice. 
 5.6 Supplementary Figures 
 
 
Supplementary Figure 5.1 Murine neuroblastoma N1E-115 cells (A) undifferentiated at 72 hours and (B) differentiated at 72 hours of differentia-
tion. 
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Chapter 6 Conclusion 
 
In this thesis we have thoroughly characterized snoRNAs and the landscape of snoRNA-mediated 
RNA modifications in several cellular systems as well as in murine brain tissues with various high-
throughput sequencing approaches. 
 
In CHAPTER 2 we have extensively studied snoRNA processing and investigated the potential role of snoR-
NA-derived processing products in post-transcriptional gene silencing. In particular we have shown that 
virtually all C/D box snoRNAs follow a defined processing pattern: in the mature form the C/D box snoRNAs 
retain very sharply defined 5’ and 3’ termini, ending four to five nucleotides upstream of the C box and two 
to five nucleotides downstream of the D box, respectively. This finding suggests that, similar to other small 
RNAs, snoRNAs are trimmed presumably by exonucleases, to boundaries that are determined by the pro-
teins with which these small RNAs are complexed, which is in line with the current understanding of snoR-
NA biogenesis. Furthermore, we have identified several novel snoRNA loci in the human genome including 
C/D box-like snoRNAs that do not exhibit the typical C-D’-C’-D box architecture, but rather lack mostly the 
D’ and C’ boxes. These loci give rise to small RNAs that are bound by the core snoRNPs. Interestingly, some 
C/D box-like snoRNAs are very short, 27-46 nucleotides in length, and we termed them mini-snoRNAs. To 
gain insight into the function of the novel snoRNAs - both highly conserved C/D box as well as H/ACA box 
snoRNAs - that we identified, we sought to determine whether they have canonical targets. Indeed, for 
some of them, we could identify canonical target sites in rRNA and snRNA. We were especially interested to 
find out whether the non-conserved C/D box-like snoRNAs particularly the mini-snoRNAs, could guide 2’-O-
methylation. Although we did identify several putative interaction sites with a computational screen, none 
of these correspond to known modification sites and thus, the targets of these C/D box-like snoRNAs, if 
there are any, remain to be validated. 
Although snoRNAs are best known for guiding modifications of rRNAs and snRNAs, in our snoRNP-PAR-CLIP 
datasets we repeatedly identified several non-coding RNAs including vault RNA1-2, 7SK RNA, and 7SL, that 
are not known to be subject of snoRNA-guided modification. We tested these targets with additional exper-
imental methods, confirming that they carry 2’-O-methylations and pseudouridines. We tried to identify 
C/D box snoRNAs that could guide the observed 2’-O-methylation, but we did not find sequences comple-
mentary to the modification sites. For pseudouridine sites found in 7SK RNA and 7SL RNA we predicted 
potential guiding H/ACA box snoRNAs. Further we identified cross-linked H/ACA box snoRNAs in PAR-CLIP 
experiments conducted with C/D box snoRNP core proteins, and similarly we observed cross-linking of sev-
eral C/D box snoRNAs in the Dyskerin PAR-CLIP. This could be caused by the close spatial arrangement of 
snoRNPs on the target molecule, or could indicate that H/ACA box snoRNAs and C/D box snoRNAs guide 
modifications on each other. Supporting this notion, by primer extension assays we identified several 2’-O-
methylations and pseudouridines in C/D-and H/ACA box snoRNAs. However, a drawback of the primer ex-
tension assay is that stoppages could be caused not only by 2’-O-methylation but can also have other caus-
es. Therefore, the 2’-O-methylations that we identified with this assay need to investigated further. In con-
trast, we can be fairly certain that we identified bona fide pseudouridylation sites. Particularly, in the case 
of the C/D box SNORD35A we were able to identify five putative pseudouridylated residues but no convinc-
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ing guiding sequence in a known H/ACA box snoRNA. This suggests either that even more snoRNAs remain 
to be identified or that these pseudouridylations are caused by a protein-only mechanism not requiring 
guidance by H/ACA box snoRNAs. Taken together, these results indicate that snoRNAs may guide RNA mod-
ifications in a wide spectrum of RNAs that goes beyond the canonical rRNA and snRNA sites. However, 
more work needs to be done to validate this hypothesis. 
Another question that we wanted to answer was whether snoRNA give rise to processing products that 
function as miRNAs in human cells, as this phenomenon was observed in Giardia lamblia [233]. To this end 
we first quantified the abundance of snoRNA-derived small RNAs in HEK293 cells. Consistent with other 
studies [125] we found that these processing products are indeed abundant. However, when we performed 
Ago2-IP-seq experiment we did not find evidence that these sdRNAs efficiently associate with Ago2 to act 
as miRNAs. We thus conclude that a microRNA-like function of snoRNA-derived small RNAs is an exception 
rather than a rule. Although here we did not confirm a general miRNA-like function of sdRNAs in human 
cells (albeit validating the one case that was described in the literature before), it is important to keep in 
mind that snoRNAs can assume alternative roles, as was previously and also most recently demonstrated 
for some C/D box snoRNAs that are involved in the modulation of alternative pre-mRNA splicing [92, 234]. 
This is achieved through direct RNA-RNA interactions without the methylation of the target RNA [234]. In 
the context of the snoRNA-derived small RNAs future work will clarify whether they are mere by-products 
of snoRNA biogenesis or whether they carry out some function in the cell. 
 
In CHAPTER 3 we have combined two recent experimental high-throughput methods (CLIP-seq and Ribo-
Meth-seq) with computational modelling to extensively study and describe C/D box snoRNA-target interac-
tions and 2’-O-methylation transcriptome-wide in human cells. We determined that many snoRNAs that 
were previously considered as orphan indeed guide 2’-O-methylation. Interestingly, they seem to act on 
canonical rRNA and snRNA sites that are targeted by other C/D box snoRNAs. We also observed numerous 
interactions between C/D box snoRNAs and mRNAs in CLIP-seq experiments. Subsequently, we conducted 
RiboMeth-seq experiments to test whether these interactions also result in 2’-O-methylation. Although the 
majority of the canonical 2’-O-Me sites were detected with RiboMeth-seq, the sites that we identified from 
the snoRNA-mRNA chimeras do not seem to undergo 2’O-methylation that is detectable with RiboMeth-
seq. One explanation for this observation is that a low expression of the examined 2’-O-methylated RNA 
could hinder their identification. This could be a problem for the identification of modification sites in tar-
gets that are expressed in a tissue-specific manner, in mRNAs or lncRNAs, whose abundance per cell is 
much lower compared to the rRNAs. Further data that we obtained with the RTL-P approach also suggests 
that at least some of the novel sites of snoRNA-target interaction that emerged from our study are not 
methylated with 100% efficiency. Thus, an increased sensitivity of detection of 2’-O-Me sites may confirm 
the role of newly discovered interactions in 2’-O-ribose methylation. It is also possible that the captured 
snoRNA-mRNA chimera are an artefact of the CLIP protocol, where the guide snoRNA is ligated to an RNA 
without this being functionally relevant. It could however also be that these interactions do occur in vivo 
but do not result in 2’-O-methylation. This possibility does not seem unreasonable in the light of a very 
recent study that identified C/D box snoRNAs with dual functions: 2’-O-methylation and alternative pre-
mRNA splicing [234]. Taken together, the significance of snoRNA expression changes can be studied with 
the techniques we established here. Our approach would be particularly interesting to apply to study the 
role of C/D box snoRNAs in development, across cell types or tissues, or in health/disease contexts where 
snoRNAs are deregulated. 
In a broader sense, it is fascinating to see how the task of identifying 2’-O-methylations and the assignment 
of their snoRNA guides, once a very tedious endeavor that involved lengthy gene-by-gene analyses, has 
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now been dramatically facilitated by high-throughput technologies. Although identified sites still need to be 
validated in low-throughput, e.g. by reverse transcription-based methods or by mass spectrometry, de novo 
identification of 2’-O-Me’s and their guide RNAs has been significantly simplified. 
Notably, other RNA modifications such as pseudouridines or N6-methyladenosines can now also be studied 
in high-throughput. Advancements of high-throughput sequencing protocols will further stimulate research 
in the relatively young field of epitranscriptomics. CHAPTER 4 illustrates how we developed a high-
throughput method (RiM-seq) to validate 2’-O-methylations. It can be considered as an alternative inde-
pendent validation method, since all three approaches (CLIP-seq, RiboMeth-seq, and RiM-seq) are based on 
different biochemical principles. 
 
In CHAPTER 5 we have extensively studied the orphan SNORD116 which are implicated in a rare neurode-
velopmental disorder called Prader-Willi syndrome. Previously it was reported that in pluripotent cells, sno-
lncRNA emerging from the PWS locus associate with the RBFOX2 splicing regulator, thereby regulating 
splicing of RBFOX2-targets. We did not observe a change in splicing in Rbfox2-regulated targets in brains 
obtained from wild-type (wt) and PWScrm+/p− mice that do not express Snord116 and decided to evaluate 
the canonical functions of the PWS-associated SNORD116. Because SNORD116 snoRNAs have most of the 
features of a genuine C/D box snoRNA we re-considered the question whether they have a snoRNP guide 
function in 2’-O-methylation. As previously reported [93], we have shown in snoRNP-CLIP experiments that 
SNORD116 snoRNAs associate with the snoRNP core proteins. We also observed, that SNORD116 associa-
tion with Fibrillarin is more pronounced in human neuronal cell lines when compared with neuronal cell 
lines of murine origin. Interestingly SNORD115, also a snoRNA with C/D box architecture that was initially 
thought to be one of the key players in PWS, was not captured extensively in our snoRNP-CLIP experiments. 
In spite of their association with core snoRNPs, neither RiboMeth-seq nor analysis of guide RNA-target hy-
brids from CLIP-seq experiments revealed convincing sites of 2’O-methylation guided by SNORD116. Never-
theless analysis of the 2’-O-methylation landscape in brains of wt mice and PWScrm+/p− mice with RiboMeth-
seq revealed reproducible differences in some transcripts. One of these corresponds to the cholecystokinin 
triacontatriapeptide (Cck), a hormone that mediates satiety after food intake. We are currently validating 
these candidate target sites with mass spectrometry and RTL-P in both wt and knock-out conditions. 
Additionally we have identified 15 new 2’-O-Me’s in both 18S and 28S rRNA, guided by canonical snoRNA 
guides, that were supported by both CLIP-seq and RiboMeth-seq. Hence we expand here the mouse snoR-
NA atlas by providing new sites of 2’-O-methylation. 
It is plausible that SNORD116 also interacts with other proteins than the core snoRNP proteins. To identify 
further potential protein binding partners of SNORD116, snythetic oligonucleotides that are coupled to 
biotin at their 5’ or 3’ ends to facilitate their purification on streptavidin-coupled beads can be used. The 
immobilized synthetic oligonucleotides then can be incubated with cellular extracts and protein(s) bound 
on the oligos could be then identified by mass spectrometry. To confirm that these interactions occur in 
vivo, the identified proteins can be co-immunoprecipitated from tissue/cell line lysate and the bound RNA 
is isolated and analyzed by northern blot or qPCR. 
An alternative approach to CLIP-seq that can reveal direct guide RNA-target RNA interactions is to use syn-
thetic RNA oligonucleotides corresponding to SNORD116 that are conjugated with psoralen and biotin at 
various positions within the oligonucleotide. Psoralen has been previously efficiently used to induce cova-
lent bonds between RNA hybrids [235]. Such chemically conjugated oligos can be transfected in neuron-
derived cell lines, e.g. SH-SY5Y cells. Upon UV exposure specific adducts between the SNORD116-mimic and 
their target RNAs are formed. These cross-linked hybrids are purified on streptavidin beads and RNA isolat-
ed using standard a Trizol protocol. Target RNA thus obtained is initially fragmented to facilitate sequenc-
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ing. Sequence reads obtained are mapped to the genome and computational tools can be used to deter-
mine the exact binding site of the snoRNA to its target. This approach may be able to reveal RNA targets of 
SNORD116 without a prior assumption about the ribonucleoprotein complex that is involved. However, 
experience with this approach applied to miRNAs indicates that a double purification, which requires 
knowledge of the proteins in the complex, is much more efficient for target enrichment. This may be espe-
cially important if the small RNA has a small number of targets, as would be expected for SNORD116. 
Upon discovery of an RNA target(s) their biological relevance will have to be confirmed. Therefore, several 
functional assays will clarify the consequence of the snoRNA interaction with its target, namely, whether 
upon binding of the snoRNA the target undergoes modification or cleavage or whether snoRNAs simply act 
as chaperones in assisting proper folding of their target RNAs. Similarly, if the target is an mRNA it is curcial 
to determine whether SNORD116 affects the translation rate of its target. Depending on the nature of the 
target RNA it is likely that diverse experimental strategies will have to be pursued. It is important to realize 
that not all C/D box snoRNA necessarily are involved in RNA nucleotide modification. For instance, U3 
snoRNA, which is a C/D box snoRNA that localizes to the nucleolus [93, 107], is involved in rRNA processing. 
It has been suggested that snoRNAs may act like chaperones to assist folding of target RNA and hence facili-
tate RNA processing [236]. 
Recent novel findings have highlighted the role of IPW116 in the PWS disorder [218]. IPW116 is a lncRNA 
hosting in its intron the SNORD116 snoRNA genes. IPW116 was shown to regulate the expression of an 
imprinted locus distinct from the PWS region. Interestingly, aberrant expression from that locus results in a 
disorder with a PWS-like phenotype [237, 238]. Since in most PWS patients the loss of SNORD116 expres-
sion is also accompanied by a loss of IPW116 expression, it will be important to decouple IPW116 and 
SNORD116 contributions to PWS development to fully understand this disorder. 
Overall, deciphering of the molecular mechanisms behind the SNORD116 function has potentially many 
implications. The gained experimental data would be critical in training predictive models to identify non-
canonical snoRNA-target interactions, because only a handful of non-canonical targets, insufficient to de-
rive general computational models, are available today. Uncovering unconventional targets would enable 
one to estimate to what extent snoRNAs participate in cellular networks that regulate gene expression and 
would therefore provide novel insights into snoRNA-mediated gene regulation. Most importantly, identifi-
cation of targets of the snoRNAs implicated in PWS would mean a major advancement towards the devel-
opment of a suitable treatment. 
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